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Abstract 
- Regioselective Synthesis of 3-Hydroxy-4,5-alkyl-substituted Pyridines Using 
1,3-Enynes as Alkynes Surrogates. 
The regioselectivity of alkyne insertion in metal-catalysed cycloadditions  is 
usually poor when the two alkyne substituents are alkyl groups, and mixtures of 
inseparable isomers are normally obtained.1 In order to circumvent such a drawback, 
Fagnou’s group used 1,3-enynes to control the regioselectivity of the insertion in 
Rh(III)-catalysed C–H functionalisation reactions applied to the synthesis of indoles.2 
In this work, we applied the same principle to the regioselective synthesis of pyridines 
by nickel-catalysed (4+2) cycloaddition with azetidinones. Thus, we showed that each 
of the regioisomers of 3-hydroxy-4,5-bisalkyl pyridines could be obtained by using 
1,3-enynes, instead of simple alkynes, after classical functional group manipulations.3 
After further functionalisation this methodology enables an easy access to highly 
functionalised pyridinols that are important building blocks in medicinal chemistry 
research. 
 
- Cross-coupling of α-Carbonyl Sulfoxonium Ylides with C–H Bonds. 
Since Corey’s first report, sulfoxonium ylides have become important reagents 
in organic chemistry.4 However, their potential to be used as carbene precursors in C–
H functionalisation reactions remained unexplored, in stark contrast to diazo 
compounds. We have now established a Rh(III)-catalysed protocol that is applicable 
 
1 K. Y. T. Ho, C. Aïssa, Chem. Eur. J., 2012, 18, 3486. 
2 D. R. Stuart, M. Bertrand-Laperle, K. M. N. Burgess, K. Fagnou, J. Am. Chem. Soc., 2008, 130, 16474. 
3 M. Barday, K. Y. T. Ho, C. T. Halsall, C. Aïssa, Org. Lett., 2016, 16, 8. 
4 E. J. Corey, M. Chaykovsky, J. Am. Chem. Soc., 1965, 87, 1353. 
VI 
 
to sp2-hybridised C–H bonds and seven directing groups.5 Moreover, we discovered 
that quinolines can be converted into benz[c]acridines in a hitherto unprecedented Ir-
catalysed dehydrative cyclisation. Finally, deuterium labelling experiments suggest 
that the proto-demetalation is the rate determining step in the catalytic cycle. 
 
  
 
5 M. Barday, C. Janot, N. R. Halcovitch, J. Muir, C. Aïssa, Angew. Chem. Int. Ed., 2017, 56, 13117. 
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Abbreviation 
- Ad: Adamantyl 
- APT: Attached proton test 
- aq.: Aqueous 
- Atm.: Atmosphere 
- BHT: Butylated 
hydroxytoluene 
- BINAP: 2,2′-
Bis(diphenylphosphino)-1,1′-
binaphthyl 
- BINOL: 1,1′-Bi-2-naphthol 
- Boc: Tert-butoxy carbonyl 
- br.: Broad 
- Calcd: Calculated 
- cAMP: Cyclic adenosine 
monophosphate 
- Cbz: Carboxybenzyl 
- CI: Chemical ionization 
- CMD: Concerted 
metallation/deprotonation 
- CNT: Carbon nanotubes 
- cod: 1,5-Cyclooctadiene 
- coe: Cyclooctene 
- conc.: Concentrated 
- Conv.: Conversion 
- cp*: 1,2,3,4,5-
Pentamethylcyclopentadiene 
- cp: Cyclopentadienyl 
- CYP17: 17α-Hydroxylase-
17,20-lyase 
- CYP11B2: Aldosterone 
synthase 
- d (NMR): Doublet 
- dba: Dibenzylideneacetone 
- 1,2-DCB: 1,2-Dichlorobenzene 
- 1,2-DCE: 1,2-Dichloroethane 
- DCM: Dichloromethane 
- DBU: 1,8-
Diazabicyclo[5.4.0]undec-7-
ene 
- DCC: N,N'-
Dicyclohexylcarbodiimide 
- DDQ: 2,3-Dichloro-5,6-
dicyano-1,4-benzoquinone 
- DFT: Density functional theory 
- DG: Directing group 
- DMF: Dimethylformamide 
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- dppb: 1,4-
Bis(diphenylphosphino)butane 
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Bis(diphenylphosphino)propan
-e 
- d.r.: Diastereomeric ratio 
- e: Even 
- e.e.: Enantiomeric excess 
- equiv.: Equivalent 
- e.r.: Enantiomeric ratio 
- ESI: Electrospray ionization 
- FT-IR: Fourier-transform 
infrared spectroscopy 
- HBQ: 10-
hydrobenzo[h]quinoline 
- HFIP: Hexafluoroisopropanol 
- HMBC: Heteronuclear 
multiple-bond correlation 
- HRMS: High-Resolution Mass 
Spectrometry 
- IMes: 1,3-Dimesitylimidazol-
2-ylidene 
- IPr: 1,3-Bis(2,6-
diisopropylphenyl)-1,3-
dihydro-2H-imidazol-2-ylidene 
- J: Coupling constant 
- KIE: Kinetic Isotope Effect 
- LDA: Lithium 
diisopropylamide 
- LSD1: Lysine specific 
demethylase 1 
- m (IR): Medium 
- m (NMR): Multiplet 
- maj: Major 
- m-CPBA: Meta-
chloroperoxybenzoic acid 
- MetAps: Methionine 
aminopeptidase 
- min: Minor 
- MOM: Methoxymethyl ether 
- m.p.: Melting pot 
- MS: Molecular sieve 
- N/A: Non-applicable 
- nbd: Norbornadiene 
- NHC: N-heterocyclic carbene 
- NMR: Nuclear Magnetic 
Resonance 
IX 
 
- NOE: Nuclear Overhauser 
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- o/n: overnight 
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- p-TSA: P-toluenesulfonic acid 
- q (NMR): Quartet 
- quant.: Quantitative 
- quint. (NMR): Quintet 
- RCM: Ring-closing metathesis 
- ROS: Reactive oxygen species 
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- r.t.: Room temperature 
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- s (NMR): Singlet 
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Experimental and analysis 
statement 
 
 
Unless otherwise noted, all reactions were carried out in flame-dried glassware 
under a dry nitrogen atmosphere. THF was used after passage through Innovative 
Technology PureSolv MD system. HFIP was purchased from Fluorochem. Dry 
toluene and 1,4-dioxane were purchased from Acros. 
 Flash chromatography: Merck silica gel 60 (230-400 mesh). NMR: Spectra 
were recorded on a Bruker DRX 500 in CDCl3; chemical shifts (δ) are given in ppm. 
The solvent signals were used as references and the chemical shifts converted to the 
TMS scale (CDCl3: δC = 77.0 ppm; residual CHCl3 in CDCl3: δH = 7.26 ppm; residual 
H2O in D2O: 4.79 ppm); apparent splitting patterns are designated using the following 
abbreviations: s (singlet), d (doublet), t (triplet), q (quartet), quint. (quintuplet), sext 
(sextuplet), sept. (septuplet), m (multiplet), br (broad), and the appropriate 
combinations. In 13C NMR, an APT sequence was used to separate methylene groups 
and quaternary carbons (e, even) from methine and methyl groups (o, odd). IR: 
PerkinElmer Spectrum 100 FT-IR spectrometer, wavenumbers in cm-1. HRMS: 
determined at the University of Liverpool on micromass LCT mass spectrometer (ES+) 
and Trio-1000 or Agilent QTOF 7200 mass spectrometers (CI). Melting points: Griffin 
melting point apparatus (not corrected). Elemental analyses: University of Liverpool. 
All commercially available compounds were used as received. 
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Foreword 
  
 
 
 
Transition-metal catalysed reactions have enabled an enormous step-forward 
in synthesis, especially in the building of complex frameworks. The activation of inert 
bonds such as C–H or C–C remains the preferred goal due to the high reward that it 
can bring. 
In this thesis will be presented two complementary projects converging to the 
same goal, namely the synthesis of valuable heterocycles. The first chapter will be 
dedicated to the development of a nickel-catalysed C–C bond activation with 
conjugated 1,3-enyne to access the 3-pyridinol framework. While the second part will 
focus on the rhodium-catalysed C–H bond activation and cross-coupling with 
sulfoxonium ylides, which allowed the functionalisation of heterocycles and further 
transformation to benz[c]acridines. 
Due to the gap between those two fields of organic chemistry, it was preferred 
to present the two projects in separate sections in order to enable a deeper introduction 
and a better emphasis of each topic. 
 
 
 
 
  
  
 
 
 
 
 
 
Regioselective synthesis of  
3-hydroxy-4,5-bis-alkyl pyridines 
using 1,3-enynes as alkyne 
surrogates  
2 
 
1 Introduction 
3-pyridinols can be found in a variety of highly interesting biologically active 
natural compounds, with the most abundant being isoforms of vitamin B6 (Figure 1). 
1, 2 Vitamin B6 is composed of six different interconvertible forms of 3-pyridinols. It 
has been reported as co-factors in a wide variety of reactions, including α/β/γ 
elimination/replacement, racemisation, transamination, and decarboxylation of amino-
acids.3, 4 Moreover, studies revealed that vitamin B6 could decrease the risks of 
cardiovascular diseases.5 When linked to either cyclodextrins or dendrimers, these 
compounds were able to mimic the role of enzymes in the racemisation of chiral α-
amino acids or decarboxylation of carboxylic acids.6, 7 
 
Figure 1 : Vitamin B6 forms 
 
 The worldwide production of pyridoxine, one of the main forms of vitamin B6, 
was estimated to be more than 2550 tonnes in 1993, showing how important this 
industry is in the current economy.8 The main producers of pyridoxine are Roche 
(Switzerland), Takeda and Daiichi (Japan). 
 Due to the interesting biological properties exhibited by vitamin B6, several 
groups have reported the incorporation of a 3-pyridinol moiety in small molecules and 
have shown a wide range of biological properties.   
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2 Biological properties 
2.1 Anti-oxidant properties 
3-pyridinols are best known for their anti-oxidant properties. As compared to 
the phenolic counterpart, 3-pyridinols exhibit a greater air-stability due to the extra 
nitrogen atom embedded into the ring.9 
They can be employed as radical scavengers, thus limiting the impact of 
Reactive Oxygen Species (ROS) within organisms.10, 11 Substitution of the methyl 
group in pyridoxine by an alkyl-telluro group increased the potency of compound 1 as 
a chain breaking anti-oxidant (Figure 2). Those derivatives were able to inhibit the 
peroxidation of linoleic acid in in vitro trials better than α-Tocopherol 2, a classical 
anti-oxidant.12  
 
Figure 2: Chain breaking anti-oxidants 
 
The same properties have been used to inhibit the 4-hydroxynonenal-induced 
cell death in adult retinal pigment epithelium (RPE), which is the major cause of 
irreversible vision loss.13, 14 4-hydroxynonenal is generated in the retinal pigment 
epithelium upon reaction with ROS, and is responsible for the degeneration of the 
RPE. The pyridinol 3 has proven potent in the inhibition of the production of 4-
4 
 
hydroxinonenal, thus preventing the degeneration of RPE and the irreversible vision 
loss (Figure 3).15 
ROS are also responsible for the decline of mitochondria in organisms, causing 
the development of degenerative diseases. Pyridinols 4a and 4b have been employed 
as radical scavengers and have shown great biological activity, along with metabolic 
stability.16 
 
Figure 3: Structures of RPE and mitochondria protectors  
 
2.2 Antiangiogenic activity 
Angiogenesis is the biological process responsible for the creation of new 
blood vessels.17 When out of control, this phenomenon is the cause of both the growth 
and spreading of tumoral cells. The angiogenesis in cancer cells is often triggered by 
a protein called vascular endothelial growth factor (VEGF).18 Jeong and co-workers 
have shown that the angiogenesis can be controlled by targeting the production of 
VEGF. The same authors also reported three generations of 3-pyridinols, 5, 6 and 7, 
capable of inhibiting VEGF induced angiogenesis with the same efficiency as the 
licensed drug Sunitinib 8 (Figure 4).19, 20, 21 
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Figure 4: Structures of functionalised 3-pyridinols, Sunitinib and their inhibition levels of VEGF 
 
2.3 Enzyme inhibitors 
Methionine aminopeptidase (MetAps) is a cobalt-containing enzyme found in 
several bacterial pathogens which are responsible for severe diseases such as 
tuberculosis, urinary- and respiratory-tract infection, pneumonia or ulcers.22 MetAps 
are key to the viability of the bacteria and are therefore a great target for the treatment 
of the associated diseases. Nan et al. have shown that the 3-pyridinol derivative 9 had 
good inhibition properties over MetAps (Figure 5).23 
A similar approach was taken for the inhibition of CYP17 and CYP11B2.24, 25 
The former enzyme is responsible for the production of androgens leading to prostate 
cancer. Abiraterone has been shown to be a CYP17 inhibitor, however, this 
unfortunately led to an increase of cardiovascular risks due to the high concentration 
of aldosterone generated by the resulting increase of the enzyme CYP11B2. Hartmann 
and his group developed the 3-pyridinol 10 and showed that this small molecule could 
inhibit both enzymes, limiting the proliferation of prostate cancer and reducing the 
associated cardiovascular risks.26 
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Type 4 phosphodiesterase (PDE4) has been shown to be involved in asthma by 
hydrolysing cAMP.27 Daxas 12, a licensed drug produced by AstraZeneca, has proven 
to be efficient in the inhibition of this enzyme but side effects are often encountered. 
Sumiyoshi et al. have reported the use of compound 11 as a PDE4 inhibitor without 
undesired side effects.28 
Finally, Song and co-worker have shown that the functionalised 3-pyridinol 
ether 13 had a great activity over LSD1, an enzyme responsible for the de-methylation 
of histones and the propagation of prostate and breast cancers.29, 30 
 
Figure 5: Structures of 3-pyridinols and their biological properties 
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3 Synthesis of 3-pyridinols 
Although highly interesting in terms of its biological properties, methodologies 
for the synthesis of functionalised 3-pyridinols are limited in numbers. Below are 
presented the major works published to access the 3-pyridinol framework.   
3.1 [4+2] Diels-Alder reaction 
Harris et al. reported a pioneering work for the synthesis of 3-pyridinol through 
a Diels-Alder reaction involving the 1,3-oxazole 14 and the electron-poor alkene 15 
(Figure 6).31 An acid-promoted rearrangement of the cycloadduct 16 afforded the 3-
pyridinol 17 in good yield. Unfortunately, only symmetrical alkenes were tolerated in 
this reaction, preventing the access to substituted pyridinols with multiple functional 
groups. 
  
Figure 6 : Harris' Diels-Alder reaction 
 
Importantly, this strategy led to the current synthesis used for the production 
of pyridoxine. The latest improved process was reported by Su and co-workers in 
which they obtained the pyridoxine in 56% over six steps (Figure 7).32 Firstly, the 
authors converted the alanine 18 to the alaninate 19 in excellent yield using oxalyl 
acid. This intermediate was transformed to the key-intermediate 20 in excellent yield 
upon cyclisation. Finally, the [4+2] Diels-Alder reaction with 21 followed by the acid-
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promoted deprotection/re-aromatisation of the intermediate afforded the pyridoxine 
hydrochloride in excellent yield.   
 
Figure 7: Synthesis of pyridoxine 
 
Renard’s group revisited this chemistry and synthesised highly-functionalised 
3-pyridinols (Figure 8).33,34,35,36 By starting from the fully functionalised oxazole 22, 
the corresponding cycloadduct 23 was obtained in good yield. The reaction was either 
catalysed by neodymium triflate or microwave-assisted. Moreover, the authors showed 
that the reaction was not limited to bis-esteralkenes and the tri-substituted pyridinol 26 
was obtained in low yield with acrylic acid 25. 
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Figure 8: Renard’s synthesis of functionalised 3-pyridinols 
 
It is worth mentioning that in all cases only electron-poor alkenes were used, 
limiting the application of this methodology. 
Finally, Arndt and co-workers reported a hetero-Diels-Alder reaction to 
synthesise 3-pyridinols. By using the highly functionalised diene 28, they were able to 
obtain the tetra-substituted pyridinol 29 in good yield, in addition to the alternate 
regioisomer 30 (Figure 9).37,38 This methodology was applied to the synthesis of 32 
which is an important building block in the synthesis of the antibiotic nosiheptide 33.  
10 
 
 
Figure 9: Arndt methodology to 3-pyridinols 
 
3.2 Synthesis of 4,5-substituted 3-pyridinols 
However, most functionalised 3-pyridinols with interesting biological activites 
were synthesised from the pyridoxine hydrochloride (Figure 10). Hecht and co-
workers reported the transformation of the pyridoxine into the iodinate 3-pyridinol 34 
in four steps with a moderate overall yield. The authors accessed the intermediate 36 
in good yield through a Buchwald-Hartwig reaction with the azetidine 35. The 
alkylation of 36 led to the two isomers 4a and 4b in moderate to low yield.  
11 
 
 
Figure 10: Synthesis of functionalised 3-pyridinol 
 
3.3 Aldol condensation 
Allevi’s group developed an intramolecular aldol condensation to obtain 4,5-
substituted 3-dihydropyridinones (Figure 11).39 Starting from the diketone 37, an aldol 
condensation followed by a crotonisation gave the 3-dihydropyridinone 38, which 
could undergo re-aromatisation under basic conditions to form the pyridinium 39. This 
method was also applied to the synthesis of pyridiniums bearing only alkyl chains, but 
with limited scope. 
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Figure 11: Allevi's route to pyridinium salts 
  
3.4 Intramolecular electronic cyclisation 
Fedorov et al. reported the rearrangement of a highly functionalised allene into 
the protected 3-pyridinol 43 (Figure 12).40 A 1,5-hydrogen shift from the allene 40 led 
to the intermediate 41 which underwent a 6-π electron cyclisation to yield 42. 
Elimination of methanol gave the protected pyridinol in excellent yield. However, 
harsh conditions were required to generate the desired pyridinol, preventing the 
general application of this method to structures bearing sensitive functional groups. 
 
Figure 12: Fedorov's 1,5-hydrogen shift of allenes 
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3.5 Ring-closing metathesis 
Recently, Yoshida and Donohoe independently reported similar methods to 
synthesise pyridinols (Figure 13).41, 42 Both strategies relied on a ring-closing 
metathesis (RCM). Yoshida reported the direct cyclisation of the α-amino ketone 44 
to afford the 3-dihydropyridinone 45, which eventually was transformed into the 
pyridinol 46 upon re-aromatisation. To improve the yield of the RCM, Donohoe added 
an extra double bond to the substrate 47, which was able to act as a relay during the 
cyclisation. Deprotection of the amine with DBU then led to the formation of 49 in 
good yield.  
 
Figure 13 : Yoshida's and Donohoe's Ring Closing Metathesis 
 
3.6 Palladium catalysed cyclisation 
In 2011, Tong’s group managed to synthesise pyridinol derivatives by applying 
an amino Heck reaction with oximes through a palladium (0) catalysis (Figure 14).43 
The cyclisation of 50 occurred to afford the six membered conjugated oxime 51, which 
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was converted to 52 via an acid-promoted hydrolysis of the oxime group followed by 
a base-induced deprotection of the amine and concomitant re-aromatisation. 
 
Figure 14 : Tong's Heck reaction 
 
3.7 Nickel-catalysed (4+2) cycloaddition 
The previous three examples highlight that catalytic cyclisation can be a 
powerful tool in the synthesis of highly substituted pyridinols. However, an extensive 
work is required to access the desired precursor of either mode of cyclisation, and this 
is particularly true for the synthesis of 3-pyridinols with varied substituents in positions 
4 and 5. 
In 2012, Aïssa’s group addressed this issue by reporting a rapid synthesis of 3-
pyridinols by the nickel catalysed (4+2) cycloaddition of alkynes with azetidinones 
(Figure 15).44 They were able to isolate 56 in good overall yield in only three synthetic 
steps from the commercially available azetidinone 53. The desired pyridinol 56 was 
obtained after the deprotection and oxidative re-aromatisation of 55, in a one-pot 
sequence. 
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Figure 15 : Aïssa's route to functionalised 3-pyridinol 
 
The substitution pattern on the final 3-pyridinol ring can be easily altered 
through this method by changing the alkyne, which appears more convenient than the 
synthesis of more complex precursors such as 44, 47 or 50. 
The field of metal-catalysed C ̶ C bond activation of four-membered rings, as 
exemplified in Figure 15, has been extensively studied and has proven useful for the 
rapid access to carbocycles and heterocycles via the insertion of unsaturated moieties. 
A brief review of this area is presented in the next section. 
4 Metal-catalysed (4+2) cycloadditions 
4.1 Cyclobutanones 
4.1.1 Nickel-catalysed (4+2) cycloaddition 
4.1.1.1 Alkynes 
Murakami’s group reported the first nickel-catalysed (4+2) cycloaddition of 
cyclobutanones with alkynes (Figure 16).45 Various alkynes were tolerated with good 
to excellent yields when symmetrical substrates were used. The catalyst loading had 
to be increased to 20 mol% in order to obtain acceptable yields in the case of the 
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diethylcyclobutanone 59. However, when using unsymmetrical alkynes, the authors 
reported a significant decrease in terms of yield along with the formation of two 
regioisomers. The problem arising from the lack of regioselectivity when dealing with 
unsymmetrical alkynes will be presented in depth later in this chapter. Nonetheless, 
this research group investigated the influence of both steric and electronic effects on 
the regioselectivity of the insertion. Steric hindrance was deemed to play an important 
role in the observed regioselectivity, as indicated by the preferential formation of 60. 
However, they did not see a significant electronic effect of either electron-withdrawing 
or -donating groups present on the benzene ring, as shown with 61 and 62.  
 
Figure 16 : Nickel-catalysed (4+2) cycloaddition of alkynes with bis-subsituted cyclobutanone 
 
When the (4+2) cycloaddition was attempted on the substrate 63, a mixture of 
the desired cycloadduct 65 and the linear ketone 66 was obtained (Figure 17). 
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However, changing the ligand from a phosphine to an N-heterocyclic carbene (NHC) 
led to the selective formation of the desired cycloadduct 65. 
 
Figure 17: Nickel-catalysed (4+2) cycloaddition of alkynes with mono-subsituted cyclobutanone 
 
 The insertion of bisalkynes was also described by Murakami and his group. 
Thus, the bicyclic product 69 could be synthesised from the gem-disubstituted 
cyclobutanone 67 in excellent yield (Figure 18).46 
 
Figure 18: Nickel-catalysed (4+2+2) cycloaddition of diynes with di-subsituted cyclobutanone 
 
4.1.1.2 Alkenes 
Murakami’s group has also reported the use of alkenes as cycloaddition 
partners. Although the intermolecular nickel catalysed (4+2) insertion of olefins in 
cyclobutanone failed regardless of the condition used, they were able to develop the 
intramolecular variant (Figure 19).47 By mixing the functionalised cyclobutanone 70 
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with the nickel catalyst in toluene, they could obtain the corresponding bicyclic ketone 
71 in 90% yield. 
 
Figure 19: Intramolecular nickel-catalysed (4+2) cycloaddition of alkene with cyclobutanone 
 
The authors expanded this reaction to the synthesis of enantio-enriched 
bicyclic ketones (Figure 20).48 Using the phosphoramidite 73 as a ligand, the authors 
obtained the cycloadduct 74 in excellent yield and enantiomeric excess. 
 
Figure 20: Asymmetric intramolecular nickel-catalysed (4+2) cycloaddition of alkene with cyclobutanone 
 
4.1.2 Rhodium-catalysed (4+2) insertion 
4.1.2.1 Alkenes 
Prior to their work on the nickel catalysed cycloaddition of olefins with 
cyclobutanones, Murakami’s group studied this reaction using a rhodium catalyst 
(Figure 21).49 This cycloaddition was efficient with both electron-donating and 
electron-withdrawing substituents, although slightly faster with the latter.  
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Figure 21 : Intramolecular rhodium-catalysed (4+2) cycloaddition of alkene with cyclobutanone 
 
Interestingly, they showed that the outcome of the reaction was catalyst 
dependent. Two different mechanisms were invoked to explain the differences 
between the rhodium and nickel catalysis (Figure 22). The coordination of the nickel 
centre to the olefin and the carbonyl gives intermediate A, which is converted to B 
after an oxidative cyclisation. The bicyclo[2.2.2]octanone 71 is released upon β-carbon 
elimination to the intermediate C, followed by a reductive elimination of the nickel 
catalyst. With a rhodium catalyst, the direct oxidative C ̶ C bond cleavage can occur 
to give E from the coordinated compex D. Intermediate F is obtained after insertion of 
the olefin into the pentarhodacycle. Reductive elimination re-generates the active 
catalyst and releases the bicyclo[3.2.1]octanone 75. 
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Figure 22: Mechanisms of the intramolecular nickel- and rhodium-catalysed (4+2) cycloaddition of alkenes 
with cyclobutanone  
 
The authors could also access eight-membered rings in an efficient manner by 
changing the position of the aryl group bearing the olefin (Figure 23).50 The two 
regioisomers 77 and 78 were produced during the process and were hydrogenated to 
give the bicyclic compounds 79 in almost quantitative yield. 
 
Figure 23: Intramolecular rhodium-catalysed (4+2) cycloaddition of alkene with 2-substituted 
cyclobutanone 
 
In 2014, Cramer and co-workers reported the asymmetric version of this 
rhodium-catalysed alkene insertion (Figure 24).51 Using the chiral bis-phosphine 
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ligand 81, the authors were able to obtain the bicyclic ketone 82 in excellent yield and 
enantiomeric ratio. The enantiomeric differentiation occured during the oxidative 
addition of the rhodium catalyst into the cyclobutanone 80. 
 
Figure 24: Asymmetric intramolecular rhodium-catalysed (4+2) cycloaddition of alkene with 
cyclobutanone 
 
In 2000, Wender et al. reported that dienes could undergo an intramolecular 
(4+2+2) cycloaddition to yield bicyclic cyclooctaenes (Figure 25).52 Remarkably, they 
were able to obtain most of their cycloadducts as single diastereoisomers. They 
reported that either the N-tosyl 83, or the ether linker 85 were tolerated. Moreover, a 
methyl substituent on the olefin led to 84 in a decreased yield, but with no reduction 
of the observed diastereoselectivity. 
 
Figure 25 : Intramolecular rhodium-catalysed (4+2+2) cycloaddition of dienes with cyclobutanone 
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 However, a common drawback of those rhodium-catalysed cycloaddition 
reactions is the competition between the (4+2) insertion and the decarbonylative 
pathway.53 Dong and co-workers addressed this issue by developing a catalytic system 
involving the in situ conversion of the cyclobutanone 86 into an imine with the amino-
pyridine additive 87. The bridged bicyclic ketone 88 was isolated in excellent yield 
upon intramolecular cycloaddition of the olefin and hydrolysis of the transient imine 
(Figure 26).54 Moreover, they showed that the reaction did not occur without the 
amino-pyridine additive, and instead a mixture of decarbonylated products was 
obtained. The asymmetric version of this reaction was reported to proceed in low yield 
with low enantiomeric excess. 
 
Figure 26: Intramolecular rhodium-catalysed (4+2) cycloaddition of alkene with activated cyclobutanone 
 
Shortly after this report, the same authors took advantage of the 
decarbonylation pathway to produce eight-membered bicyclic compounds (Figure 
27).55 By changing to another rhodium pre-catalyst with XPhos, they could isolate the 
bridged eight-membered ring 89 in average yield. Interestingly, the cyclobutanone 70 
gave only the decarbonylated cycloadduct 90, as opposed to Murakami’s and Cramer’s 
reports. 
23 
 
 
Figure 27: Intramolecular decarbonylative rhodium-catalysed (4+2) cycloaddition of alkene with 
cyclobutanone/comparison with previous work 
 
4.1.2.2 Allenes 
Whilst working on the rhodium-catalysed (4+2+2) cycloaddition of dienes, 
Wender and co-workers also applied this methodology to more challenging substrates 
such as allenes. For example, 92 could be obtained as the major diastereoisomer, in 
91% yield from 91 (Figure 28).52 
 
Figure 28 : Intramolecular rhodium-catalysed (4+2+2) cycloaddition of allene with cyclobutanone  
 
 In 2015, Dong’s group reported that allenes could behave as a vinyl carbenoid 
and undergo a rhodium-catalysed (4+1) cycloaddition, as opposed to Wender’s (4+2) 
cycloaddition (Figure 29).56 By treating the tri-substituted allene 93, the authors could 
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isolate the corresponding bridged bicyclo[3.2.1]nonanone ±94 in good yield. They also 
showed that the asymmetric version of this reaction could occur in excellent 
enantiomeric excess with the chiral phosphoramidite ligand 95. 
 
Figure 29: Intramolecular rhodium-catalysed (4+1) cycloaddition of allenes with cyclobutanone 
 
4.1.3 Palladium-catalysed (4+4) cycloaddition 
In 2014, Murakami and his group reported the use of a palladium catalyst for 
the cycloaddition of cyclobutanones bearing a silacyclobutane group (Figure 30).57 
Through C ̶ C and C ̶ Si bond cleavages, they could obtain the silabicyclo[5.2.1]decane 
97 in excellent yield and diastereoselectivity. Moreover, the authors showed that the 
outcome of the reaction was ligand dependent as they could completely switch to the 
synthesis of the aldehyde 98 by using a less bulky phosphine. 
25 
 
 
Figure 30: Intramolecular palladium-catalysed (4+4) cycloaddition of silacyclobutane with 
cyclobutanone/ring opening of the cyclobutanone 
 
4.2 Cyclobutenone 
4.2.1 Nickel-catalysed (4+2) cycloaddition 
As compared to cyclobutanones, the strain-energy of cyclobutenones is greatly 
increased because of the addition of an endocyclic double bond (31-34 kcal.mol-1 as 
compared to 26 kcal.mol-1 in cyclobutanones), explaining why most cycloaddition 
reactions must be executed at low temperature.58  
Liebeskind et al. reported the (4+2) cycloaddition of alkynes with 
cyclobutenones to obtain functionalised phenols (Figure 31).59 It is interesting that a 
phosphine ligand was not required to catalyse the reaction. Instead, it is believed that 
due to its nucleophilic character, a phosphine would inhibit the reaction by direct attack 
and opening of the cyclobutenone in an uncontrolled fashion.60 Moreover, two 
additions of the nickel catalyst were required to drive the reaction to full conversion. 
Nonetheless, yields of the cycloaddition were ranging from 60% to 81%, without any 
selectivity when unsymmetrical alkynes were used, as illustrated with the product 100. 
26 
 
 
Figure 31: Nickel-catalysed (4+2) cycloaddition of alkynes with cyclobutenones 
 
More recently, Harrity’s group published two papers on the coupling of alkynes 
bearing with cyclobutenones (Figure 32).61,62 Remarkably, they showed how, in a one 
pot reaction, nickel complexes could catalyse first the alkyne insertion followed by a 
Suzuki cross-coupling reaction to yield the biphenyl 105. 
 
Figure 32: One-pot nickel-catalysed (4+2) cycloaddition of alkyne with cyclobutenone/Suzuki cross-
coupling 
 
4.2.2 Rhodium-catalysed (4+2) cycloaddition 
Mitsudo’s group showed that a rhodium complex could catalyse the 
cycloaddition of cyclobutenones and alkenes. At elevated temperature the authors 
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observed the insertion of 2-norbornene 107 into the cyclobutenone 106 (Figure 33).63 
Interestingly, the cyclohexenone 108 was obtained in excellent yield when the reaction 
was carried out under a carbon monoxide atmosphere. However, the cyclopentene 
derivative 109 was recovered as the sole product when the reaction was performed 
under an argon atmosphere. According to the authors, a reversible decarbonylation 
step can occur during the reaction, explaining why the cyclohexenone 108 was 
obtained when carbon monoxide was added to the reaction. 
 
Figure 33: Rhodium-catalysed (4+2) cycloaddition/Decarbonylative rhodium-catalysed (4+2) cycloaddition 
of norbornene with cyclobutenone 
 
In 2007, the same group reported the cycloaddition of both alkynes and 
electron-poor alkenes into cyclobutenone 110, yielding the functionalised phenols 112 
and 114 (Figure 34).64 The authors did not observe the formation of a possible 
decarbonylated product, in contrast to the reaction of 106. 
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Figure 34: Rhodium-catalysed (4+2) cycloaddition of alkyne and alkene with cyclobutenone 
 
4.2.3 Mechanistic insights 
In 1990, Liebeskind et al. proposed that depending on the metal used, the 
cyclobutenone 115 could undergo ring-opening reaction via two pathways (Figure 35 
and Figure 36).65 With the cobalt complex 116, they showed that the ring opens to 
generate the corresponding vinyl ketene complex 117. The latter was further reacted 
with the alkyne 111 to yield the phenol 118, which suggests that 117 is an intermediate 
in the cobalt-catalysed (4+2) cycloaddition of alkynes with cyclobutenones.  
 
Figure 35: Cobalt-catalysed (4+2) cycloaddition of alkyne with cyclobutenone 
 
However, another pathway was proposed proceeding via a direct oxidative 
addition of the metal inside the ring to form intermediate A (Figure 36). Insertion of 
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the alkyne would generate the heptametalacycle B which could give the desired 
product upon reductive elimination and re-aromatisation. In support of this rationale, 
the authors reported that the pentarhodacycle 120 was obtained when Wilkinson’s 
catalyst 119 was reacted with the cyclobutenone 115.66  
 
Figure 36: Alternative mechanism for the metal-catalysed (4+2) insertion of alkyne in 
cyclobutenone/isolation of a rhodium complex 
 
These experiments suggest that both vinylketene complexes and metalla-
cyclopentenones are possibly involved in the metal-catalysed cycloaddition of 
cyclobutenones. 
The involvement of nickel complexes similar to 117 or 120 is likely, however, 
Liebeskind and Huffman were not able to isolate any intermediates. Harrity et al. 
isolated the ester 124 which arises from the attack of the phenol 123 onto the ketene-
nickel intermediate 122 (Figure 37). Substituting the alkyne for phenol in the reaction 
gave the ester 125, confirming that the vinyl ketene complex is more likely to be 
involved in the nickel catalysed (4+2) cycloaddition of cyclobutenones than a possible 
pentanickelacycle. 
30 
 
 
Figure 37: Isolation of intermediates in the nickel-catalysed (4+2) cycloaddition of alkynes with 
cyclobutenone 
 
4.3 Benzocyclobutenone 
4.3.1 Nickel-catalysed (4+2) cycloaddition 
In contrast to cyclobutenones, benzocyclobutenones often require elevated 
temperatures to undergo ring-opening reactions.  
Martin’s group has shown that a nickel catalyst could trigger the ring opening 
reaction of benzocyclobutenones. The insertion of unsaturated substrates can occur in 
two positions, ie. proximal or distal (Figure 38). The reactivity of 
benzocyclobutenones typically involves the cleavage of the C1–C8 bond, as illustrated 
in the rearrangement of 126.67 
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Figure 38: Distal C ̶ C bond cleavage of benzocyclobutenone 
 
However, Martin and co-workers reported that in the case of the α-substituted 
benzocyclobutenone 128, the reaction proceeded through the unusual proximal C1 ̶ C2 
bond cleavage (Figure 39).68 The reactions of the diene 129 and alkyne 131 with the 
benzocyclobutenone 128 gave the corresponding benzocyclooctanone 130 and 
naphthol 132 respectively. Interestingly, when alkynes were used, the 
nickel/phosphine ratio had to be decreased to 1:1, in order to reach full conversion. 
 
Figure 39: Nickel-catalysed (4+2) cycloaddition of diene and alkyne with benzocyclobutenone 
 
4.3.2 Rhodium-catalysed (4+2) cycloaddition 
Dong’s group reported the rhodium-catalysed intramolecular insertion of 
alkene 133, alkyne 135 and methyl oxime 137 in benzocyclobutenones (Figure 40).69, 
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70, 71 The asymmetric version of the alkene insertion has been reported by the same 
group.72 Recently, they have used this approach to synthesise (–)-cycloclavine and the 
(–)-5-epi-cycloclavine derivative.73 
 
Figure 40: Intramolecular rhodium-catalysed (4+2) cycloaddition of alkene/alkyne/oxime with 
benzocyclobutenone 
 
Moreover, Dong and co-workers have extended the reactivity of 
benzocyclobutenones to the intramolecular cobalt-catalysed (4+2) insertion of 
alkynes.74  
4.4 Azetidinones & oxetanones 
Investigations towards the reactivity of azetidinones and oxetanones in the 
presence of metal catalysts have also been reported. As seen previously, Aïssa’s group 
reported an extensive study of the nickel-catalysed (4+2) cycloaddition of alkynes 
139a-f in the Boc-protected azetidinone 53.44  Symmetrical alkynes reacted almost 
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quantitatively (Table 1, entry 1), while unsymmetrical alkynes led to a mixture of 
cycloadducts 140 and 141 (Table 1, entry 2-6). Although highly regioselective, a trend 
connecting the steric hindrance of the alkyne and the corresponding ratio of products 
was observed. By decreasing the steric bulk of the alkyl group, a slight erosion of the 
regioselectivity was obtained (Table 1, entry 3 vs 4). With a sterically biased alkyne, 
only one regioisomer was obtained, confirming that the steric hindrance is the main 
factor influencing the regioselectivity (Table 1, entry 6).  Moreover, electronic factors 
did not seem to guide the regioselectivity of the insertion, as both electron-donating 
and electron-withdrawing substituents on the aromatic ring led to the same 
regioisomeric ratio (Table 1, entry 3 vs 5).  
 
Entry R1 R2 
Ratio 
(140/141) 
Yield 
[%]a 
1 Ph Ph N/A 90 
2 Me Ph 87:13 92 
3 n-Bu p-MeOC6H4 89:11 89 
4 i-Bu p-MeOC6H4 84:16 91 
5 n-Bu p-MeCOC6H4 89:11 99 
6 Me t-Bu 100:0 87 
a) Combined yield of 140 and 141. b) Ratio determined by 1H NMR of an inseparable mixture of 140 
and 141.  
Table 1: Nickel-catalysed (4+2) cycloaddition of alkyne with  Boc-protected azetidinone 
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In the same study, the authors reported the nickel-catalysed insertion of the 
alkyne 139e into oxetanone 142 to obtain the pyranone 143 in high yield (Figure 41). 
However, a small decrease of regioselectivity was observed due to the lower steric 
impact of the oxygen during the regioselectivity-determining alkyne insertion, which 
will be presented in the next section. 
 
Figure 41: Nickel-catalysed (4+2) cycloaddition of alkyne with oxetanone 
 
Shortly after this work was disclosed, two reports on the nickel-catalysed (4+2) 
cycloaddition of alkynes with azetidinone were published from Murakami’s and 
Louie’s group.75, 76 Both groups showed that the catalyst loading could be decreased 
whilst maintaining good reactivity. The scope of substrates was extended to α-
substituted azetidinones and to stannyl-substituted alkynes (Figure 42). 
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Figure 42: Nickel-catalysed (4+2) cycloaddition of alkyne with Boc-protected azetidinone reported by 
Louie and Murakami 
 
Louie’s group also showed that both the Boc-protected azetidinone 53 and the 
oxetanone 142 were suitable for the nickel-catalysed (4+2+2) cycloaddition of dienes 
and diynes with small rings (Figure 43).77,78 Interestingly, they showed that the 
insertion of the diyne 148 could proceed at low temperature, whilst the diene 151 
required an increase of both the amount of catalyst and the temperature. Nonetheless, 
they obtained the corresponding eight-membered rings in good yields. 
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Figure 43: Nickel catalysed (4+2+2) cycloaddition of diyne and (4+4) cycloaddition of diene in oxetanone 
 
4.5 Regioselectivity of the nickel-catalysed (4+2) cycloaddition of 
alkynes with four-membered rings 
As shown previously, good levels of regioselectivity were achieved when 
alkynes bearing an aryl and alkyl substitutents were used in the reaction (See Table 1, 
entry 2-5). Moreover, excellent selectivity was also achieved when the unsymmetrical 
alkyne 139f was used, due to the significant steric differentiation between the two 
substituents of the alkyne. Similarly, the same outcome was obtained when the 
electronically biased alkyne 154 was mixed with the Boc-protected azetidinone 53 
(Figure 44).  
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Figure 44: Regioselective nickel-catalysed (4+2) cycloaddition of biased alkynes with Boc-protected 
azetidinone 
 
Two plausible mechanisms have been described for the nickel-catalysed (4+2) 
cycloaddition of alkynes in four membered rings (Figure 45). Both mechanisms rely 
on the complexation of the alkyne and the ring to the nickel center to generate the 
complex A. In 2005, Ogoshi and co-workers reported the formation and isolation of 
157 which was converted to 158 in quantative yield, upon addition of trimethyl 
aluminium. 79,80 Thus, it was hypothesised that the mechanism leading to the six-
membered ring could occur via the formation of the intermediate B through an 
oxidative cyclisation. A β-carbon elimination followed by reductive elimination would 
lead to the release of the active species along with the cycloadduct. 
However, DFT calculations reported by Lin and co-workers suggested an 
alternative pathway. Although thought to be facile due to release of the ring strain, the 
authors have shown that the β-carbon elimination step is unlikely to proceed because 
of the high energy barrier (46.7 kcal.mol-1 and 56.5 kcal.mol-1 depending on the 
coordination model).81 Instead, the oxidative addition of the nickel catalyst into the 
azetidinone ring through a C–C bond cleavage can afford complex D. The insertion of 
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the alkyne can occur in two positions, leading to either C or E. A final reductive 
elimination can regenerate the catalyst and liberate the cycloadduct. 
 
Figure 45: Plausible mechanisms for the nickel-catalysed (4+2) cycloaddition of alkyne with azetidinone 
 
If considering the oxidative cyclisation pathway, an explanation for the 
observed regioselectivity was given based on the steric hindrance of the alkyne (Figure 
46). After the coordination of the alkyne to the nickel catalyst, the two complexes 159 
and 160 can be generated. The β-carbon elimination of these species would lead to 161 
and 162, whose reductive elimination would give the observed products. However, 
when comparing the stability of 159 versus 160, it is easy to understand that a 
distabilising interaction between the large group of the alkyne and the azetidine ring 
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prevents the formation of 162. Thus, the cycloadduct with the largest group in distal 
position in respect to the carbonyl group is thus favoured. 
 
Figure 46 : Mechanism of the nickel catalysed (4+2) cycloaddition of alkynes with azetidinone 
 
When considering the second mechanism Lin et al. proposed a different 
explanation. During the migratory insertion of an unsymmetrical alkyne bearing two 
alkyl groups, four different transition states can be considered (Figure 47). 
Calculations suggest that the migratory insertion of the alkyne into the Csp3–Ni bond 
is disfavoured (TS-1 and TS-2). Thus, the insertion must occur via the cleavage of the 
Csp2–Ni bond with the largest group on the alkyne away from the carbonyl moiety in 
order to limit steric interactions (TS-4). This mechanism leads to the same 
regioselectivity that is observed experimentally and that was explained by the 
formation of the oxidative cyclisation intermediate 159. 
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Figure 47: Four possible transition-states of the nickel-catalysed (4+2) cycloaddition of alkyne with 
azetidinone 
 
Moreover, the calculation showed that the reactivity is completely reversed in 
the case of a silyl-substituted alkyne. Thus, the cleavage of the Csp3–Ni becomes 
favoured and the alkyne acts as the electrophile. Due to the polarisation of the alkyne, 
a partial positive charge can be assumed on the methyl-substituted carbon, making the 
nucleophilic attack preferred on this site, and the transition-state TS-1 favoured 
(Figure 48).   
 
Figure 48: Four possible transition-states of the nickel-catalysed (4+2) cycloaddition of silylated-alkyne 
with azetidinone 
 
Nonetheless, using the alkyne 163 with a decreased steric bias led to almost no 
selectivity and both products 164 and 165 were obtained as a 60:40 ratio (Figure 49). 
It is important to understand that this mixture of regioisomers could not be resolved 
by normal purification methods, making this (4+2) cycloaddition extremely limited in 
terms of possible applications.  
41 
 
 
Figure 49: Non-regioselective nickel catalysed (4+2) cycloaddition of unsymmetrical alkynes 
 
5 Aims and objectives 
As seen previously in the introduction, efficient syntheses of functionalised 
pyridinols are scarce. Although elegant, the intramolecular cyclisations developed by 
Donohoe, Yoshida, Fedorov and Tong to access functionalised 3-pyridinols require an 
extensive synthesis of complex precursors prior to the key-step. However, methods 
relying on transition-metal catalysed cycloaddition have proven to be a possible 
alternative to overcome these issues. Aïssa, Louie and Murakami groups have shown 
that nickel catalysts could be used to access 3-dihydropyridinones from azetidinones 
and alkynes.44, 75, 76 The transformation of those intermediates could give the desired 
4,5-substituted 3-pyridinols upon re-aromatisation of the ring, enabling a rapid access 
to biologicaly interesting compounds such as 166 and 167 (Figure 50).  
 
Figure 50: Possible target for the synthesis of 4,5-substituted 3-pyridinols 
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However, one remaining issue is the lack of regioselectivity regarding the 
cycloaddition of unsymmetrical alkynes substituted with alkyl groups. The aim of this 
project is to develop a new methodology enabling the access to 4,5-substituted 3-
pyridinols via a regioselective nickel-catalysed (4+2) insertion of alkynes as the key-
step of the synthesis. 
6 Preliminary results and hypothesis 
6.1 Effect of the ligand on the regioselectivity 
The issue of regioselectivity is particularly relevant in the case of substituted 
alkynes without electronic or steric bias. Improvement of the regioselectivity was 
attempted by changing the ligand used for the (4+2) cycloaddition (Table 2). When 
subjecting the tosyl-protected azetidinone 168 and the non-biased alkyne 163 to the 
previously optimised conditions with triphenyl phosphine, the expected mixture of 
regioisomers 169/170 was obtained in good yield with a ratio of 54:46 (Table 2, entry 
1). When changing to a bulkier and more electron-rich phosphine, i.e. tricyclohexyl 
phosphine, the yield decreased and the selectivity switched in favour of 170 (Table 2, 
entry 2). With another aromatic phosphine, the yield decreased as compared to the 
original attempt (Table 2, entry 3). Using trimethyl phosphine did not improve the 
result (Table 2, entry 4). Finally, using IMes·HCl led to the decomposition of the 
starting material due to the base used to generate the N-heterocarbene (NHC) (Table 
2, entry 5). Changing the solvent from THF to toluene and decreasing the NHC/base 
loading gave the same result, and decomposition of the azetidinone was observed 
(Table 2, entry 6). 
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Entry Ligand Yield (%)a 
Ratio  
(169/170)b 
1 PPh3 97 54:46 
2 PCy3 77 42:58 
3 P(Ph2)t-Bu 83 52:48 
4 PMe3 67 56:44 
5c IMes.HCl Decomposition N/A 
6d IMes.HCl Decomposition N/A 
a) Combined yield. b) Determined by 1H NMR using 
trimethoxybenzene as an internal standard. c) Using 10 mol% Ni(cod)2, 
20 mol% IMes, 20 mol% t-BuOK in THF. d) Using 12 mol% Ni(cod)2, 10 
mol% IMes, 10 mol% t-BuOK in toluene.  
Table 2 : Optimisation of the regioselectivity of the nickel-catalysed (4+2) cycloaddition of alkyne with  
Tosyl-protected azetidinone 
 
The low regioselectivity could not be resolved by changing the ligand and all 
attempts led to an unseparable mixture of products. A more comprehensive ligand 
screening would be required to gain further insight into the possible effects on the 
regioselectivity of the nickel catalysed reaction of unsymmetrical alkynes. 
6.2 Conjugated 1,3-enynes as alkyne surrogates 
In 2008, whilst working on a (3+2) cycloaddition of alkynes with α-unsaturated 
amides, Fagnou et al. reported the same issues of regioselectivity, when dealing with 
unsymmetrical bisalkylalkynes (Figure 51).82 Using a rhodium catalyst, the authors 
obtained a mixture of 173 and 174 in 78% yield with a ratio of 1.8:1. Similarly to the 
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nickel-catalysed (4+2) cycloaddition, the compounds were inseparable through normal 
purification techniques and the mixture could not be resolved. 
 
Figure 51 : Rhodium-catalysed (3+2) cycloaddition of alkynes with phenyl-acetamide 
 
Nonetheless, in 2011 the authors reported the highly regioselective addition of 
conjugated 1,3-enynes that is controlled by electronic effects of the extra alkene 
(Figure 52).83 To their delight, they were able to obtain one regioisomer over the other 
by changing the position of the double bond on the substrate. Hence, the 1,3-enyne 
176 led to the formation of 177, whereas the 1,3-enyne 179 gave 180. It is noteworthy 
that, in all cases, only one isomer was observed with the double bond at the 2-position 
of the synthesised indole. Upon hydrogenation of the alkene, the complementary (3+2) 
regioisomers 178 and 181 were obtained in good yields. Thus, 176 and 179 were used 
as surrogates of the bis-alkylalkyne 182, which would have led to a mixture of 178 and 
181 if used in the rhodium catalysed (3+2) cycloaddition with 175.  
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Figure 52 : Regioselective rhodium-catalysed (3+2) cyloaddition of conjugated 1,3-enynes with vinyl-
acetamide 
 
Jamison and Montgomery have also observed excellent regioselectivities in the 
nickel-catalysed reductive coupling of aldehydes with 1,3-enynes (Figure 53).84, 85 
 
Figure 53: Nickel catalysed reductive coupling of 1,3-enynes with aldehydes 
 
 A computational study suggested that the complexation of the double bond to 
the metallic centre significantly decreases the energy barrier of the transition state, 
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making pathway A the most favoured (Figure 54).86 When the alkene is not 
coordinated to the metal in pathway B, the calculated energy of the transition-state was 
almost 10 kcal.mol-1 higher, showing that this coordination is important both for the 
reactivity and the selectivity. Finally, pathway C, would lead to the formation of the 
minor regioisomer but was highly disfavoured with an energy barrier of 32.5 kcal.mol-
1.  
 
Figure 54 : Computational studies of a nickel catalysed coupling of aldehyde with conjugated 1,3-enynes 
 
Therefore, when applying the same reasoning to the nickel catalysed (4+2) 
insertion of 1,3-enynes in azetidinones, the observed regioselectivity can be explained 
by the coordination of the olefin in the transition-state TS-AB in the regioselevity-
determining step (Figure 55). The six-membered cycloadduct D is obtained with the 
alkene distal to the carbonyl group after β-carbon elimination to C and reductive 
elimination of the catalyst. 
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Figure 55 : Plausible mechanism of the nickel catalysed (4+2) cycloaddition of conjugated 1,3-enynes in 
azetidinone 
 
However, if the reaction proceeds via the mechanism proposed by the 
computational study reported by Lin, then the regioselectivity could be explained by 
looking at the two transition states TS-1 and TS-2 (Figure 56).81 In the case of the 
cycloaddition of unsymmetrical bis-alkylalkynes it has been shown that the Csp2–Ni 
bond cleavage is favoured over Csp3–Ni bond cleavage, thus only those two transition 
states are discussed here to explain the regioselectivity. If the coordination of the olefin 
to the metal is responsible of the regioselectivity of the reaction, then TS-2 must be 
favoured over TS-1, leading to the same regioisomer observed experimentally. 
 
Figure 56: Two possible transition-states of the nickel-catalysed (4+2) cycloaddition of 1,3-enynes with 
azetidinone through the alternative mechanism 
 
 Thankfully, the conjugated 1,3-enyne 176 underwent the nickel-catalysed 
(4+2) cycloaddition with the Boc-protected azetidinone 53 to give a mixture of the 
regioisomers 189 and 190 (Figure 57).44 Although the selectivity was not as good as 
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in the rhodium-catalysed (3+2) work described by Fagnou, Montgomery and Jamison, 
a simple column chromatography could resolve the mixture, making this method 
convenient to use.  
 
Figure 57 : Regioselective nickel catalysed (4+2) cycloaddition of conjugated 1,3-enynes with the boc-
protected azetidinones 
 
6.3 Hypothesis 
It has been shown by the Aïssa group that Boc-protected azetidinone underwent 
the 2-steps sequence to 3-pyridinols, smoothly. However, the re-aromatisation of the 
ring was relatively demanding and required several manipulations to isolate the desired 
product. On the other hand, tosyl-protected azetidinones showed great results when 
used in the nickel-catalysed (4+2) insertion of alkynes and would allow an easier 
access to 3-pyridinols by elimination of the protecting group followed by immediate 
re-aromatisation. 
The selectivity induced through electronic effects from the conjugated 1,3-
enynes could allow an elegant and quick process towards the regioselective synthesis 
of 3-dihydropyridinones. Removal of the undesired double bond via hydrogenation 
followed by re-aromatisation of the ring would lead to the 4,5-substitued 3-pyridinol 
(Figure 58). By carefully selecting the 1,3-enyne used, a library of 3-pyridinols acting 
as pair of regioisomers could be accessed. 
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Figure 58: Regioselective synthesis of 3-hydroxy-4,5-alkyl-substituted pyridines using 1,3-enynes as 
alkynes surrogates 
 
7 Nickel catalysed (4+2) cycloaddition of conjugated 1,3-enynes 
with azetidinones 
7.1 1,3-Enynes synthesis 
To judge the applicability of 1,3-enynes towards the (4+2) insertion in 
azetidinones, a panel of 1,3-enynes were carefully selected for their diversity with 
respect to the substitution pattern to assess the regioselectivity (Figure 59). Molecules 
191a,c,e,g,i,k,m will allow the study of the possible effects of the coordination of the 
alkene to the metal centre. Both highly hindered alkenes (191a and 191e) and more 
accessible ones (191c, 191g and 191k) will be screened for the reaction. With 
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191b,d,f,h,j,l, the goal is to address the effects of the alkyl chain on the regioselectivity 
of the insertion. Different alkyl chains, with various substitution patterns, were 
selected in order to inverstigate as much as possible the impact of the steric hindrance 
on this side of the alkyne on the regioselectivity. Compounds 191i, 191j and 191m 
will also provide information on the reaction selectivity when both steric and electronic 
factors are competing to direct the outcome of the insertion. 
 
Figure 59 : Selected conjugated 1,3-enynes 
 
All enynes but 191l and 191m were synthesised via a Sonogashira cross-
coupling from a terminal alkyne and the corresponding alkenylbromide (Table 3). The 
use of classical conditions led, in most cases, to the desired 1,3-enyne in good to 
excellent yields. In the case of 191a (Table 3, entry 1), cyclohexenyl triflate had to be 
used instead of the corresponding bromide due to the high cost of the latter.  
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Interestingly, classical conditions did not allow the access to 191c, 191e nor 191g, as 
no reaction occurred when subjected to the palladium catalyst (Table 3, entry 3, 5 and 
7). 
 
Entry R1 
Alkene 
x (mol%) 
y 
(mol%) 
Product 
Yield 
(%) R2 R3 
1 Ph(CH2)2 
 
5 7 191a 51 
2 
 
H Ph 5 7 191b 85 
3 Ph(CH2)2 Me H 5 7 191c 0 
4 iPr H Ph 5 7 191d 90 
5 Ph(CH2)2  5 7 191e 0 
6 iBu H Ph 5 7 191f Quant. 
7 Ph(CH2)2  2 3 191g 0 
8 CH3(CH2)7 H Ph 2 3 191h 85 
9 Cy H Ph 5 7 191i 85 
10 Cy Me H 2 3 191j 62 
11 Ph(CH2)2 H H 5 7 191k 97 
Table 3: Synthesis of 1,3-enynes via Sonogashira cross-coupling 
 
A palladium tetrakis(triphenylphosphine) catalyst was used for those entries 
instead of the palladium (II) pre-catalyst (Table 4). The addition of an external base 
was not required in this case as the solvent used was able to deprotonate the terminal 
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alkyne and generate the alkynyl copper derivative needed for the transmetallation step 
in the catalytic cycle. 1,3-enynes 191c, 191e and 191g could thus be obtained in good 
yields. 
 
Entry R1 
Alkene 
Product 
Yield 
(%) R2 R3 
1 Ph(CH2)2 Me H 191c 93 
2 Ph(CH2)2  191e 83 
3 Ph(CH2)2  191g 60 
Table 4: Alternative conditions for the Sonogashira cross-coupling 
 
Following the general procedure to synthesise 191l would involve using 1-
butyne, a gas at room temperature. To avoid this obstacle, another route was developed 
involving the cross-coupling of styrene 192 with trimethylsilylacetylene 193. 
Deprotection of 194 and alkylation with iodoethane would then give 191l (Figure 60). 
The desired product was obtained in good yield over the three steps with traces of the 
Z-isomer that was formed from the small amount of Z-bromostyrene present in 192. 
 
Figure 60: Three steps synthesis to 191l 
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Finally, the tetra-substituted alkene 191m was selected to assess whether a 
tetra-substituted alkene can still influence the regioselectivity of the insertion. Due to 
the extremely high cost of the brominated partner for a Sonogashira coupling, several 
alternative paths were proposed.  
In 2006, Jung and Duclos showed that 195 could be converted to the hydrazine 
196 and that its treatment with iodine followed by a base-mediated elimination could 
lead to the alkenyl iodide 197 in excellent yield over the two steps (Figure 61).87 
 
Figure 61: Regioselective synthesis of tetra-substituted iodoalkene 
 
When applied to the cyclobutanone 198, the reaction was unsuccessful and led 
to a complex mixture of products, of which none appeared to be a major component 
by 1H NMR (Figure 62).  
 
Figure 62: Attempt for the regioselective synthesis of tetra-substituted iodoalkene 
 
Therefore, a second approach was considered with the key-step being a 
regioselective elimination. It was thought that after nucleophilic addition of an alkyne 
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onto the α-methylcyclohexanone 198, the corresponding alcohol could be eliminated 
to afford the most stable tetra-substituted alkene 200 (Figure 63). 
 
Figure 63: Alternative route to tetra-substituted alkene 
 
The desired alcohol 202 was formed in moderate yield after addition of the 
corresponding lithiated cyclohexylacetylene, generated from 201 and n-BuLi, onto the 
cyclohexanone 198 (Figure 64). Extension of the stirring time did not increase the 
formation of the desired product but led to undesired by-products.  
 
Figure 64: Alkynylation of α-substituted cyclobutanone 
 
With the tertiary alcohol in hand, several conditions for the elimination were 
examined. Two sets were selected involving the activation of the hydroxyl group 
followed by a base-promoted elimination (Figure 65). Phosphoryl chloride and thionyl 
chloride were used based on published results on elimination reactions.88, 89 A 
significant excess of phosphoryl chloride had to be used to reach full conversion of the 
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starting material and led to the formation of the corresponding eliminated product 
191m in poor yield and as a mixture of tetra- and tri-substituted alkene (Δ1-2/ Δ1-6) in 
a 2.3:1 ratio. Those isomers could not be separated by flash column chromatography. 
This result was improved with thionyl chloride, as only 5 equivalents of the activating 
agent were required and the produt was isolated in better yield, but still as a mixture 
of regioisomers with the same ratio. 
 
Figure 65: Regioselective elimination of the tetra-substituted alcohol 202 
 
Due to the increased stability of a tetra-substituted over the tri-substituted 
isomer, it was believed that an isomerisation could resolve the mixture of product 
obtained in the previous step. Among possible isomerisation agents, hydrated rhodium 
chloride has been well studied and has proven to be extremely efficient with a wide 
functional group tolerance.90 Unfortunately, when the mixture of alkenes was exposed 
to rhodium in ethanol at reflux, only decomposition of the starting material was 
observed (Figure 66). 
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Figure 66: Attempt at the rhodium catalysed isomerisation of 191m 
 
Due to time constraints, the mixture of regioisomers was used to examine the 
scope of the (4+2) cycloaddition of conjugated 1,3-enynes. 
7.2 Optimisation of the reaction conditions 
7.2.1 First generation of conditions 
Previously optimised reaction conditions were used to assess the methodology 
on the 1,3-enynes 191c and 191f (Figure 67). Pleasingly, when 191f was subjected to 
those conditions, 203f was obtained in good yield as a single regioisomer observed by 
1H NMR. Unfortunately, when the same reaction conditions were used with 191c, a 
complex mixture of products was recovered. Based on the crude NMR, insertion 
products were formed in a ratio of 90:10, and both products 203c and 204c were 
isolated in 40% and 8% respectively. The significant decrease of yield was explained 
by the formation of 205c in 35%. This isomer arose from a C ̶ H bond activation of 
168 followed by attack on the triple bond of the enyne.  
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Figure 67 : Nickel catalysed (4+2) cycloaddition of 191f and 191c with 168 using reported conditions 
 
7.2.2 Competition between C  ̶ C and C  ̶ H activation 
The formation of 205c was surprising as the conditions used in Figure 67 had 
been previously optimised in order to avoid this C ̶ H bond activation process (Table 
5). The optimisation of the reaction was reported by the Aïssa group in 2012.44 When 
the Boc-protected azetidinone 53 was reacted with 1.5 equivalent of 131 in toluene at 
110 °C, the cycloadduct 140a and the azetidinone derivative 206 were obtained in a 
1.4:1 ratio. The compound 140a could be isolated in 55% (Table 5, Entry 1). By 
changing the solvent to 1,4-dioxane at lower temperature with 1.1 equivalent of 131, 
the authors were able to isolate 140a in higher yield with an increased selectivity in 
favour of the cycloadduct (Table 5, entry 2). Finally, decreasing the temperature to 90 
°C with 30 mol% of PPh3 led to the formation of 140a only, in excellent yield (Table 
5, entry 3). 
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Entry Solvent T (° C) 
Ratio 
(140a/206)a 
Yield 
[%]b 
1 Toluene 110 1.4:1 55 
2 c, d 1,4-dioxane 100 5:1 77 
3 c, d  1,4-dioxane 90 >20:1 90 
a) Determined by 1H NMR. b) Isolated yield. c) 1.1 equiv. of 131. 
d) 30 mol% of PPh3 
Table 5: Reported optimisation of the nickel-catalysed (4+2) cycloaddition over the C ̶ H activation 
 
However, the formation of azetidinone derivatives such as 206 was limited to 
bis-aryl acetylenes and Boc-protected azetidinone 53, and Tosyl-protected azetidinone 
gave only the desired (4+2) cycloadducts. 
7.2.3 Second generation of conditions 
When performing the reaction of 191c with 168 at 60 °C instead of 90 °C, a 
slight increase of yield for the desired cycloadduct was observed (Table 6, entry 1 vs 
2). More importantly, the formation of the corresponding C ̶ H activated product was 
almost prevented and the selectivity between 203c and 204c remained approximately 
the same. When the solvent was changed to toluene instead of 1,4-dioxane, no sign of 
205c was detected and 203c was obtained in good yield from an 88:12 mixture of 
regioisomers (Table 6, Entry 2 vs 3). 
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Entry Solvent 
Temperature 
(°C) 
203c 
(%)a 
204c 
(%)a 
205c 
(%)a 
1 1,4-dioxane 90 40 8 35 
2 1,4-dioxane 60 47 8 8 
3 Toluene 60 73 10 0 
a) Isolated yield  
Table 6 : Optimisation of the nickel-catalysed (4+2) cycloaddition of 191c with 168 
 
When those new conditions were applied to the (4+2) cycloaddition of 191f 
with 168, 203f was obtained in good yield as a single regioisomer, albeit traces of the 
other regioisomer 204f could be seen by crude NMR (Figure 68).  
 
Figure 68 : Nickel-catalysed (4+2) cycloaddition of 191f with 168 
 
As both regioselectivities and yields of the (4+2) cycloaddition were high, 
those conditions were kept, and the scope of the reaction could be investigated. 
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7.2.4 Product identification 
All regioisomers obtained in this work were identified by HMBC. A correlation 
between the carbonyl and the alkyl chain could be seen for all major products (Figure 
69). 
 
Figure 69: HMBC correlation of the carbonyl (blue) with the alkyl chain (orange) 
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7.3 Scope of the reaction 
 Pleasingly, when subjected to the optimised conditions, all selected 1,3-enynes 
gave the desired (4+2) adduct. It is noteworthy that in several cases, the phosphine 
loading could be reduced to 20 mol% without erosion of neither the efficiency nor the 
selectivity (Table 7, entry 2, 5, 6, 7 and 8). When looking at the regioselectivity of this 
reaction, several conclusions can be drawn. Firstly, all enynes gave the same 
regioisomer as the major product. Secondly, the substitution of the double bond of the 
enynes 191a,c,e,g did not affect the regioselectivity in a significant manner (Table 7, 
entry 1, 3, 5 and 7). Similarly, the steric hindrance of the alkyl substituent on the alkyne 
did not have an impact on the yield or the selectivity in cases where the olefin was 
substituted with a phenyl group (Table 7, entry 2, 4, 6 and 8). Conversely, the steric 
hindrance of the alkyl group on the alkyne led to a slight decrease of the 
regioselectivity when the olefin was substituted with other alkyl groups (Table 7, entry 
1 vs 10 and 3 vs 9). Moreover, with the enynes 191i and 191j, a decrease in yields were 
observed due to an increase of the steric hindrance around the triple bond, but 
synthetically useful regioselectivities were still observed (Table 7, entry 9 and 10).  
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Table 7 : Nickel catalysed (4+2) cycloaddition of conjugated 1,3-enynes with tosyl-protected azetidinone 
 
The 1,3-enyne 191m could not be prepared as the pure tetra-substituted alkene 
form but was obtained as a mixture of tri/tetra-substituted in a 2:1 ratio, as discussed 
previously. When subjected to the optimised conditions, the desired cycloadduct was 
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obtained with good regioselectivity (83:17) but with a significant decrease in yield 
(Figure 70). 
 
Figure 70: Nickel catalysed (4+2) cycloaddition of 1,3-enyne bearing a tetra-substituted alkene 
 
Surprisingly, when the seemingly less challenging enyne 191k was used with 
the optimised conditions, the reaction became sluggish and almost no product was 
isolated after 144 hours (Table 8, entry 1). Optimisation of the reaction was attempted 
by extending the addition time of the enyne in the mixture with a syringe-pump. It was 
believed that due to the absence of steric hindrance around the alkene, the 1,3-enyne 
could saturate the catalyst and generate an unreactive species.91 It was hypothesised 
that decreasing the concentration of 191k over time could prevent this behaviour. 
Indeed, an increase in conversion was observed and an addition over 2.5 hours was the 
best compromise (Table 8, entry 2 and 3). Increasing the addition time to overnight 
led to the same result (Table 8, entry 4). Moreover, increasing the temperature of the 
reaction worsened the outcome, giving almost no conversion (Table 8, entry 5). 
Finally, changing the stoichiometry by using an excess of 168 led to no reaction (Table 
8, entry 6 and 7).  
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Entry Addition time 
of 191k 
(h) 
Reaction time 
(h) 
Temperature 
(°C) 
Ratio 
(168/203k)a 
1 0 144 60 3 : 1 
2 2 18 60 9 : 1 
3 2.5 18 60 1.5 : 1 
4 Overnight 18 60 1.5 : 1 
5 Overnight 72 90 9 : 1 
6b 3 18 60 No reaction 
7c 3 18 60 No reaction 
a) Determined by 1H NMR of the crude. b) 168 (2 equiv.), 191k (1 equiv.). c) 168 (2 equiv.), 
191k (1 equiv.), without PPh3 
Table 8 : Optimisation of the nickel-catalysed (4+2) cycloaddition of 191k with 168 
 
To circumvent the poor reactivity of the tosyl-azetidinone, the focus was placed 
on the more reactive Boc-protected equivalent 53. Re-optimisation of the conditions 
was a necessity and both solvent and temperature were assessed. Changing the solvent 
back to 1,4-dioxane gave a good yield of 55% after stirring at 60 °C for 17 hours (Table 
9, entry 1). Both tetrahydrofuran and toluene gave lower yields (Table 9, entry 2 and 
3). It is interesting to point out that when toluene was used, the reaction time had to be 
extended to 40 hours in order to reach full conversion of the starting material. 
Increasing the temperature to 90 °C gave, overall, better results with a decent yield of 
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60% when the reaction was performed in 1,4-dioxane (Table 9, entry 4). In all cases, 
207k was the only regioisomer seen by crude 1H NMR. 
 
Entry Solvent 
Temperature 
(°C) 
207k 
(%)a 
1 1,4-dioxane 60 55 
2 THF 60 34 
3 b Toluene 60 39 
4 1,4-dioxane 90 60 
5 THF 90 48 
6 Toluene 90 41 
a) Isolated yield. b) mixture stirred for 40 h. 
Table 9: Nickel catalysed (4+2) cycloaddition of 191k with 53 
 
Several reports have shown that the substitution of the azetidinone does not 
impede the insertion of alkynes.44, 75, 76 Thus, when 208 was subjected to the optimised 
reaction conditions with the model substrate 176, the 3-dihydropyridinone 209 was 
obtained as the single regioisomer in a slightly lower yield than that obtained with non-
substituted azetidinone 168 (Figure 71).44  
 
Figure 71 : Nickel catalysed (4+2) cycloaddition of 176 with the α-substituted tosyl-protected azetidinone 
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7.4 Hydrogenation/Re-aromatisation 
7.4.1 Tosyl-protected 3-dihydropyridinones 
As the aim of the project is to show the potency of 1,3-enynes as surrogates of 
unsymmetrical bis-alkyl-alkynes, it is necessary to develop a general process to 
convert the products 203. To do so, the focus was placed on the most wide-ranging 
method, namely palladium on charcoal with hydrogen gas.92 Several methods could 
be then used to re-aromatise the cycloadduct. As seen in the introduction, whilst 
working on the synthesis of 3-pyridinols through a ring closing metathesis, Donohoe 
et al. reported the re-aromatisation of tosyl-protected 3-dihydropyridinone with basic 
conditions in good yields.42  
All cycloadducts previously formed by (4+2) cycloaddition were subjected to 
a sequence of hydrogenation with palladium on charcoal followed by base-mediated 
re-aromatisation. In all cases, the crude material obtained after hydrogenation was used 
without purification and all yields are reported for the overall two steps (Table 10). 
Pleasingly, most 3-dihydropyridinones were transformed into pyridinols in 
high yields, with the hydrogenation step giving almost quantitative yields in many 
cases. Some issues where encountered during the hydrogenation of some of the 
examples. When 203g was used, it was essential to stop the reaction after 5 hours to 
prevent hydrogenation of the endocyclic double bond (Table 10, entry 7). Whilst 203b 
underwent the sequence smoothly to give 210b in good yield (Table 10, entry 2), the 
corresponding regioisomer 203a proved to be more challenging to hydrogenate. 
Conditions had to be modified due to the stability of endocyclic alkenes. Thus, the 
hydrogenation was carried out in a sonicating bath, leading to the desired intermediate 
in excellent yields (Table 10, entry 1). It is believed that sonication can activate the 
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catalyst by changing the morphology of the metal particles.93 Via this sequence, 
pyridinol 210a was obtained in excellent yield of 80%.  Finally, two interesting cases 
were 203i and 203j. Despite all efforts, their further transformation was impossible 
due to the uncontrolled reactivity towards hydrogenation, which is likely explained by 
the steric hindrance around the alkene.  
 
Table 10: Hydrogenation/Re-aromatisation sequence 
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A comprehensive optimisation of the hydrogenation step was attempted in 
order to circumvent the limitation that 203j brought to light. Firstly, using the 
optimised conditions, a complex mixture of compounds was obtained (Table 11, entry 
1). Subjecting this mixture to the re-aromatisation protocol did not give significant 
results. With an increase of both the catalyst loading and the temperature, some 
reactivity was observed but the reaction mixture obtained was too complex to proceed 
further (Table 11, entry 2). The hydrogenation of endocyclic alkenes has been 
described using ethanol as a solvent, which is believed to increase the reactivity of the 
palladium towards reduction of the alkene.83 However, either no reaction was 
observed, or another complex mixture of hydrogenated and deprotected products was 
recovered, when the temperature was increased (Table 11, entry 3 and 4). As the 
problem of reactivity observed for 203a could be solved using a sonicating bath, the 
same method was tried in this case, but no reactivity was observed neither at room 
temperature nor at 45 °C (Table 11, entry 5 and 6). Performing the hydrogenation with 
a pressure of 5 bars of hydrogen in ethanol for twenty hours led to no reaction (Table 
11, entry 7).  Finally, two other catalysts were tried, namely Raney nickel and rhodium 
supported on alumina, leading to the same outcome as observed previously (Table 11, 
entry 8 and 9).94, 95 
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Entry  % (w/w) 
Pd/C  
%w/w 
 
T°C  Solvent  Time 
(h)  
Result  
1 10 10 r.t. EtOAc 17 Complex mixture 
2 10 20 80 EtOAc 17 ≈20% conversion 
3 5 20 80 EtOH 17 No Reaction 
4a 5 20 r.t. EtOH 48 
Complex mixture;  
cleavage of tosyl 
5b 10 10 r.t. EtOAc 5 No Reaction 
6b 10 10 r.t. to 45°C EtOAc 7 No Reaction 
7c 5 10 r.t. EtOH 20 No Reaction 
8 Ni Raney NA r.t. MeOH 17 No Reaction 
9d Rh/Al2O3 NA r.t. EtOAc 17 No Reaction 
 a) A hydrogen bubbling was kept for 15 min. b) Using a sonicating bath. c) H2, 5 bars. d) 100% 
(w/w).  
Table 11 : Optimisation of the hydrogenation of 203j 
 
Although this pair of enynes illustrates the limits of this methodology, eight 
highly functionalised pyridinols were successfully synthesised in good yields and high 
regioselectivities. As a result, four pairs of regioisomers have been obtained with 
conjugated 1,3-enynes working as unsymmetrical alkyl-alkyne surrogates. 
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7.4.2 Boc-protected 3-dihydropyridinone 
The case of 207k is slightly different as the starting azetidinone had to be 
changed for the reactive Boc-protected azetidinone. Therefore, the use of DBU for the 
final re-aromatisation step was not suitable.  
 
It has been reported that when the 1,2-dihydroquinoline 211 was subjected to 
acidic conditions in the presence of silica and with a mild oxidising agent, the 
quinoline 212 was isolated in excellent yield (Figure 72).96 
 
Figure 72: Re-aromatisation of 1,2-dihydroquinolines 
 
Following a modified procedure based on this work and developed by a former 
PhD student from the group, the cycloadduct 207k was successfully converted to the 
corresponding pyridinol 210k (Figure 73).44 After hydrogenation according to the 
optimised conditions, the Boc-protecting group was removed with TFA which 
subsequently acted as the acid needed for the re-aromatisation. By adding silica and 
sodium nitrite, the pyridinol could be obtained in a good yield within 2 hours. It is 
interesting to note that the three steps of the re-aromatisation were done as a one-pot 
sequence. 
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Figure 73: Hydrogenation/Re-aromatisation of 207k 
 
7.4.3 Alternative re-aromatisation 
Due to the toxicity of DBU, an alternative protocol to access pyridinol was 
developed using sodium bicarbonate. In 2005, Rault et al.  reported the re-
aromatisation of 213 to the corresponding quinolinol 214 in good yield using a mild 
base (Figure 74).97 Despite harsher conditions, i.e. reflux overnight, this reaction 
remains significantly more advantageous and more feasible in a process than DBU in 
THF. 
 
Figure 74: Deprotection and re-aromatisation with sodium bicarbonate 
 
After the general hydrogenation procedure to remove the exocyclic double 
bond of 209, the crude mixture was re-aromatised using Rault’s conditions which 
pleasingly led to the pyridinol 215 in 56% yield over the two steps (Figure 75). 
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Figure 75: Hydrogenation/re-aromatisation of 209 
 
7.5 Nickel (II) catalysis 
The main issue arising from this new methodology comes from the pre-catalyst 
used. Nickel (0) is notorious for being highly sensitive to oxygen, thus requiring 
extreme care and a glovebox when setting up those reactions. Issues of reproducibility 
can be observed and scaling up the reaction seems hardly achievable. 
However, nickel (II) complexes show increased stability and can be stored in 
air, making them good candidates to avoid this drawback. The nickel (0) catalyst can 
be generated in situ by reduction with a metal. The focus was placed on one type of 
nickel pre-catalyst, NiBr2(PPh3)2, and three reductive agents, zinc, indium and 
manganese. 
The conditions were optimised in the lab by a former PhD student and were 
tried on a model enyne in order to judge the potency of the pre-catalyst. Thankfully, 
both the regioselectivity and yield of the major compound were comparable to that 
with nickel (0), highlighting how efficient the new pre-catalyst can be (Figure 76).  
 
Figure 76 : Nickel catalysed (4+2) cycloaddition of 176 with 168 using a nickel (II) pre-catalyst 
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Encouraged by this result, the scope of enynes was examined under slightly 
modified conditions, whereby both catalytic charges of nickel and zinc were increased 
to 10% and 50% respectively in order to obtain decent conversions (Table 12). In all 
cases, except for entry 5, the reactivity decreased leading to a drop of at least 10% in 
yield, as compared to the previously reported nickel (0) catalysed insertion. 
Nonetheless, the high selectivities remained intact and in the same range as observed 
when using nickel (0). 
 
Table 12: Nickel-catalysed (4+2) cycloaddition of conjugated 1,3-enynes with tosyl-protected azetidinone 
using a nickel (II) pre-catalyst 
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One plausible explanation to understand this decrease in yield comes from a 
side reaction. When 191f was treated under the optimised condition, 216f was obtained 
in 10% yield (Figure 77). Due to the presense of the Lewis acidic zinc bromide that is 
generated during the reduction of the pre-catalyst, an aldol reaction between the 
product and the activated starting material occurs. 
 
Figure 77: Aldol side-reaction of 191f with 168 
 
From this unexpected reactivity, it is obvious that conditions can be optimised 
to avoid this side reaction. However, changing the reductant to indium or manganese 
did not improve the reaction. Another possibility would be to change the complex to 
alternative nickel (II) pre-catalysts which have been reported recently in the literature, 
which give unreactive by-products after the generation of the active catalyst.98 
7.6 Late-stage Functionalisation 
Extra substitution could be accessed from α-substitued azetidinones, i.e. 208 
(Part 7.3, Figure 71). However, a late-stage functionalisation of the pyridinol moiety 
seems more attractive and could resolve the small decrease of reactivity observed with 
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the substituted azetidinone. Several sequences were investigated to functionalise the 
pyridinol ring.  
It is worth mentioning that all attempts of further functionalisation were done 
on the model substrate 203n. In order to accumulate enough material, the sequence 
(4+2) cycloaddition/hydrogenation/re-aromatisation was scaled-up to 1 mmol and the 
catalyst loading was halved (Figure 78). Diminished reactivity was observed, and the 
reaction time had to be extended to 40 hours to reach a good yield. No erosion of the 
regioselectivity was observed in those attempts. Moreover, the alternative re-
aromatisation procedure using sodium bicarbonate in refluxing ethanol was performed 
and gave 210n in good yield and purity after recrystallisation. 
 
Figure 78: Large scale nickel-catalysed (4+2) cycloaddition/hydrogenation/re-aromatisation with 176 and 
168  
 
7.6.1 Ortho-lithiation 
After protection of the alcohol with a methoxy-methyl ether (MOM), it was 
believed that the corresponding product could be deprotonated with a lithiated base 
and trapped with an electrophile.99 Deprotonating the protected pyridinol 217 with n-
BuLi and using butylbromide as the electrophile gave no reaction, even if TMEDA 
was used as an additive to improve the nucleophilicity of the lithiated species 
generated after deprotonation (Figure 79).  
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Figure 79: MOM-protection and attempt at the ortho-lithiation of 210n 
 
Other protecting groups than MOM could be used. In 2011, Cossy et al. 
reported the selective ortholithiation of the 3-pyridinol 218 protected as a methyl ether 
(Figure 80).100 After generation of the carbanion in position 2, they were able to trap 
it with iodine in an excellent yield. Functionalisation of the C-2 position with iodine 
is extremely interesting as it offers options for cross-coupling reactions. 
 
Figure 80: Iodination of 3-pyridinol  
 
Those conditions were applied to 210n. The transformation of the pyridinol to 
the corresponding methyl ether proved to be less trivial than initially believed. 
Sluggish reactions were observed in many cases when strong bases were used (Figure 
81). 
 
Figure 81: Protection of 210n to the methyl ether 
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Interestingly, when the relatively weak base K2CO3 was used, the activated 
pyridinium 221 was isolated in quantitative yield (Figure 82).  
 
Figure 82: Methylation of 210n to the pyridinium salt 
 
Although the formation of 221 was unexpected, an attempt of alkylation of this 
pyridinium was experimented.101 Activation of the nitrogen atom should increase the 
electrophilicity, promoting the attack of a nucleophile in position 2 or 4. Methyl 
lithium was selected because of its small size (Figure 83). However, full 
decomposition of the starting material was observed after only 1 hour, thus, the ortho-
lithiation strategy was resumed. 
 
Figure 83: Direct methylation of the pyridinium salt 221 
 
Changing the methylating agent from methyl iodide to TMS-diazomethane 
gave access to the desired protected pyridinol 220 in average yield (Figure 84).102 
However, when Cossy’s conditions of ortho-lithiation were used, decomposition of 
the starting material occurred without observable traces of the expected functionalised 
pyridinol. 
78 
 
 
Figure 84: Protection of 210n and attempt at ortholithiation 
 
7.6.2 Cyanation 
As the direct functionalisation of the ring through ortho-lithiation revealed to 
be more difficult than anticipated, alternative routes were explored. As seen 
previously, activation of the nitrogen atom could enable the nucleophilic attack on 
position 2 and 4.101 Among those activated species, N-oxides are well known. A 
particularly interesting example was published in 1983 by Krolikiewicz and 
Vorbrüggen, where a cyano group was added on a pyridinol ring after formation of the 
N-oxide 222.103 With trimethylsilyl cyanide, the authors were able to regioselectively 
access the functionalised pyridinol 224 (Figure 85). Interestingly, the alcohol was 
protected with TMS during the process and stirring in methanol was required to release 
the expected cyanated pyridinol 224 in 73% yield. 
 
Figure 85: Direct cyanation of pyridinium N-oxide 
 
Unfortunately, when the more substituted N-oxide 225 was subjected to the 
cyanation conditions, an unseparable mixture of compounds was recovered, showing 
how unapplicable this strategy was in this case (Figure 86). 
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Figure 86: Synthesis of pyridinium N-Oxide and attempt at the direct cyanation 
 
7.6.3 Iodination 
The functionalisation of the pyridinol core to the iodo-cycloadduct is highly 
interesting as it could broaden the scope of possible further functionalisations. Cossy 
et al. showed the applicability of iodination of pyridinol ring.100 However, harsh 
conditions seem detrimental for highly functionalised 3-pyridinols. The use of milder 
conditions could solve the issues of decomposition which were observed in all the 
examples. Koch’s group managed to regioselectively access the iodinated pyridinol 
227 in excellent yield with extremely mild conditions by using sodium carbonate and 
iodine (Figure 87).104 A small fraction of the over-iodinated pyridinol 228 was 
obtained in the crude mixture.  Moreover, the reaction was later scaled-up to several 
hundred of grams by Slaich’s group with a significantly decreased yield.105 The solvent 
was changed from water to dimethylformamide, and the reaction led to a mixture of 
C-2 and C-4 iodinated product, 227 and 228 respectively. The ratio between the two 
products was not reported. 
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Figure 87: Direct iodination of 3-pyridinol 
 
Applying Koch’s optimised conditions to the prepared pyridinol 210n enabled 
the direct iodination of C-2 in average yield (Figure 88). 
 
Figure 88: Direct iodination of 210n 
 
Suprisingly, when the solvent was changed to a 1:1 mixture of water and 
tetrahydrofuran and the temperature was increased to 85 °C, the reaction proceeded in 
almost quantitative yields without traces of impurities (Figure 89).106 
 
Figure 89: Improved iodination of 210n 
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In order to prove the usefulness of this functionalisation, the classical 
Sonogashira cross-coupling was attempted. Based on observations made during the 
synthesis of the 1,3-enynes (Part. I), palladium tetrakis-triphenylphosphine with 
piperidine was used and the starting material 229 was fully converted overnight 
(Figure 90). However, the expected product 231 was not observed, instead, the bicyclic 
product 232 was obtained in good yield.  
 
Figure 90: Sonogashira cross-coupling/cyclisation of 229 
 
Manaba’s group and Sekar’s group have reported similar reactions catalysed 
by either copper or palladium.107, 108 After formation of the Csp–Csp2 bond, the copper 
or the palladium catalyst can activate the newly formed alkynyl product and trigger 
the cyclisation. Although unexpected, this iodination/Sonogashira sequence can be a 
valuable tool in synthesis. 
7.6.4 Mannich reaction  
In 1999, Park and coworkers reported the direct functionalisation of 3-
pyridinol 226 via a one-pot Mannich reaction with secondary amines and 
paraformaldehyde (Figure 91).109 They showed that pyridinol can undergo highly 
regioselective substitution with several amines in excellent yields. 
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Figure 91: Regioselective functionalisation of 3-pyridinol through Mannich reaction 
  
Thankfully, using their optimised conditions, the pyridinol 210n was smoothly 
functionalised to the corresponding morpholine and pyrrole derivative 234 and 235, in 
excellent yields (Figure 92). Since the use of benzene remains problematic due to the 
high toxicity of this solvent, toluene was used for the synthesis of 235. A slight 
decrease of yield was observed in this case. Alkylation only occurred in position 2 and 
was confirmed through a series of selective NOEs. 
 
Figure 92: Regioselective functionalisation of 210n through a Mannich reaction 
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8 Conclusion & outlook 
8.1 Summary 
As a conclusion, we successfully addressed the regioselectivity issue observed 
with the nickel-catalysed (4+2) cycloddition of unsymmetrical alkynes by using 
conjugated 1,3-enynes as surrogates.  
Fourteen 3-dihydropyridinones were synthesised in yields ranging from 
average to good (Figure 93). In all cases, high regioselectivities were observed with 
traces of the minor regioisomer in the crude reaction. Resolution of the regioisomeric 
mixture was possible with a classical column chromatography. Eleven of those 3-
dihydropyridinones were successfully transformed into the corresponding pyridinols 
through a hydrogenation/re-aromatisation sequence. Three different re-aromatisation 
processes were reported allowing a better diversity in functional group tolerance. 
Unfortunately, the hydrogenation of two of the 3-dihydropyridinones failed due to the 
low reactivity of the alkene. 
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Figure 93: 1,3-enynes as unsymmetrical alkylalkynes surrogates in the regioselective synthesis of 
functionalised 3-pyridinols 
 
The (4+2) cycloaddition could be expanded to the use of the air stable nickel 
(II) pre-catalyst without loss of selectivity (Figure 94). A side reaction was observed 
due to the generation of a Lewis acid during the process, diminishing the recovered 
yields. 
 
Figure 94: Nickel-catalysed (4+2) cycloaddition of conjugated 1,3-enynes with tosyl-protected azetidinone 
using a nickel (II) pre-catalyst 
 
Further functionalisation of the pyridinol ring was possible (Figure 95). The 
selective addition of an iodine atom on the ring is highly interesting as the possibilities 
of functionalisation are high. A Sonogashira cross-coupling was attempted and led to 
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the unexpected bicyclic compound 178 after C ̶ C bond formation and intramolecular 
cyclisation catalysed by copper or palladium. Moreover, a direct functionalisation of 
the 2-position on the pyridinol ring was reported with a Mannich type reaction. 
Excellent yields were obtained for this process.  
 
Figure 95: Summary of the late functionalisation 
 
8.2 Outlook 
This methodology proved to be powerful with protected-azetidinones, and an 
expansion to other strained rings such as the ones seen in the introduction, i.e. 
cyclobutanones, cyclobutenones, benzocyclobutenones and oxetanones, could prove 
to be a powerful tool in the synthesis of complex frameworks. 
Moreover, the lack of regioselectivity is a common drawback in metal-
catalysed cycloaddition, as depicted in the two examples below (Figure 96).110, 111 The 
use of conjugated 1,3-enynes as alkyne surrogates in those reactions could enable a 
highly regioselective cycloaddtion, as seen in this chapter. 
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Figure 96: Regioselectivity issues in rhodium- and cobalt-catalysed (4+2) cycloadditions 
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9 Experimental Part 
9.1 Synthesis of four-membered rings 
Compound 53.  
 
 
A round bottom flask was charged with 3-hydroxyazetidine hydrochloride (10.0 g, 91 
mmol, 1.4 equiv.) and dissolved in methanol (91 mL) at 0 °C. Triethylamine (17.2 mL, 
127 mmol, 2 equiv.) was added dropwise at 0 °C followed by di-tert-butyl decarbonate 
(13.9 g, 64 mmol, 1 equiv.). The mixture was stirred overnight at room temperature. 
The mixture was diluted with DCM and washed with H2O. The organic layer was dried 
with MgSO4 and concentrated to afford the 53-int as a white solid (7.2 g, 66%). The 
product was used without further purification.  
Under N2, at  ̶ 78 °C, oxalyl chloride (4.7 mL, 55 mmol, 1.3 equiv.) was diluted in 
DCM (91 mL) and DMSO (7.8 mL, 109 mmol, 2.6 equiv.) was slowly added. The 
mixture was stirred for 15 min at   ̶ 78 °C, then 53-int (7.23 g, 42 mmol, 1 equiv.), 
diluted in DCM (53 mL), was added. The mixture was stirred for another 15 min at   ̶
78 °C, then triethylamine (29 mL, 218 mmol, 5.2 equiv.) was added. The mixture was 
stirred 2 h at room temperature, then the reaction was quenched with a saturated 
solution of NH4Cl. The aqueous layer was extracted with diethyl ether. The gathered 
organic layer was washed with H2O, brine, dried over MgSO4, filtered and 
concentrated. Purification by flash chromatography (PE:EtOAc/2:1 to 1:1) afforded 
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53 as a white solid (5.6 g, 78%). 1H NMR (500 MHz, CDCl3): δ 4.69 (s, 4H), 1.49 (s, 
9H), the NMR data is in accordance with that reported in the literature.112 
 
Compound 168.  
 
 
A round bottom flask was charged with 3-hydroxyazetidine hydrochloride (4.0 g, 37 
mmol, 1 equiv.) and suspended in methanol (37 mL). Triethylamine (15 mL, 110 
mmol, 3 equiv.) was added dropwise at 0 °C, then the clear mixture was allowed to 
stir at room temperature for 30 min. Afterwards, tosyl chloride (7.0 g, 37 mmol, 1 
equiv.) was added portionwise at 0 °C. The mixture was stirred overnight at room 
temperature. Afterwards, all volatiles were evaporated and then partitioned between 
EtOAc and H2O. The aqueous layer was extracted 3 times with EtOAc. The gathered 
organic layer was washed with H2O, brine, dried over MgSO4 filtered and concentrated 
to afford 168-int as a white solid (7.9 g, 95%). The product was used without further 
purification.  
  Under N2, at  ̶ 78 °C, oxalyl chloride (3.8 mL, 45 mmol, 1.3 equiv.) was diluted 
in DCM (78 mL) and DMSO (6.4 mL, 90 mmol, 2.6 equiv.) was slowly added. The 
mixture was stirred for 15 min at  ̶ 78 °C, then a solution of 168-int (7.9 g, 35 mmol, 
1 equiv.) in DCM (43 mL), was added. The mixture was stirred for another 15 min at 
 ̶ 78 °C, then triethylamine (25 mL, 180 mmol, 5.2 equiv.) was added. The mixture 
was stirred 2 h at room temperature, then the reaction was quenched with a saturated 
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solution of NH4Cl. The aqueous layer was extracted with diethyl ether. The gathered 
organic layer was washed with H2O, brine, dried over MgSO4, filtered and 
concentrated. Purification by flash chromatography (PE:EtOAc/2:1 to 1:1) gave a 
yellow solid. The latter was washed in pentane then filtered to give 168 as white solid 
(5.0 g, 61%). 1H NMR (500 MHz, CDCl3): δ 7.78 (d, J = 8.2 Hz, 2H), 7.40 (d, J = 8.2 
Hz, 2H), 4.63 (s, 4H), 2.47 (s, 3H), the NMR data is in accordance with that reported 
in the literature.113 
 
9.2 Synthesis of 1,3-enynes : 
Method I : Representative example for the synthesis of 191d. 
 A flame dried schlenk was loaded with palladium dichloride (97 mg, 0.14 mmol, 0.05 
equiv.) under nitrogen. The schlenk was vacuumed out for 15 min, then back filled 
with nitrogen. Dry THF (10 mL) was added, followed by triethylamine (1.1 mL, 8.3 
mmol, 3 equiv.), copper iodide (37 mg, 0.19 mmol, 0.07 equiv.) and (E)-β-
bromostyrene (350 µL, 2.75 mmol, 1 equiv.), in that order. A constant argon bubbling 
was kept during the set-up. The mixture was stirred 5 min at room temperature, then 3-
methyl-1-butyne (400 µL, 3.6 mmol, 1.3 equiv.) was added. The mixture was stirred 
overnight. Then, the mixture was diluted with Et2O and quenched with NH4Cl. The 
aqueous layer was extracted with Et2O. The combined organic layer was washed with 
H2O, brine, dried with MgSO4 and evaporated under vacuum. Purification by flash 
chromatography (PE: 100%) gave 191d as a yellowish oil (0.42 g, 90%). 
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Method II : Representative example for the synthesis of 191c.  
Under nitrogen, Pd(PPh3)4 (89 mg, 0.08 mmol, 0.02 equiv.) was added to a flame dried 
schlenk followed 2-bromopropene (0.34 mL, 3.8 mmol, 1 equiv.) diluted in piperidine 
(3.8 mL). The mixture was stirred for 5 min, then, 4-phenyl-1-butyne (0.54 mL, 3.8 
mmol, 1 equiv.) and copper iodide (51 mg, 0.27 mmol, 0.07 equiv.) were added. The 
mixture was stirred at room temperature overnight. Then, the mixture was diluted with 
Et2O and quenched with NH4Cl. The aqueous layer was extracted with Et2O. The 
combined organic layer was washed with H2O, brine, dried with MgSO4 and 
evaporated under vacuum. Purification by flash chromatography (PE: 100%) gave 
191c as a colourless oil (0.6 g, 93%). 
 
Compound 191a. This product was obtained as a colourless oil (95 mg, 51%) from 
4-phenyl-1-butyne (124 µL, 0.9 mmol, 1.3 equiv.) and 1-
cyclohexenyl trifluoromethanesulfonate (119 µL, 0.7 mmol, 1 
equiv.)  following method I. 1H NMR (500 MHz, CDCl3): δ 7.33 -7.27 (m, 2H), 7.25 
-7.19 (m, 3H), 6.03 -5.99 (m, 1H), 2.85 (t, J = 7.7 Hz, 2H), 2.58 (t, J = 7.7 Hz, 2H), 
2.13-2.03 (m, 4H), 1.66-1.51 (m, 4H); 13C NMR (125 MHz, CDCl3): δ 140.9 (e), 133.4 
(o), 128.5 (o, 2C), 128.3 (o, 2C), 126.2 (o), 120.9 (e), 86.5 (e), 83.0 (e), 35.4 (e), 29.5 
(e), 25.5 (e), 22.4 (e), 21.6 (e, 2C); IR (neat): ν = 3456 (w), 3026 (s), 2970 (s), 2927 
(s), 2858 (m), 2838 (m), 1737 (vs), 1453 (s), 1366 (vs), 1228 (vs), 2076 (w), 917 (m), 
840 (m), 799 (w), 747 (m), 696 (s); HRMS (CI (NH3)) calcd for (C16H18 + H): 
211.1481; found: 211.1489. 
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Compound 191b. This product was obtained as a yellow oil (492 mg, 85%) from β-
bromostyrene (0.35 mL, 2.8 mmol, 1 equiv.) and 
cyclohexylacetylene (0.47 mL, 3.6 mmol, 1.3 equiv.) following 
method I. 1H NMR (500 MHz, CDCl3): δ 7.38-7.34 (m, 2H), 7.33-7.29 (m, 2H), 7.27-
7.23 (m, 1H), 6.87 (d, J = 16.3 Hz, 1H), 6.18 (dd, J = 16.2, 2.1 Hz, 1H), 2.58-2.50 (m, 
1H), 1.90-1.82 (m, 2H), 1.78-1.70 (m, 2H), 1.59-1.43 (m, 3H), 1.39-1.28 (m, 3H); 13C 
NMR (125 MHz, CDCl3): δ 139.8 (o), 136.7 (e), 128.6 (o, 2C), 128.1 (o), 126.0 (o, 
2C), 108.9 (o), 97.1 (e), 79.6 (e), 32.7 (e, 2C), 29.9 (o), 25.9 (e, 2C), 25.6 (e); IR (neat): 
ν = 3050 (w), 3027 (w), 2927 (vs), 2852 (s), 2206 (w), 1943 (w), 1789 (w), 1614 (w), 
1597 (w), 1491 (m), 1447 (s), 1361 (w), 1349 (w), 1297 (m), 1233 (w), 950 (vs), 908 
(m), 888 (w), 746 (vs), 690 (vs); HRMS (CI (NH3)) calcd for (C16H18 + H): 211.1481; 
found: 211.1490. 
 
Compound 191c. This product was obtained as a colourless oil (607 mg, 93%) from 
4-phenyl-1-butyne (0.54 mL, 3.8 mmol, 1 equiv.) and 2-
bromopropene (0.34 mL, 3.8 mmol, 1 equiv.) following method II. 
1H NMR (500 MHz, CDCl3): δ 7.32-7.28 (m, 2H), 7.25-7.19 (m, 3H), 5.20 (s, 1H), 
5.14 (s, 1H), 2.85 (t, J = 7.7 Hz, 2H), 2.59 (t, J = 7.6 Hz, 2H), 1.86-1.85 (m, 3H); 13C 
NMR (125MHz, CDCl3) : δ 140.7 (e), 128.5 (o, 2C), 128.3 (o, 2C), 127.2 (e), 126.3 
(o), 120.5 (e), 88.6 (e), 82.6 (e), 35.2 (e), 23.7 (o), 21.6 (e), the NMR data is in 
accordance with that reported in the literature.114 
 
Compound 191d. This product was obtained as a yellowish oil (423 mg, 90%) from 
(E)-β-bromostyrene (0.35 mL, 2.8 mmol, 1 equiv.) and 3-methyl-1-
butyne (0.37 mL, 3.6 mmol, 1.3 equiv.) following method I. 1H 
92 
 
NMR (500 MHz, CDCl3): δ 7.38-7.34 (m, 2H), 7.33-7.28 (m, 2H), 7.27-7.23 (m, 1H), 
6.87 (d, J = 16.3 Hz, 1H), 6.16 (dd, J = 16.3, 2.1 Hz, 1H), 2.80-2.78 (m, 1H), 1.23 (d, 
J = 6.8 Hz, 6H); 13C NMR (125 MHz, CDCl3): δ 139.9 (o), 136.6 (e), 128.6 (o, 2C), 
128.2 (o), 126.0 (o, 2C), 108.8 (o), 98.3 (e), 78.9 (e), 23.0 (o, 2C), 21.3 (o); IR (neat): 
= 3027 (w), 2968 (s), 2931 (m), 2870 (m), 2213 (w), 1792 (br), 1594 (w), 1494 (m), 
1466 (m), 1446 (s), 1382 (m), 1362 (m), 1316 (s), 1270 (w), 1210 (w), 1185 (w), 1132 
(w), 1103 (w), 1103 (w), 951 (vs), 908 (s), 746 (vs), 733 (vs), 690 (vs); HRMS (CI 
(NH3)) calcd for (C13H14 + H): 171.1168; found: 171.1176. 
 
Compound 191e. This product was obtained as a colourless oil (586 mg, 83%) from 
1-bromo-2-methyl-1-propene (0.39 mL, 3.8 mmol, 1 equiv.) and 
4-phenyl-1-butyne (0.54 mL, 3.8 mmol, 1 equiv.) following method II. 1H NMR (500 
MHz, CDCl3): δ 7.32-7.27 (m, 2H), 7.25-7.18 (m, 3H), 5.22 (s, 1H), 2.86 (t, J = 7.5 
Hz, 2H), 2.63 (dt, J = 7.5, 2.3 Hz, 2H), 1.82 (s, 3H), 1.77 (s, 3H); 13C NMR (125 MHz, 
CDCl3): 147.1 (e), 140.9 (e), 128.5 (o, 2C), 128.3 (o, 2C), 126.2 (o), 105.2 (o), 91.2 
(e), 79.1 (e), 35.5 (e), 24.6 (o), 21.7 (e), 20.7 (o), the NMR data is in accordance with 
that reported in the literature.114 
 
Compound 191f. This product was obtained as a yellow oil (522 mg, quant.) from β-
bromostyrene (0.35 mL, 2.8 mmol, 1 equiv.) and 4-methyl-1-
pentyne (0.42 mL, 3.6 mmol, 1.3 equiv.) following method I. 1H 
NMR (500 MHz, CDCl3): δ 7.38-7.35 (m, 2H), 7.33-7.29 (m, 2H), 7.27-7.23 (m, 1H), 
6.88 (d, J = 16.2 Hz, 1H), 6.18 (dt, J = 16.3, 2.2 Hz, 1H), 2.26 (dd, J = 6.5, 2.2 Hz, 
2H), 1.87 (m, 1H), 1.03 (d, J = 6.7 Hz, 6H); 13C NMR (125 MHz, CDCl3): δ 139.9 (o), 
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136.6 (e), 128.6 (o, 2C), 128.2 (o), 126.0 (o, 2C), 108.9 (o), 92.0 (e), 80.6 (e), 28.8 (e), 
28.2 (o), 22.0 (o, 2C); IR (neat): ν = 3027 (w), 2957 (s), 2898 (w), 2869 (w), 2828 (w), 
2208 (w), 1789 (br), 1596 (m), 1490 (m), 1464 (m), 1448 (m), 1426 (w), 1384 (w), 
1367 (w), 1343 (w), 1279 (s), 1167 (br), 951 (vs), 747 (vs), 690 (vs); HRMS (CI (NH3)) 
calcd for (C14H16 + H): 185.325; found: 185.1334. 
 
Compound 191g.  This product was obtained as a colourless oil (106 mg, 77%) from 
trans-1-iodo-1-octene (80 µL, 0.6 mmol, 1 equiv.) and 4-
phenyl-1-butyne (147 µL, 0.6 mmol, 1 equiv.) following 
method II. 1H NMR (500 MHz, CDCl3): δ 7.32-7.27 (m, 2H), 7.24-7.19 (m, 3H), 6.06 
(dt, J = 15.7, 7.2 Hz, 1H), 5.47-5.41 (m, 1H), 2.86 (t, J = 7.7 Hz, 2H), 2.58 (dt, J = 7.8, 
1.9 Hz, 2H), 2.08 (q, J = 7.5 Hz, 2H), 1.41-1.22 (m, 8H), 0.90 (t, J = 6.7 Hz, 3H); 13C 
NMR (125 MHz, CDCl3): δ 143.8 (o), 140.8 (e), 128.4 (o, 2C), 128.3 (o, 2C), 126.2 
(o), 109.6 (o), 87.7 (e), 79.9 (e), 35.3 (e), 33.0 (e), 31.7 (e), 28.8 (e, 2C), 22.6 (e), 21.6 
(e), 14.1 (o); IR (neat): ν = 3026 (w), 2955 (m), 2925 (vs), 2855 (s), 1944 (w), 1604 
(w), 1496 (m), 1454 (s), 1377 (w), 1340 (w), 1305 (w), 1259 (w), 1165 (w), 1076 (w), 
953 (vs), 909 (s), 734 (vs), 697 (vs); HRMS (CI (NH3)) calcd for (C18H24 + H): 
241.1951; found: 241.1958. 
 
Compound 191h. This product was obtained as a yellow oil (558 mg, 85%) from β-
bromostyrene (0.35 mL, 2.8 mmol, 1 equiv.) and 1-decyne (0.6 mL, 
3.6 mmol, 1.3 equiv.) following method I. 1H NMR (500 MHz, 
CDCl3): δ 7.38-7.34 (m, 2H), 7.34-7.29 (m, 2H), 7.37-7.23 (m, 1H), 6.87 (d, J = 16.3 
Hz, 1H), 6.16 (d, J = 16.5 Hz, 1H), 2.37 (dt, J = 7.2, 2.2 Hz, 2H), 1.57 (quint, J = 7.2 
Hz, 2H), 1.46-1.39 (m, 2H), 1.36-1.22 (m, 8H), 0.92-0.86 (m, 3H);  13C NMR (125 
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MHz, CDCl3): δ 140.0 (o), 136.6 (e), 128.6 (o, 2C), 128.2 (o), 126.0 (o, 2C), 108.9 (o), 
93.1 (e), 79.7 (e), 31.9 (e), 29.2 (e), 29.2 (e), 29.0 (e), 28.8 (e), 22.7 (e), 19.7 (e), 14.1 
(o); IR (neat): ν = 3027 (w), 2924 (vs), 2854 (s), 2211 (w), 1465 (m), 1448 (m), 950 
(vs), 745 (vs), 722 (m), 689 (vs); HRMS (CI (NH3)) calcd for (C18H24 + H): 241.1951; 
found: 241.1952. 
 
Compound 191i. This product was obtained as a yellow oil (423 mg, 62%) from 2-
bromopropene (0.53 mL, 6 mmol, 1.3 equiv.) and 
cyclohexylacetylene (0.6 mL, 4.6 mmol, 1 equiv.) following method 
I. 1H NMR (500 MHz, CDCl3): δ 5.20-5.18 (m, 1H), 5.14-5.11 (m, 1H), 2.5-2.43 (m, 
1H), 1.87 (s, 3H), 1.84-1.67 (m, 4H), 1.53-1.40 (m, 3H), 1.37-1.26 (m, 3H); 13C NMR 
(125 MHz, CDCl3): δ 127.4 (e), 120.5 (e), 93.5 (e), 82.3 (e), 32.7 (e, 2C), 29.5 (o), 
25.9 (e, 2C), 24.9 (e), 24.0 (o); IR (neat): ν = 2927 (vs), 2854 (s), 2219 (w), 1785 (w), 
1614 (m), 1448 (s), 1372 (m), 1318 (w), 1302 (m), 1284 (m), 1233 (w), 1134 (w), 1011 
(w), 986 (w), 887 (vs), 861 (w), 844 (w), 791 (w); HRMS (CI (NH3)) calcd for (C11H16 
+ H): 149.1325; found: 149.1330. 
 
Compound 191j. This product was obtained as a colourless oil (206 mg, 70%) from 
1-cyclohexenyl trifluoromethanesulfonate (0.35 mL, 2 mmol, 1 
equiv.) and 3-methyl-1-butyne (0.27 mL, 2.6 mmol, 1.3 equiv.) 
following method I. 1H NMR (500 MHz, CDCl3): δ 6.02-5.99 (m, 1H), 2.66 (sept, J = 
6.9 Hz, 1H), 2.12-2.02 (m, 4H), 1.65-1.53 (m, 4H), 1.18 (d, J = 6.9 Hz, 6H) ; 13C NMR 
(125 MHz, CDCl3): δ 133.2 (o), 120.9 (e), 91.9 (e), 81.4 (e), 29.7 (e), 25.6 (e), 23.2 (o, 
2C), 22.4 (e), 21.6 (e), 21.0 (o); IR (neat): ν = 3028 (w), 2968 (m), 2929 (s), 2870 (m), 
1634 (w), 1448 (m), 1436 (m), 1381 (w), 1360 (w), 1342 (w), 1319 (s), 1269 (w), 1239 
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(w), 1214 (w), 1135 (w), 1104 (w), 1077 (w), 1045 (w), 977 (w), 970 (vs), 856 (w), 
840 (m), 804 (w), 732 (vs); HRMS (CI (NH3)) calcd for (C11H16 + H): 149.1325; 
found: 149.1331. 
 
Compound 191k. This product was obtained as a yellow oil (580 mg, 97%) from 
vinyl bromide (12 mL, 1.6 M in THF, 19 mmol, 5 equiv.) and 4-
phenyl-1-butyne (648 µL, 3.8 mmol, 1 equiv.) following method I. 1H NMR (500 
MHz, CDCl3): δ 7.33-7.28 (m, 2H), 7.25-7.19 (m, 3H), 5.78 (dt, J = 11.0, 2.0 Hz, 1H), 
5.55 (dd, J = 17.8, 2.0 Hz, 1H), 5.39 (dd, J = 11.0, 2.0 Hz, 1H), 2.86 (t, J = 7.5 Hz, 
2H), 2.60 (dt, J = 7.6, 1.9 Hz, 2H); 13C NMR (125 MHz, CDCl3): δ 140.6 (e), 128.4 
(o, 2C), 128.3 (o, 2C), 126.3 (o), 125.7 (e), 117.5 (o), 90.2 (e), 80.0 (e), 35.1 (e), 21.5 
(e), the NMR data is in accordance with that reported in the literature. 115 
 
Compound 191l.  
 
 
A flame dried schlenk was loaded with palladium dichloride (77 mg, 0.1 mmol, 0.03 
equiv.) under nitrogen. The schlenk was vacuumed out for 15 min, then back filled 
with nitrogen. Dry THF (20 mL) was added, followed by triethylamine (2.2 mL, 16.6 
mmol, 4.3 equiv.), copper iodide (21 mg, 0.1 mmol, 0.03 equiv.) and (E)-β-
bromostyrene (496 µL, 3.9 mmol, 1 equiv.), in that order. A constant argon bubbling 
was kept during the set-up. The mixture was stirred 5 min at room temperature, 
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then trimethylsilylacetylene (1 mL, 7.2 mmol, 1.8 equiv.) was added. The mixture was 
stirred overnight. Then, the mixture was diluted with Et2O and quenched with NH4Cl. 
The aqueous layer was extracted with Et2O. The combined organic layer was washed 
with H2O, brine, dried with MgSO4 and evaporated under vacuum. Purification by 
flash chromatography (PE: 100%) gave 194 as a colourless oil (675 mg, 87%).  
To a mixture of 194 (675 mg, 3.4 mmol, 1 equiv.) in methanol (10 mL) at room 
temperature was added potassium carbonate (4.7 g, 33.8 mmol, 10 equiv.) and the 
mixture was stirred overnight. All volatiles were evaporated and the crude mixture was 
partitioned between Et2O and H2O. The aqueous layer was extracted 3 more times with 
Et2O. The gathered organic layer was washed with H2O, brine, dried over MgSO4 
filtered and concentrated to afford the deprotected terminal alkyne as a colourless oil 
(304 mg, 70%). The product was used without purification 
Under N2, at  ̶ 78 °C, n-BuLi (1.2 mL, 2.5 M in Hexanes, 3.1 mmol, 1.3 equiv.) was 
added dropwise to the residue (304 mg, 2.4 mmol, 1 equiv.) in THF (10 mL). The 
mixture was warmed up to room temperature and iodoethane (0.2 mL, 2.4 mmol, 1 
equiv.) was added. The mixture was stirred at room temperature overnight. Then, the 
mixture was diluted with Et2O and quenched with NH4Cl. The aqueous layer was 
extracted with Et2O. The combined organic layer was washed with H2O, brine, dried 
with MgSO4 and evaporated under vacuum. Purification by flash chromatography (PE: 
100%) afforded 191l as a yellowish oil (0.157 g, 42%) as a mixture of E/Z isomers in 
a 80:20 ratio. E-isomer: 1H NMR (500 MHz, CDCl3): δ 7.38-7.29 (m, 5H), 6.88 (d, J 
= 16.4 Hz, 1H), 6.16 (dt, J = 16.3, 2.2 Hz, 1H), 2.39 (dq, J = 7.7, 2.1 Hz, 2H), 1.21 (t, 
J = 7.6 Hz, 3H) ; Z-isomer:  1H NMR (500 MHz, CDCl3): δ 7.87 (d, J = 7.34 Hz, 2H), 
7.29-7.20 (m, 3H), 6.56 (d, J = 11.9 Hz, 1H), 5.70 (dt, J = 12.0, 2.4, 1H), 2.47 (dq, J 
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= 7.6, 2.5, 2H), 1.25 (t, J = 7.6 Hz, 3H), the NMR data is in accordance with that 
reported in the literature.116 
 
Compound 191m.  
 
 
A flame-dried round bottom flask, under nitrogen was loaded with 201 (1.5 mL, 11.5 
mmol, 1.1 equiv.) and THF (25 mL). The mixture was cooled to  ̶ 78 °C and n-BuLi 
(4.6 mL, 2.5M in hexanes, 11.5 mmol, 1.1 equiv.) was added dropwise. The mixture 
was stirred at  ̶ 78 °C for 15 min with a vigorous stirring. Then, 198 (1.1 mL, 8.2 mol, 
1 equiv.) in THF (8 mL) was added. The mixture was stirred at room temperature for 
4 hours. The reaction was quenched with sat. NH4Cl and the aqueous layer was 
extracted with Et2O. The gathered organic layer was washed with water and brine, was 
dried with MgSO4 and evaporated under vacuum. Purification by flash 
chromatography (PE/EtOAc:95/5) afforded 202 as a colourless oil (626 mg, 35%).  
202 (300 mg, 1.4 mmol, 1 equiv.) was dissolved in pyridine (5.6 mL). The mixture 
was cooled to 0 °C and SOCl2 (0.5 mL, 6.9 mmol, 5 equiv.) was added dropwise. The 
mixture was stirred at 0 °C for another 1 h before the reaction was quenched with sat. 
NaHCO3 and the aqueous layer was extracted with Et2O. The gathered organic layer 
was thoroughly washed with water, brine, dried with MgSO4 and evaporated under 
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vacuum. Purification by flash chromatography (PE: 100%) gave 191m as a 2:1 mixture 
of isomers as a colourless oil (117 mg, 43%). 1H NMR (500 MHz, CDCl3): δ 6.00 (dt, 
J = 4.0, 1.8 Hz, 0.5H, min.), 2.58-2.45 (m, 1.4H, maj.+min.), 2.26-2.16 (m, 0.6H, 
min.), 2.14-2.07 (m, 2H, maj.), 2.06-1.95 (m, 3H, maj.), 1.85 (s, 3H, maj.), 1.84-1.66 
(m, 6.6H, maj.+min.), 1.62-1.55 (m, 4H, maj.), 1.53-1.41 (m, 4.8H, maj.+min.), 1.38-
1.25 (m, 5.1H, maj.+min.), 1.13 (d, J = 7.1 Hz, 1.6 H, min.); 13C NMR (125 MHz, 
CDCl3): δ 139.8 (e, maj.), 133.0 (o, min.), 126.5 (e, min.), 114.4 (e, maj.), 96.0 (e, 
maj.), 92.6 (e, min.), 81.2 (e, min.), 81.1 (e, maj.), 33.1 (e), 32.9 (e), 32.9 (o), 32.9 (e), 
31.1 (e), 30.8 (e), 30.3 (e), 29.8 (o), 26.0 (e), 26.0 (e), 25.9 (e), 24.9 (e), 22.6 (e), 22.0 
(o), 20.4 (o), 19.9 (e); IR (neat): ν = 2925 (vs), 2852 (s), 1447 (s), 1361 (m), 1297 (w), 
1234 (w), 1139 (w), 1111 (w), 1001 (w), 932 (w), 887 (m), 811 (m), 602 (m); HRMS 
(CI (NH3)) calcd for (C15H22 + H): 203.1794; found: 203.1800.   
9.3 Nickel-catalysed (4+2) cycloaddition 
Method III: Representative example for the synthesis of 203c.  
Inside a glovebox, a Teflon-screw flame-dried Schlenk equipped with a small stirrer 
bar was charged with Ni(cod)2 (6.1 mg, 0.022 mmol, 0.1 equiv.), sealed and taken out 
of the glovebox. Under N2, PPh3 (17.3 mg, 0.066 mmol, 0.3 equiv.) is added with 
toluene (0.2 mL). The mixture was stirred at room temperature for 10 min, then, 168 
(50 mg, 0.22 mmol, 1 equiv.) was added followed by 191c (42 mg, 0.024 mmol, 1.1 
equiv.) diluted in toluene (0.8 mL). Then, the tube was sealed and the mixture was 
stirred at 60 °C overnight and filtered through a small plug of silica. Purification by 
flash chromatography (PE:EtOAc/95:5 to 90:10) afforded 203c as a colourless paste 
(64 mg, 73%). 
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Method IV: Same procedure as before but 0.2 equiv. of PPh3 were used. 
 
Method V: Representative example for the synthesis of 203f.  
A flame-dried Schlenk tube equipped with a small stirrer, under N2, was charged with 
NiBr2(PPh3)2 (33 mg, 0.044 mmol, 0.1 equiv.), zinc (14 mg, 0.22 mol, 0.5 equiv.), 168 
(100 mg, 0.44 mmol, 1 equiv.), 191f (90 mg, 0.49 mmol, 1.1 equiv.) and THF (1.6 
mL). Then the flask was sealed and the mixture was stirred at 70 °C overnight. 
Afterwards, the mixture was cooled down and filtered through a plug of silica before 
evaporation. Purification by flash chromatography (PE:EtOAc/95:5 to 90:10) afforded 
203f as a colourless paste (97 mg, 54%). 
All the results obtained with method III, IV and V are compiled in the table 
below. Most attempts were reproduced, and the yields presented previously are 
averages of those duplicates. The Boc-protected azetidinone 53 was used with 191k 
(Table 13, entry 12). The α-substituted tosyl-protected azetidinone 208 was used with 
176 (Table 13, entry 15). 
Entry Enyne 
Yield of the isolated major isomer (%) 
Method III Method IV Method V 
1 191a 79/71 72/67 66 
2 191b 54/54 43/53/40 31 
3 191c 78/73/67 64/60 51 
4 191d 79/76 67/75 59 
5 191e 75/78 72/70 69 
6 191f 72/70 76/70 54/47 
7 191g / 65/69 / 
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8 191h / 77/77 / 
9 191i 64/65 63/50 / 
10 191j 62/65 61/53 / 
11 191k 69 / 69/64 
12 53+191k 60/55 / / 
13 191m 51 / / 
14 176 69 / / 
15 208+176n 64/64 / / 
Table 13 : Summary of the resulsts for the (4+2) insertion of 1,3-enynes in azetidinone 
 
The analytical data for 203a-n, 207k and 209 are compiled below: 
Compound 203a. Colourless oil. (method III: first attempt: 76 mg (79%), second 
attempt: 69 mg (71%)). 1H NMR (500 MHz, CDCl3): δ 7.69-7.65 
(m, 2H), 7.34 (d, J = 8.0 Hz, 2H), 7.28-7.23 (m, 2H), 7.19-7.13 (m, 
1H), 7.10-7.07 (m, 2H), 5.40-5.35 (m, 1H), 3.89 (s, 2H), 3.81 (s, 
2H), 2.48-2.37 (m, 7H), 2.09-2.04 (m, 2H), 1.92-1.88 (m, 2H), 1.69-1.57 (m, 4H); 13C 
NMR (125 MHz, CDCl3): δ 191.8 (e), 155.9 (e), 144.2 (e), 141.8 (e), 134.2 (e), 133.2 
(e), 132.9 (e), 130.0 (o, 2C), 128.3 (o, 4C), 127.7 (o, 2C), 127.3 (o), 125.9 (o), 52.6 
(e), 48.0 (e), 35.5 (e), 28.3 (e), 27.3 (e), 24.9 (e), 22.3 (e), 21.6 (e), 21.5 (o); IR (neat): 
ν = 3026 (w), 2926 (m), 2857 (w), 2256 (w), 1674 (s), 1598 (m), 1495 (m), 1438 (m), 
1400 (w), 1350 (s), 1305 (w), 1291 (w), 1268 (w), 1234 (w), 1210 (w), 1180 (vs), 1137 
(w), 1118 (m), 1088 (s), 991 (w), 961 (m), 909 (m), 880 (w), 847 (w), 814 (m), 802 
(w), 780 (w), 754 (w), 729 (vs), 693 (s), 674 (m), 660 (w); HRMS (ESI) calcd for 
(C26H29NO3S + Na): 458.1766; found: 458.1757. 
 
101 
 
Compound 203b. Yellow solid. (method III: first attempt: 52 mg (54%), second 
attempt: 52 mg (54%)). 170 and 193b were added as a solution. 
m.p.: 178-182 °C; 1H NMR (500 MHz, CDCl3): δ 7.67 (d, J = 8.2 
Hz, 2H), 7.50 (d, J = 7.4 Hz, 2H), 7.42 (t, J = 7.2 Hz, 2H), 7.39-7.34 
(m, 1H), 7.32 (d, J = 8.3 Hz, 2H), 7.24 (d, J = 16.5 Hz, 1H), 6.96 (d, J = 16.4 Hz, 1H), 
4.26 (s, 2H), 3.80 (s, 2H), 2.72-2.64 (m, 1H), 2.41 (s, 3H), 1.84-1.64 (m, 5H), 1.31-
1.21 (m, 5H); 13C NMR (125 MHz, CDCl3): δ 191.5 (e), 145.0 (e), 144.2 (e), 139.4 
(e), 135.9 (e), 135.5 (o), 133.3 (e), 130.0 (o, 2C),  129.4 (o), 129.0 (o, 2C), 127.6 (o, 
2C), 127.2 (o, 2C), 123.0 (o), 53.2 (e), 45.2 (e), 37.8 (o), 30.1 (e, 2C), 27.0 (e, 2C), 
25.8 (e), 21.4 (o); IR (neat): ν = 2927 (m), 2853 (m), 1661 (vs), 1607 (s), 1576 (m), 
1557 (m), 1494 (m), 1442 (s), 1392 (m), 1342 (vs), 1324 (s), 1303 (s), 1264 (w), 1243 
(m), 1226 (w), 1160 (vs), 1121 (m), 1089 (s), 1051 (s), 981 (s), 956 (s), 860 (s), 842 
(m), 814 (m), 806 (m), 751 (s), 730 (s), 707 (m), 684 (s); HRMS (ESI) calcd for 
(C26H29NO3S + Na): 458.1766; found: 458.1759; elemental analysis (%) calcd for 
C26H29NO3S: C 71.7, H 6.7, N 3.2, S 7.4; found C 70.77, H 6.86, N 2.88, S 6.71.    
 
Compound 203c. Colourless paste. (method III: first attempt: 68 mg (78%), second 
attempt: 64 mg (73%)). 1H NMR (500 MHz, CDCl3): δ 7.68 (d, J 
= 8.2 Hz, 2H), 7.34 (d, J = 8.0 Hz, 2H), 7.27-7.23 (m, 2H), 7.16 
(tt, J = 7.3, 1.4 Hz, 1H), 7.12-7.08 (m, 2H), 5.09 (br s, 1H), 4.69 
(br s, 1H), 3.94 (s, 2H), 3.85 (s, 2H), 2.42 (s, 7H), 1.79 (s, 3H); 13C NMR (125 MHz, 
CDCl3): δ 191.5 (e), 154.9 (e), 144.3 (e), 141.6 (e), 140.6 (e), 133.2 (e), 132.9 (e), 
130.0 (o, 2C), 128.3 (o, 3C), 127.7 (o, 2C), 126.0 (o, 2C), 115.8 (e), 52.6 (e), 47.6 (e), 
35.4 (e), 28.2 (e), 21.6 (o), 21.5 (o); IR (neat): ν = 3343 (br), 3060 (w), 3028 (w), 2923 
(w), 1681 (s), 1620 (w), 1598 (m), 1496 (m), 1440 (m), 1400 (w), 1346 (s), 1305 (w), 
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1292 (w), 1263 (m), 1234 (w), 1180 (vs), 1122 (m), 1090 (m), 1029 (m), 1002 (w), 
961 (m), 908 (m), 886 (w), 816 (m), 755 (m), 733( m), 700 (s), 665 (vs); HRMS (ESI) 
calcd for (C23H25NO3S + Na): 418.1453; found: 418.1457. 
 
Compound 203d. Yellow solid. (method III: first attempt: 69 mg (79%), second 
attempt: 67 mg (76%)). m.p.: 138-140 °C; 1H NMR (500 MHz, 
CDCl3): δ 7.68 (d, J = 8.3 Hz, 2H), 7.53-7.48 (m, 2H), 7.43-7.38 (m, 
2H), 7.38-7.34 (m, 1H), 7.32 (d, J = 8.3 Hz, 2H), 7.21 (d, J = 16.3 
Hz, 1H), 6.97 (d, J = 16.6 Hz, 1H), 4.27 (s, 2H), 3.81 (s, 2H), 3.09 (sept, J = 7.5 Hz, 
1H), 2.40 (s, 3H), 1.1 (d, J = 7.08 Hz, 6H); 13C NMR (125 MHz, CDCl3): δ 191.3 (e), 
144.6 (e), 144.2 (e), 140.0 (e), 135.8 (e), 135.6 (o), 133.3 (e), 130.0 (o, 2C), 129.5 (o), 
129.0 (o, 2C), 127.6 (o, 2C), 127.3 (o, 2C), 122.6 (o), 53.1 (e), 45.1 (e), 26.6 (o), 21.4 
(o), 20.6 (o, 2C); IR (neat): ν = 2961(w), 2926 (w), 2871 (w), 1662 (vs), 1609 (m), 
1576 (w), 1564 (w), 1495 (w), 1446 (m), 1340 (vs), 1321 (s), 1304 (m), 1238 (w), 
1173 (m), 1180 (vs), 1130 (w), 1099 (s), 1020 (w), 998 (s), 971 (m), 956 (s), 930 (w), 
884 (w), 860 (w), 841 (s), 812 (s), 752 (s), 711 (s), 687 (vs), 659 (vs); HRMS (ESI) 
calcd for (C23H25NO3S + Na): 418.1453; found: 418.1445; elemental analysis (%) 
calcd for C23H25NO3S: C 69.8, H 6.3, N 3.5, S 8.1; found C 67.83, H 6.30, N 3.26, S 
7.31. 
 
Compound 203e. Colourless paste. (method III: first attempt: 68 mg (75%), second 
attempt: 71 mg (78%)). 1H NMR (500 MHz, CDCl3): δ 7.67 (d, J 
= 8.4 Hz, 2H), 7.34 (d, J = 8.4 Hz, 2H), 7.26-7.22 (m, 2H), 7.16 
(t, J = 7.7 Hz, 1H), 7.12-7.08 (m, 2H), 5.55 (s, 1H), 3.85 (s, 2H), 
3.78 (s, 2H), 2.42 (s, 7H), 1.81 (s, 3H), 1.58 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 
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191.4 (e), 150.7 (e), 144.3 (e), 141.7 (e), 141.0 (e), 134.3 (e), 132.0 (e), 130.0 (o, 2C), 
128.4 (o, 2C), 128.3 (o, 2C), 127.7 (o, 2C), 125.9 (o), 120.4 (o), 52.8 (e), 48.2 (e), 34.4 
(e), 27.7 (e), 26.2 (o), 21.6 (o), 20.3 (o); IR (neat): ν = 3026 (w), 2928 (m), 2859 (w), 
2254 (w), 1672 (vs), 1598 (m), 1495 (m), 1442 (m), 1378 (w), 1349 (vs), 1316 (m), 
1291 (w), 1234 (m), 1185 (w), 1163 (vs), 1118 (m), 1088 (m), 1024 (s), 961 (s), 910 
(m), 853 (m), 814 (s), 751 (w), 731 (s), 698 (s), 678 (m); HRMS (ESI) calcd for 
(C24H27NO3S + Na): 432.1609; found: 432.1601; elemental analysis (%) calcd for 
C24H27NO3S: C 70.4, H 6.60, N 3.42, S 7.84; found C 66.22, H 6.28, N 3.11, S 7.08. 
 
Compound 203f. Yellow solid. (method IV: first attempt: 69 mg (76%), second 
attempt: 63 mg (70%)). m.p.: 154-158 °C; 1H NMR (500 MHz, 
CDCl3): δ 7.70 (d, J = 8.3Hz, 2H), 7.50 (d, J = 7.5 Hz, 2H), 7.43-
7.39 (m, 2H), 7.38-7.35 (m, 1H), 7.34 (d, J = 8.3 Hz, 2H), 7.14 (d, J 
= 16.6 Hz, 1H), 6.95 (d, J = 16.4 Hz, 1H), 4.28 (s, 2H), 3.84 (s, 2H), 2.43 (s, 3H), 2.30 
(d, J = 7.0 Hz, 2H), 1.61 (sept, J = 6.8 Hz, 1H), 0.82 (d, J = 6.6 Hz, 6H); 13C NMR 
(125 MHz, CDCl3): δ 191.4 (e), 145.7 (e), 144.3 (e), 136.0 (e), 135.4 (o), 135.0 (e), 
133.0 (e), 130.0 (o, 2C), 129.5 (o), 129.0 (o, 2C), 127.6 (o, 2C), 127.3 (o, 2C), 123.3 
(o), 52.6 (e), 44.6 (e), 32.6 (e), 29.1 (o), 22.5 (o, 2C), 21.5 (o); IR (neat): ν = 2947 (m), 
2865 (w), 1662 (s), 1613 (m), 1597 (m), 1582 (m), 1495 (w), 1465 (w), 1447 (m), 1396 
(w), 1382 (w), 1367 (w), 1343 (s), 1330 (s), 1305 (m), 1283 (w), 1246 (m), 1224 (w), 
1202 (w), 1182 (w), 1180 (vs), 1124 (m), 1088 (m), 1026 (m), 960 (s), 865 (m), 848 
(m), 839 (m), 812 (m), 753 (m), 709 (m), 692 (m), 675 (s); HRMS (ESI) calcd for 
(C24H27NO3S + Na): 432.1609; found: 432.1606. 
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 Compound 203g. Yellow paste. (method IV: first attempt: 71 mg (69%), second 
attempt: 69 mg (71%)). 1H NMR (500 MHz, CDCl3): δ 7.66 (d, 
J = 8.3 Hz, 2H), 7.32 (d, J = 8.3 Hz, 2H), 7.29-7.23 (m, 2H), 7.19-
7.11 (m, 3H), 6.26 (d, J = 16.0 Hz, 1H), 6.16 (dt, J = 15.8, 6.9 Hz, 
1H), 4.11 (s, 2H), 3.83 (s, 2H), 2.56-2.50 (m, 2H), 2.44-2.37 (m, 5H), 2.18 (q, J = 7.2 
Hz, 2H), 1.47-1.39 (m, 2H), 1.38-1.27 (m, 6H), 0.91 (t, J = 7.1 Hz, 3H); 13C NMR 
(125 MHz, CDCl3): δ 191.4 (e), 146.0 (e), 144.2 (e), 141.4 (e), 140.5 (o), 133.3 (e), 
132.8 (e), 130.0 (o, 2C), 128.3 (o, 4C), 127.6 (o, 2C), 126.0 (o), 125.0 (o), 52.6 (e), 
44.7 (e), 35.1 (e), 33.9 (e), 31.6 (e), 28.9 (e), 28.7 (e), 26.1 (e), 22.6 (e), 21.5 (o), 14.1 
(o); IR (neat):  ν = 3028 (w), 2926 (s), 2855 (m), 1670 (s), 1627 (m), 1597 (m), 1545 
(w), 1495 (m), 1454 (m), 1350 (s), 1306 (m), 1238 (w), 1163 (vs), 1121 (m), 1088 (m), 
1031 (m), 1009 (m), 962 (s), 846 (w), 813 (s), 752 (m), 699 (s), 677 (s); HRMS (ESI) 
calcd for (C28H35NO3S + Na): 488.2235; found: 488.2230; elemental analysis (%) 
calcd for C28H35NO3S: C 72.22, H 7.52, N 3.00, S 6.89; found C 71.34, H 7.53, N 2.87, 
S 6.62.    
 
Compound 203h. Yellowish foam. (method IV: first attempt: 160 mg (77%), second 
attempt: 80 mg (77%)). 1H NMR (500 MHz, CDCl3): δ 7.68 (d, J = 
8.6 Hz, 2H), 7.53-7.49 (m, 2H), 7.44-7.34 (m, 3H), 7.32 (d, J = 8.4 
Hz, 2H), 7.10 (d, J = 16.3 Hz, 1H), 6.96 (d, J = 16.4 Hz, 1H), 4.29 
(s, 2H), 3.87 (s, 2H), 2.41 (s, 3H), 2.37-2.31 (m, 2H), 1.34-1.20 (m, 10H), 1.18-1.09 
(m, 2H), 0.87 (t, J = 6.7 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 191.2 (e), 144.7 (e), 
144.2 (e), 135.9 (e), 135.8 (e), 135.7 (o), 133.4 (e), 130.0 (o, 2C), 129.5 (o), 129.0 (o, 
2C), 127.6 (o, 2C), 127.3 (o, 2C), 122.9 (o), 52.6 (e), 44.6 (e), 31.8 (e), 29.7 (e), 29.6 
(e), 29.3 (e), 29.2 (e), 24.0 (e), 22.6 (e), 21.5 (o), 14.1 (o); IR (neat): ν = 2923 (s), 2853 
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(m), 1720 (w), 1664 (vs), 1613 (m), 1581 (w), 1494 (w),1448 (m), 1342 (vs), 1306 
(m), 1243 (m), 1161 (vs), 1121 (m), 1089 (m), 1024 (m), 958 (s), 862 (w), 815 (m), 
751 (m), 680 (s); HRMS (ESI) calcd for (C28H35NO3S + Na): 488.2235; found: 
488.2233. 
 
Compound 203i. Colourless paste. (method III: first attempt: 54 mg (65%), second 
attempt: 53 mg (64%)). 1H NMR (500 MHz, CDCl3): δ 7.64 (d, J = 
8.3 Hz, 2H), 7.32 (d, J = 8.3 Hz, 2H), 5.07 (s, 1H), 4.72 (s, 1H), 3.89 
(s, 2H), 3.74 (s, 2H), 2.41 (s, 3H), 2.22 (tt, J = 11.9, 3.11 Hz, 1H), 
1.87 (s, 3H), 1.81-1.55 (m, 5H), 1.18-1.04 (m, 5H); 13C NMR (125 MHz, CDCl3): δ 
191.4 (e), 154.1 (e), 144.2 (e), 141.1 (e), 137.2 (e), 133.1 (e), 130.0 (o, 2C), 127.6 (o, 
2C), 115.1 (e), 53.3 (e), 47.9 (e), 39.8 (o), 29.9 (e, 2C), 26.7 (e, 2C), 25.6 (e), 22.0 (o), 
21.4 (o); IR (neat): ν = 2925 (s), 2852 (m), 1670 (vs), 1597 (m), 1494 (w), 1444 (s), 
1345 (vs), 1306 (m), 1272 (m), 1242 (m), 1190 (vs), 1088 (s), 1044 (m), 1012 (w), 982 
(m), 960 (vs), 926 (s), 917 (m), 901 (m), 886 (w), 842 (w), 822 (m), 812 (m), 802 (s), 
790 (s), 734 (s), 707 (m), 682 (vs), 654 (s); HRMS (ESI) calcd for (C21H27NO3S + Na): 
396.1609; found: 396.1601. 
 
Compound 203j. White solid. (method III: first attempt: 51 mg (62%), second 
attempt: 54 mg (65%)). m.p.: 102-106 °C; 1H NMR (500 MHz, 
CDCl3): δ 7.65 (d, J = 8.4 Hz, 2H), 7.32 (d, J = 8.3 Hz, 2H), 5.47-
5.43 (m, 1H), 3.86 (s, 2H), 3.73 (s, 2H), 2.60 (sept, J = 7.0 Hz, 1H), 
2.42 (s, 3H), 2.11-2.05 (m, 2H), 2.03-1.97 (m, 2H), 1.73-1.67 (m, 2H), 1.65-1.59 (m, 
2H), 0.99 (d, J = 7.0 Hz, 6H); 13C NMR (125 MHz, CDCl3): δ 191.5 (e), 154.5 (e), 
144.1 (e), 137.8 (e), 134.6 (e), 133.1 (e), 129.9 (o, 2C), 127.6 (o, 2C), 126.3 (o), 53.3 
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(e), 48.2 (e), 28.8 (o), 27.4 (e), 24.7 (e), 22.2 (e), 21.4 (e), 21.4 (o), 20.6 (o, 2C); IR 
(neat): ν = 2929 (m), 2875 (w), 2838 (w), 1675 (vs), 1598 (m), 1448 (m), 1346 (vs), 
1317 (s), 1297 (m), 1237 (w), 1162 (vs), 1091 (s), 989 (s), 966 (s), 891 (m), 844 (m), 
804 (s), 777 (m), 696 (s); HRMS (ESI) calcd for (C21H27NO3S + Na): 396.1609; found: 
396.1605. 
 
Compound 203m. White foam (method III: 48 mg (51%), 52 mg (54%)). 1H NMR 
(500 MHz, CDCl3): δ 7.65 (d, J = 8.3 Hz, 
3.2H, maj.+min.), 7.34-7.30 (m, 3.2H, 
maj.+min.), 5.45-5.40 (m, 0.6H, min.), 4.05 
(d, J = 18.0 Hz, 0.6H, min.), 3.90 (dd, J = 16.4, 1.4Hz, 0.6H, min.), 3.88 (dd, J = 18.0, 
1.7Hz, 1H, maj.), 3.76 (dd, J = 16.3, 1.7 Hz, 1H, maj.), 3.70 (dd, J = 17.9, 1.7 Hz, 1H, 
maj.), 3.64 (dd, J = 16.3, 1.7 Hz, 1H, maj.), 3.51 (d, J = 17.9 Hz, 0.6H, min.), 3.42 (dd, 
J = 16.5, 1.5 Hz, 0.6H, min.), 2.42 (s, 4.9H, maj.+min.), 2.39-2.24 (m, 1.3H, min.), 
2.14 (tt, J = 12.2, 3.1 Hz, 1H, maj.), 2.10-1.96 (m, 4.4H, maj.+min.), 1.91-1.53 (m, 
16.5H, maj.+min.), 1.46 (s, 3H, maj.), 1.43-1.31 (m, 1H, maj.), 1.29-1.02 (m, 9.7H, 
maj.+min.), 0.91 (d, J = 7.1 Hz, 2H, min.); 13C NMR (125 MHz, CDCl3): δ 191.7 (e, 
min.), 191.5 (e, maj.), 155.1 (e, maj.), 154.9 (e, min.), 144.2 (e, min.), 144.1 (maj.), 
139.6 (e, min.), 138.2 (e, min.), 137.8 (e, maj.), 133.0 (e, maj.), 132.8 (e, min.), 130.3 
(e, maj.), 129.9 (o, 2C, min.), 129.9 (o, 2C, maj.), 128.0 (e, maj.), 127.7 (o, 4C, 
maj.+min.), 126.9 (o, min.), 53.5 (e, min.), 53.4 (e, maj.), 48.5 (e, min.), 47.5 (e, maj.), 
40.4 (o, min.), 40.3 (o, maj.), 31.5 (o, min.), 31.2 (e, maj.), 30.5 (e, maj.), 30.4 (e, min.), 
30.3 (e, maj.), 29.2 (e, min.), 29.4 (e, maj.), 28.9 (e, maj.), 27.1 (e, maj.), 27.0 (e, maj.), 
27.0 (e, min.), 26.9 (e, min.), 25.8 (e, maj.), 25.7 (e, min.), 25.3 (e, min.), 22.7 (e, min.), 
22.6 (e, maj.), 21.5 (o, maj.+min.), 20.6 (o, maj.), 20.0 (e, min.), 19.7 (o, min.); IR 
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(neat): ν = 2924 (s), 2853 (m), 1674 (s), 1598 (m), 1494 (w), 1449 (m), 1350 (s), 1305 
(m), 1241 (w), 1162 (vs), 1121 (w), 1090 (m), 1046 (m), 978 (m), 965 (m), 888 (w), 
837 (w), 813 (m), 753 (w), 732 (m), 677(s); HRMS (ESI) calcd for (C25H33NO3S + 
Na): 450.2079; found: 450.2067.  
 
Compound 203n. This product was obtained as a white solid (486 mg, 69%) from 
168 (500 mg, 2.2 mmol, 1 equiv.) and 176 (303 µL, 2.4 mmol, 1.1 
equiv.). m.p.: 90-92 °C; 1H NMR (500 MHz, CDCl3): δ 7.66 (d, J = 
8.2 Hz, 2H), 7.32 (d, J = 8.2 Hz, 2H), 5.13-5.09 (m, 1H), 4.79-4.76 (m, 
1H), 3.94 (s, 2H), 3.82 (s, 2H), 2.42 (s, 3H), 2.13 (q, J = 7.2 Hz, 2H), 1.88 (s, 3H), 
0.77 (t, J = 7.4 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 191.5 (e), 153.8 (e), 144.3 
(e), 140.7 (e), 135.2 (e), 133.3 (e), 130.0 (o, 2C), 127.8 (o, 2C), 115.7 (e), 52.7 (e), 
47.6 (e), 21.8 (o), 21.5 (o), 19.2 (e), 14.0 (e); IR (neat): ν = 3675 (m), 2973 (s), 2901 
(s), 2818 (w), 1676 (s), 1614 (m), 1597 (m), 1494 (w), 1438 (s), 1404 (m), 1345 (s), 
1321 (w), 1255 (m), 1226 (w), 1180 (vs), 1088 (br s), 1026 (vs), 980 (s), 907 (s), 812 
(vs), 769 (m), 708 (m), 677 (s); HRMS (ESI) calcd for (C17H21NO3S + Na): 342.1140; 
found: 342.1135. 
 
Compound 207k. Yellowish paste. (method III: first attempt: 40 mg (5%), second 
attempt: 44 mg (60%)). 1H NMR (500 MHz, CDCl3): δ 7.30-7.25 
(m, 2H), 7.22-7.16 (m, 3H), 6.72 (dd, J = 17.8, 11.0 Hz, 1H), 5.68 
(br, 1H), 5.49 (d, J = 11.0 Hz, 1H), 4.37 (s br, 2H), 4.11 (s, 2H), 
2.76-2.71 (m, 2H), 2.67-2.61 (m, 2H), 1.49 (s, 9H); 13C NMR (125 MHz, CDCl3): δ 
193.5, 154.2, 147.5, 141.4, 134.5, 131.7, 128.5 (2C), 128.4 (2C), 126.0, 121.4, 80.97, 
51.6, 42.4, 35.5, 28.4 (3C), 26.3; IR (neat): ν = 3375 (w), 3026 (w), 2974 (m), 2929 
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(m), 2869 (m), 1698 (vs), 1671 (vs), 1620 (w), 1583 (w), 1496 (w), 1453 (m), 1417 
(s), 1366 (vs), 1281 (m), 1243 (s), 1163 (vs), 1125 (vs), 1084 (m), 1029 (w), 984 (w), 
924 (w), 894 (m), 857 (w), 748 (m), 699 (s); HRMS (ESI) calcd for (C21H27NO3S + 
Na): 350.1732; found: 350.1726; elemental analysis (%) calcd for C20H25NO3: C 
73.35, H 7.64, N 4.28; found C 73.29, H 7.72, N 3.80.    
 
Compound 209. White paste. (method III: first attempt: 58 mg (64%), second 
attempt: 58 mg (64%)). 1H NMR (500 MHz, CDCl3): δ 7.53 (d, J 
= 8.2 Hz, 2H), 7.30-7.14 (m, 7H), 5.04-5.00 (m, 1H), 4.67 (t, J= 
6.62 Hz, 1H), 4.56 (s, 1H), 4.25 (d, J = 20.2 Hz, 1H), 3.81 (d, J = 
20.2 Hz, 1H), 3.09-3.00 (m, 2H), 2.36 (s, 3H), 2.09-1.89 (m, 2H), 1.72 (s, 3H), 0.61 (t, 
J = 7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 194.2 (e), 153.0 (e), 143.8 (e), 140.4 
(e), 136.5 (e), 136.2 (e), 134.1 (e), 129.8 (o, 2C), 129.4 (o, 2C), 128.4 (o, 2C), 127.0 
(o, 2C), 127.0 (o), 115.4 (e), 61.9 (o), 44.6 (e), 37.5 (e), 21.8 (o), 21.4 (o), 19.2 (e), 
13.4 (o); IR (neat): ν = 3086 (w), 2963 (m), 1671 (s), 1618 (m), 1598 (m), 1494 (m), 
1456 (m), 1435 (m), 1348 (s), 1339 (s), 1307 (m), 1288 (w), 1260 (w), 1180 (vs), 1120 
(m), 1089 (m), 987 (m), 951 (m), 936 (m), 907 (s), 873 (m), 847 (m), 914 (s), 799 (m), 
740 (s), 704 (s), 675 (s); HRMS (CI (NH3)) calcd for (C24H27NO3S + H): 410.1784; 
found : 410.1801. 
9.4 Hydrogenation/Re-aromatisation 
Method VI: Representative example for the synthesis of 210b.  
A flame-dried Schlenk was charged with 10% Pd/C (10 % w/w) and 203b (76 mg, 0.2 
mmol, 1 equiv.) dissolved in EtOAc (2 mL). The mixture was frozen with liquid 
nitrogen and the Schlenk was evacuated, then back filled with a balloon of hydrogen. 
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This process was repeated 3 times. 1 atmosphere of hydrogen was kept with a balloon 
and the mixture was stirred vigorously for 16 h. Afterwards, the mixture was filtered 
through a small plug of celite and the mixture was concentrated, affording the 
hydrogenated residue (76 mg, quant.). The residue (64 mg, 0.15 mmol, 1 equiv.) was 
dissolved in THF (290 μL) and DBU (110 μL, 0.73 mmol, 5 equiv.) was added. The 
mixture was stirred overnight, then all volatiles were removed and the residue was 
loaded on top of a silica column. Purification by flash chromatography 
(DCM:MeOH/98:2 to 95:5) afforded 210b as a white solid (32 mg, 78%). 
 
The -OH proton was not observed in 1H NMR in compounds 210a-n, 215, 234 and 
235. 
Compound 210a. Beige amorphous solid (19 mg, 80%) from of 203a (35 mg, 0.08 
mmol, 1 equiv.) using method VI (5% Pd/C; 10% w/w; stirred for 7 
h) in a sonicating bath. 1H NMR (500 MHz, CDCl3): δ 8.22 (s, 1H), 
7.97 (s, 1H), 7.31-7.26 (m, 2H), 7.23-7.17 (m, 3H), 3.08-3.02 (m, 2H), 
2.93-2.87 (m, 2H), 2.59-2.50 (m, 1H), 1.86-1.60 (m, 5H), 1.42 (q, J = 12.3 Hz, 2H), 
1.36-1.19 (m, 3H); 13C NMR (125 MHz, CDCl3): δ 153.8 (e), 143.0 (e), 141.8 (e), 
137.2 (e), 136.9 (o), 132.3 (o), 128.5 (o, 2C), 128.4 (o, 2C), 126.0 (o), 38.6 (o), 35.2 
(e), 34.0 (e, 2C), 27.6 (e), 27.0 (e, 2C), 26.0 (e); IR (neat): ν = 2922 (s), 2848 (m), 
2518 (br), 1803 (br), 1567 (m), 1495 (m), 1428 (vs), 1382 (m), 1290 (vs), 1190 (s), 
1146 (s), 1123 (m), 994 (m), 865 (s), 752 (s), 699 (vs); HRMS (CI (CH4)) calcd for 
(C19H23NO + H): 282.1852; found: 282.1859. 
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Compound 210b. White solid (32 mg, 78%) from 203b (76 mg, 0.17 mmol, 1 equiv.) 
using method VI (10% Pd/C; 10% w/w; stirred for 16 h). m.p.: 179-180 
°C; 1H NMR (500 MHz, CDCl3): δ 8.18 (s, 1H), 7.83 (s, 1H), 7.32 (t, J 
= 7.7 Hz, 2H), 7.25-7.19 (m, 3H), 2.99-2.81 (m, 5H), 2.44-2.30 (m, 
2H), 1.91-1.83 (m, 2H), 1.80-1.73 (m, 1H), 1.62-1.54 (m, 2H), 1.44-1.31 (m, 3H); 13C 
NMR (125 MHz, CDCl3) : δ 154.6, 142.7, 141.1, 139.5, 136.5, 134.6, 128.6 (2C), 
128.3 (2C), 126.2, 38.9, 38.0, 33.5, 29.9 (2C), 27.1 (2C), 25.9; IR (neat): ν =  3022 
(w), 2929 (s), 2913 (s), 2850 (m), 2512 (br), 1801 (br), 1588 (m), 1563 (m), 1495 (m), 
1462 (w), 1450 (m), 1422 (vs), 1365 (w), 1335 w), 1292 (vs), 1227 (m), 1188 (m), 
1155 (s), 1129 (m), 1073 (m), 1028 (s), 893 (m), 862 (vs), 839 (w), 827 (w), 789 (m), 
752 (s), 720 (m), 698 (vs);  HRMS (CI (CH4)) calcd for (C19H23NO + H): 282.1852; 
found: 282.1859. 
 
Compound 210c. Off-white solid (39 mg, 69%) from of 203c (93 mg, 0.24 mmol) 
using method VI (10% Pd/C; 10% w/w; stirred for 16 h). m.p.: 125-
127 °C; 1H NMR (500 MHz, CDCl3): δ 8.23 (s, 1H), 8.03 (s, 1H), 
7.32-7.22 (m, 4H), 7.22-7.18 (m, 1H), 3.11-3.03 (m, 3H), 2.95-2.89 
(m, 2H), 1.21 (d, J = 6.9Hz, 6H); 13C NMR (125 MHz, CDCl3): δ 153.7 (e), 143.8 (e), 
141.8 (e), 136.8 (e), 136.7 (o), 132.6 (o), 128.5 (o, 2C), 128.3 (o, 2C), 126.0 (o), 35.2 
(e), 27.9 (o), 27.5 (e), 23.7 (o, 2C); IR (neat): ν =  3061 (w), 3026 (w), 2963 (m), 2928 
(m), 2866 (m), 2534 (br), 1762 (br), 1599 (m), 1567 (s), 1494 (m), 1427 (vs), 1391 
(m), 1364 (w), 1292 (vs), 1192 (m), 1157 (m), 1137 (w), 1078 (w), 1016 (s), 907 (m), 
877 (w), 863 (vs), 805 (m), 762 (s), 749 (vs), 701 (vs), 690 (vs); HRMS (CI (CH4)) 
calcd for (C16H19NO + H): 242.1539; found: 242.1549. 
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Compound 210d. White solid (24 mg, 60%) from 203d (65 mg, 0.17 mmol) using 
method VI (10% Pd/C; 10% w/w; stirred for 16 h). m.p.: 175-179 °C; 
1H NMR (500 MHz, CDCl3): δ 8.18 (s, 1H), 7.82 (s, 1H), 7.30 (t, J = 
7.3 Hz, 2H), 7.24-7.18 (m, 3H), 3.28 (sept, J = 6.9 Hz, 1H), 2.99-2.92 
(m, 2H), 2.89-2.83 (m, 2H), 1.43 (d, J = 7Hz, 6H); 13C NMR (125 MHz, CDCl3): δ 
154.4 (e), 142.9 (e), 141.1 (e), 140.2 (o), 136.0 (e), 135.1 (o), 128.5 (o, 2C), 128.3 (o, 
2C), 126.2 (o), 37.9 (e), 33.1 (e), 28.5 (o), 19.9 (o, 2C); IR (neat): ν =  3061 (w), 3026 
(w), 2963 (m), 2928 (w), 2866 (w), 2534 (br), 1762 (br), 1599 (m), 1567 (s), 1494 (m), 
1453 (w), 1427 (vs), 1391 (s), 1364 (m), 1292 (vs), 1192 (m), 1157 (m), 1016 (s), 907 
(m), 863 (vs), 805 (m), 762 (m), 749 (vs), 701 (vs), 690 (s); HRMS (CI (CH4)) calcd 
for (C16H19NO + H): 242.1539; found: 242.1542. 
 
Compound 210e. Off-white solid (26 mg, 71%) from 203e (64 mg, 0.16 mmol) using 
method VI (10% Pd/C; 10% w/w; stirred for 16 h). m.p.: 162-164 °C; 
1H NMR (500 MHz, CDCl3): δ 8.24 (s, 1H), 7.88 (s, 1H), 7.33-7.19 
(m, 5H), 3.05-2.99 (m, 2H), 2.94-2.88 (m, 2H), 2.41 (d, J = 7.4 Hz, 
2H), 1.84 (sept, J = 6.8 Hz, 1H), 0.94 (d, J = 6.7 Hz, 6H); 13C NMR (125 MHz, CDCl3): 
δ 154.0 (e), 142.0 (e), 140.4 (o), 138.1 (e), 137.0 (e), 133.1 (o), 128.4 (o, 2C), 128.3 
(o, 2C), 126.0 (o), 39.2 (e), 34.8 (e), 29.7 (o), 28.6 (e), 22.5 (o, 2C); IR (neat): ν =  3064 
(w), 3026 (w), 2953 (m), 2926 (w), 2494 (br), 1804 (br), 1589 (m), 1563 (s), 1495 (m), 
1464 (m), 1422 (vs), 1366 (s), 1298 (vs), 1266 (m), 1165 (m), 1146 (s), 1031 (m), 906 
(m), 874 (s), 763 (s), 747 (s), 660 (vs); HRMS (CI (CH4)) calcd for (C17H21NO + H): 
256.1707; found: 256.1696. 
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Compound 210f.  Off-white solid (71 mg, 70%) from 203f (165 mg, 0.4 mmol)  using 
method VI (10% Pd/C; 10% w/w; stirred for 16 h). m.p.: 169-171 °C; 
1H NMR (500 MHz, CDCl3): δ 8.19 (s, 1H), 7.92 (s, 1H), 7.31 (t, J = 
7.3 Hz, 2H), 7.25-7.18 (m, 3H), 2.97-2.92 (m, 2H), 2.91-2.85 (m, 2H), 
2.63 (d, J = 7.4 Hz, 2H), 2.07 (sept, J = 6.8 Hz, 1H), 0.97 (d, J = 6.7 Hz, 6H); 13C 
NMR (125 MHz, CDCl3): δ 154.0 (e), 141.2 (e), 139.5 (o), 138.0 (e), 137.5 (e), 133.3 
(o), 128.6 (o, 2C), 128.3 (o, 2C), 126.2 (o), 37.4 (e), 34.5 (e), 32.4 (e), 28.5 (o), 22.7 
(o, 2C); IR (neat): ν =  3030 (w), 2961 (m), 2945 (w), 2925 (w), 2863 (m), 2481 (br), 
1761 (br), 1595 (m), 1564 (s), 1494 (m), 1463 (m), 1423 (vs), 1381 (s), 1366 (s), 1337 
(m), 1297 (vs), 1260 (m), 1220 (w), 1191 (w), 1161 (s), 1127 (m), 1112 (m), 1073 (m), 
1027 (w), 985 (w), 935 (m), 869 (vs), 847 (m), 818 (w), 756 (s), 747 (vs), 719 (s), 690 
(vs); HRMS (CI (CH4)) calcd for (C17H21NO + H): 256.1696; found: 256.1706. 
 
Compound 210g. Brown paste (12 mg, 54%) from 203g (42 mg, 0.09 mmol) using 
method VI (5% Pd/C; 10% w/w; stirred for 7.5 h). 1H NMR (500 
MHz, CDCl3): δ 8.21 (s, 1H), 7.91 (s, 1H), 7.32-7.18 (m, 5H), 3.04-
2.98 (m, 2H), 2.93-2.87 (m, 2H), 2.54-2.48 (m, 2H), 1.54 (quint, J = 
7.1 Hz, 2H), 1.38-1.22 (m, 10H), 0.88 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, 
CDCl3): δ 153.8 (e), 142.0 (e), 139.7 (o), 138.2 (e), 137.7 (e), 133.1 (o), 128.4 (o, 2C), 
128.4 (o, 2C), 126.0 (o), 34.9 (e), 31.8 (e), 31.1 (e), 30.1 (e), 29.7 (e), 29.4 (e), 29.2 
(e), 28.4 (e),  22.6 (e), 14.1 (o); IR (neat): ν = 2956 (m), 2917 (s), 2617 (br), 1602 (m), 
1572 (s), 1495 (m), 1451 (s), 1431 (vs), 1379 (m), 1312 (vs), 1201 (m), 1147 (m), 1029 
(m), 905 (w), 751 (s), 695 (vs); HRMS (CI (CH4)) calcd for (C21H29NO + H): 
312.2322; found: 312.2328. 
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Compound 210h. Beige solid (28 mg, 56%) from 203h (75 mg, 0.16 mmol) using 
method VI (10% Pd/C; 10% w/w; 5 h). m.p.: 79-82 °C; 1H NMR (500 
MHz, CDCl3): δ 8.17 (s, 1H), 7.91 (s, 1H), 7.34-7.28 (m, 2H), 7.25-7.18 
(m, 3H), 2.96-2.85 (m, 4H), 2.75-2.67 (m, 2H), 1.64-1.52 (m, 2H), 1.48-
1.39 (m, 2H), 1.38-1.22 (m, 8H), 0.92-0.83 (m, 3H); 13C NMR (125 MHz, CDCl3): δ 
153.7 (e), 141.2 (e), 139.7 (o), 139.1 (e), 136.8 (e), 133.4 (o), 128.5 (o, 2C), 128.3 (o, 
2C), 126.2 (o), 37.6 (e), 32.4 (e), 31.9 (e), 30.1 (e), 29.5 (e), 29.3 (e), 29.1 (e), 26.0 (e), 
22.7 (e), 14.1 (o); IR (neat): ν = 2954 (w), 2922 (s), 2852 (m), 2539 (br), 1565 (s), 
1495 (m), 1463 (m), 1422 (vs), 1366 (s), 1298 (vs), 1262 (m), 1165 (s), 1119 (s), 1072 
(m), 749 (s), 695 (vs); HRMS (CI (CH4)) calcd for (C21H29NO + H): 312.2322; found: 
312.2327. 
 
Compound 210k. A flame-dried Schlenk was charged with 10% Pd/C (10 % w/w) 
and 207k (30 mg, 0.09 mmol, 1 equiv.) dissolved in EtOAc (1 mL). 
The mixture was frozen with liquid nitrogen and the Schlenk was 
evacuated, then back filled with hydrogen. The process was repeated 
3 times. 1 atmosphere of hydrogen was kept with a balloon and the mixture was stirred 
vigorously for 4 h. Afterwards, the mixture was filtered through celite and was 
concentrated, affording the hydrogenated residue (30 mg, 99%). Under air, a 
suspension of the residue (25 mg, 0.08 mmol, 1 equiv.), SiO2 (25 mg) and TFA (76 
μL, 0.1 mmol, 1.3 equiv.) in DCM (271 μL) was stirred at room temperature for 1 h. 
NaNO2 (8 mg, 0.11 mmol, 1.5 equiv.) was then added and the suspension was stirred 
30 min. Afterwards, Et3N (271 μL, 0.2 mmol, 2.7 equiv.) was added and the suspension 
was stirred for another 30 min. Finally, all volatiles were removed in vacuo. The 
residue was loaded on a column and purified by flash chromatography 
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(DCM:MeOH/98:2), affording 210k as a beige foam (10 mg, 57%). 1H NMR (500 
MHz, CDCl3): δ 8.24 (s, 1H), 7.94 (s, 1H), 7.32-7.27 (m, 2H), 7.26-7.18 (m, 3H), 3.06-
2.99 (m, 2H), 2.94-2.87 (m, 2H), 2.58 (q, J = 7.7 Hz, 2H), 1.20 (t, J = 7.6 Hz, 3H); 13C 
NMR (125 MHz, CDCl3): δ 154.0 (e), 141.8 (e), 139.7 (e), 138.7 (e), 138.0 (o) 132.2 
(o), 128.5 (o, 2C), 128.4 (o, 2C), 126.1 (o), 34.7 (e), 28.3 (e), 23.2 (e), 15.2 (o); IR 
(neat): ν = 3027 (w), 2965 (w), 2932 (w), 2525 (br), 1820 (br), 1599 (m), 1568 (s), 
1495 (m), 1458 (m), 1424 (vs), 1376 (m), 1299 (vs), 1193 (m), 1147 (s), 1056 (w), 
1029 (m), 867 (s), 814 (m), 751 (s), 698 (vs); HRMS (CI (CH4)) calcd for (C15H17NO 
+ H): 228.1383; found: 228.1392. 
 
Compound 215. A flame-dried Schlenk was charged with 10% Pd/C (10 % w/w) and 
209 (58 mg, 0.14 mmol, 1 equiv.) dissolved in EtOAc (1.4 mL). The 
mixture was frozen with liquid nitrogen and the Schlenk was 
evacuated, then back filled with hydrogen. The process was repeated 
3 times. 1 atmosphere of hydrogen was kept with a balloon and the mixture was stirred 
vigorously for 2 h. Afterwards, the mixture was filtered through celite and was 
concentrated, affording the hydrogenated residue (55 mg, 95%). The residue (55 mg, 
0.13 mmol, 1 equiv.) was dissolved in EtOH (0.7 mL) and a saturated solution of 
NaHCO3 (4 mL) was added. The mixture was stirred under reflux overnight. The 
volume of the reaction mixture was reduced by half under vacuum and was extracted 
3 times with EtOAc. The combined organic layer was washed with brine, dried over 
MgSO4, filtered and concentrated under reduced pressure. Purification by flash 
chromatography (DCM:MeOH/98:2 to 95:5) afforded 215 as a yellow paste (20 mg, 
59%). 1H NMR (500 MHz, CDCl3): δ 8.06 (s, 1H), 7.29 (d, J = 4.5 Hz, 4H), 7.25-7.20 
(m, 1H), 4.20 (s, 2H), 3.08 (sept, J = 6.8 Hz, 1H), 2.66 (q, J = 7.6 Hz, 2H), 1.28 (d, J 
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= 6.8 Hz, 6H), 1.12 (t, J = 7.6 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 148.6 (e), 
144.0 (e), 141.4 (e), 138.6 (e), 138.2 (o), 137.7 (e), 128.9 (o, 2C), 128.7 (o, 2C), 126.8 
(o), 39.6 (e), 27.6 (o), 23.8 (o, 2C), 18.5 (e), 13.8 (o); IR (neat): ν = 3065 (m), 2959 
(s), 2930 (m), 2870 (br), 1595 (m), 1551 (m), 1494 (m), 1453 (m), 1417 (s), 1372 (w), 
1338 (w), 1318 (w), 1273 (m), 1231 (m), 1185 (vs), 1166 (s), 1149 (s), 1109 (m) 1060 
(m), 1012 (s), 962 (m), 890 (s), 867 (m), 716 (vs), 693 (vs), 656 (m); HRMS (ESI) 
calcd for (C17H21NO + H): 256.1701; found: 256.1696. 
 
Compound 210n. A flame-dried Schlenk was charged with 10% Pd/C (10 % w/w) 
and 203n (246 mg, 0.78 mmol, 1 equiv.) dissolved in EtOAc (7.8 mL). 
The mixture was frozen with liquid nitrogen and the Schlenk was 
evacuated, then back filled with hydrogen. The process was repeated 3 
times. 1 atmosphere of hydrogen was kept with a balloon and the mixture was stirred 
vigorously for 2 h. Afterwards, the mixture was filtered through celite and was 
concentrated affording the hydrogenated residue (246 mg, 97%). The residue (246 mg, 
0.76 mmol, 1 equiv.) was dissolved in EtOH (4 mL) and a saturated solution of 
NaHCO3 (20 mL) was added. The mixture was stirred under reflux overnight. The 
volume of the reaction mixture was reduced by half under vacuum and was extracted 
3 times with EtOAc. The combined organic layer was washed with brine, dried over 
MgSO4, filtered and concentrated under reduced pressure. Purification by flash 
chromatography (DCM:MeOH/98:2 to 95:5) afforded 210n as a white solid (93 mg, 
73%). Instead of using a flash chromatography, the crude mixture could be 
recrystallised from EtOAc (80 mg, 63%). m.p.: 164-165 °C; 1H NMR (500 MHz, 
CDCl3): δ 8.18 (s, 1H), 8.01 (s, 1H), 3.18 (sept, J = 6.9 Hz, 1H), 2.78 (q, J = 7.4 Hz, 
2H), 1.29 (d, J = 6.8 Hz, 6H), 1.20 (t, J = 7.6 Hz, 3H); 13C NMR (125 MHz, CDCl3): 
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δ 153.4 (o), 143.4 (o), 139.3 (o), 136.8 (e), 132.6 (e), 27.6 (o), 23.8 (o, 2C), 18.6 (e), 
13.8 (o); IR (neat): ν = 2970 (s), 2936 (m), 2874 (w), 2508 (br), 1781 (br), 1591 (m), 
1562 (s), 1466 (m), 1422 (vs), 1368 (s), 1320 (w), 1282 (vs), 1192 (m), 1168 (m), 1152 
(m), 1050 (s), 908 (s), 871 (s), 807 (s), 770 (m), 672 (m); HRMS (CI (CH4)) calcd for 
(C19H23NO + H): 166.1226; found: 166.1228; elemental analysis (%) calcd for 
C10H15NO: C 72.67, H 9.08, N 8.48; found C 72.68, H 9.08, N 8.44.    
9.5 Functionalisation 
Compound 229. Under nitrogen, 210n (50 mg, 0.3 mmol, 1 equiv.) was added to an 
oven dried Schlenk tube. A 1:1 mixture of distilled water and THF (3 
mL) was added at room temperature, followed by I2 (85 mg, 0.33 mmol, 
1.1 equiv.) and NaHCO3 (140 mg, 0.33 mmol, 1.1 equiv.). The mixture 
was stirred at 85 °C for 4 h. Then, the reaction mixture was cooled down to room 
temperature and the excess of iodine was quenched with a 10% solution of Na2SO3. 
The aqueous layer was extracted with DCM, the gathered organic layer was dried with 
MgSO4 and all volatiles were removed in vacuo to afford 229 as a yellowish solid (81 
mg, 93%). The product was used for the next step without further purification. m.p.: 
83-86 °C; 1H NMR (500 MHz, CDCl3): δ 7.89 (s, 1H), 5.3 (s, 1H), 3.10 (sept, J = 7.0 
Hz, 1H), 2.75 (q, J = 7.6 Hz, 2H), 1.27 (d, J = 7.0 Hz, 6H), 1.15 (t, J = 7.6 Hz, 3H); 
13C NMR (125 MHz, CDCl3): δ 149.5 (e), 143.2 (e), 141.5 (o), 136.4 (e), 108.7 (e), 
27.2 (o), 23.7 (o, 2C), 19.9 (e), 16.5 (o); IR (neat): ν = 2963 (s), 2927 (m), 2867 (m), 
2541 (br), 1566 (m), 1540 (w), 1458 (m), 1381 (vs), 1324 (s), 1284 (m), 1262 (m), 
1210 (vs), 1152 (s), 1054 (s), 962 (m), 904 (m), 835 (vs), 787 (m), 674 (m); HRMS 
(CI (CH4)) calcd for (C10H14NIO + H): 292.0193; found: 292.0190. 
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Compound 232. Under nitrogen, Pd(PPh3)4 (2 mg, 0.02 mmol, 0.05 equiv.) was added 
to a flame dried Schlenk tube followed by 229 (100 mg, 0.3 mmol, 1 
equiv.) in piperidine (1 mL). The mixture was stirred for 5 min, then, 
4-phenyl-1-butyne (49 μL, 0.3 mmol, 1 equiv.) and copper iodide (5 
mg, 0.02 mmol, 0.07 equiv.) were added. The mixture was stirred at 
room temperature overnight. Then, the mixture was diluted with Et2O and quenched 
with NH4Cl. The aqueous layer was extracted with Et2O. The combined organic layer 
was washed with H2O, brine, dried with MgSO4 and evaporated under vacuum. 
Purification by flash chromatography (PE:EtOAc/90:10) aforded 232 as a yellow solid 
(67 mg, 69%). m.p.: 64-66 °C; 1H NMR (500 MHz, CDCl3): δ 8.37 (s, 1H), 7.32-7.27 
(m, 2H), 7.24-7.19 (m, 3H), 6.53 (s, 1H), 3.23 (sept, J = 7.0 Hz, 1H), 3.16-3.05 (m, 
4H), 2.94 (q, J = 7.6 Hz, 2H), 1.34 (d, J = 7 Hz, 6H), 1.28 (t, J = 7.6 Hz, 3H); 13C 
NMR (125 MHz, CDCl3): δ 161.6, 146.9, 145.7, 143,7, 140.6, 136.5, 132.3, 128.5 
(2C), 128.3 (2C), 126.2, 103.7, 33.8, 30.6, 27.4, 24.3 (2C), 18.8, 14.4; IR (neat): ν = 
2960 (s), 2924 (m), 2866 (m), 1615 (m), 1594 (s), 1560 (w), 1495 (m), 1473 (w), 1450 
(s), 1383 (vs), 1303 (w), 1269 (w), 1238 (s), 1197 (s), 1049 (m), 966 (m), 933 (s), 871 
(w), 808 (s), 785 (m), 765 (w), 747 (s), 698 (vs); HRMS (CI (CH4)) calcd for 
(C20H23NO + H): 294.1852; found: 294.1855. 
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Compound 234. A flame-dried Schlenk tube, under nitrogen, was charged with a 
solution of 210n (50 mg, 0.3 mmol, 1 equiv.) in benzene (0.3 
mL). Paraformaldehyde (11 mg, 0.4 mmol, 1.2 equiv.) and 
morpholine (31 µL, 0.4 mmol, 1.2 equiv.) were added at room 
temperature. The mixture was stirred at 80 °C for 24 h. Afterwards, all volatiles were 
removed in vacuo. Purification by flash chromatography (DCM:MeOH/98:2) afforded 
234 as a white solid (78 mg, 98%). m.p.: 43-45 °C; 1H NMR (500 MHz, CDCl3): δ 
7.94 (s, 1H), 3.90 (s, 2H), 3.77 (br s, 4 H), 3.11 (sept, J = 7.0 Hz, 1H), 2.70 (q, J = 7.6 
Hz, 2H), 2.63 (br s, 4H), 1.27 (d, J = 7.0 Hz, 6H), 1.15 (t, J = 7.5 Hz, 3H); 13C NMR 
(125 MHz, CDCl3): δ  151.7 (e), 142.1 (e), 137.5 (e), 137.4 (o), 137.2 (e), 66.7 (e, 2C), 
63.6 (e), 53.0 (e, 2C), 27.5 (o), 23.8 (o, 2C), 18.2 (e), 13.8 (o); IR (neat): ν = 2961 (s), 
2930 (m), 2878 (m), 2849 (s), 2757 (w), 1556 (m), 1498 (w), 1453 (s), 1407 (vs), 1364 
(m), 1347 (m), 1270 (s), 1213 (m), 1114 (vs), 1069 (s), 1023 (s), 979 (m), 954 (w), 
913 (m), 890 (s), 863 (vs), 808 (s), 734 (s), 665 (w); HRMS (CI (NH3)) calcd for 
(C15H25N2O2 + H): 265.1911; found: 265.1915; elemental analysis (%) calcd for 
C15H24N2O2: C 68.14, H 9.08, N 10.60; found C 67.92, H 9.13, N 10.24.   
 
Compound 235. A flame-dried Schlenk tube, under nitrogen, was charged with a 
solution of 210n (50 mg, 0.3 mmol, 1 equiv.) in toluene (0.3 mL). 
Paraformaldehyde (11 mg, 0.4 mmol, 1.2 equiv.) and 
pyrrrolidine (31 µL, 0.4 mmol, 1.2 equiv.) were added at room 
temperature. The mixture was stirred at 80 °C for 24 h. Afterwards, all volatiles are 
removed in vacuo. Purification by flash chromatography (DCM:MeOH/98:2) afforded 
235 as a colourless paste (60 mg, 80%). 1H NMR (500 MHz, CDCl3): δ 7.91 (s, 1H), 
4.00 (s, 2H), 3.09 (sept, J = 6.9 Hz, 1H), 2.85-2.63 (m, 6H), 1.95-1.82 (m, 4H), 1.27 
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(d, J = 6.9 Hz, 6H), 1.15 (t, J = 7.5 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 151.9 (e), 
141.5 (e), 139.2 (e), 137.3 (o), 136.4 (e), 60.9 (e), 53.6 (e, 2C), 27.5 (o), 23.9 (o, 2C), 
23.7 (e, 2C), 18.2 (e), 13.9 (o); IR (neat): ν = 2970 (s), 2874 (m), 1740 (vs), 1555 (w), 
1461 (m), 1407 (s), 1366 (vs), 1274 (m), 1216 (vs), 1120 (m), 900 (s), 730 (s); HRMS 
(ESI) calcd for (C15H24N2O + H): 249.1967; found: 249.1962. 
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1 Introduction 
Sulfoxonium and sulfonium ylides are stable carbene precursors which were 
discovered in the 1960’s and 30’s respectively.1,2 Sulfur-based ylides have become a 
great tool in organic chemistry, providing robust alternatives for the synthesis of small 
rings such as epoxides and cyclopropanes.3,4,5 Another substantial part of the reactivity 
of sulfonium ylides is dedicated to the (2,3) rearrangement of allylic sulfoniums which 
has been extended to the asymmetric version. 
In 1966, Trost reported the copper-catalysed cyclopropanation of cyclohexene 
with sulfonium ylides.6 Since this report, many metals have been used in collaboration 
with sulfonium ylides, such as rhodium, palladium, iridium, gold and iron.7,8,9,10,11 
Those species have also been used in the metal-catalysed epoxidation, cyclisation and 
C–H bond insertion reactions. 
Although sulfoxonium ylides share some resemblance with sulfonium ylides a 
more indepth study of the former is required to gain an understanding to rival that of 
sulfonium ylides. Thus, a thorough review on the chemistry involving sulfoxonium 
ylides, and their application when coupled with a metal-catalysts, will be presented 
hereafter. 
2 Sulfoxonium ylides reactivity 
2.1 Dimethyl sulfoxonium methylide 
2.1.1 Epoxidation  
The simplest sulfoxonium ylide is dimethyl sulfoxonium methylide 2. It was 
identified and used for the first time by Corey and Chaykovsky in 1962.1 This species 
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was generated from trimethylsulfoxonium chloride 1 upon deprotonation with sodium 
hydride (Figure 1). The ylide was used as a solution in THF for epoxidation reactions. 
Numerous epoxides were thus accessed from ketones and aldehydes in excellent 
yields.12 However, several ketones such as desoxybenzoin 6 and Δ4-cholestenone 7 
proved to be inert under these conditions.  
 
Figure 1: Epoxidation of ketones and aldehydes using dimethylsulfoxonium methylide 
 
Since this work, epoxidation conditions have been refined allowing access to 
chiral frameworks. In 2008, Shibasaki and his group reported the epoxidation of the 
ketone 8 in excellent yield and enantiomeric excess (Figure 2).13 Interestingly, the 
combination of the chiral lanthanide 9 and a catalytic amount of the phosphine oxide 
was required to obtain good levels of stereoselectivity.  
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Figure 2: Enantioselective epoxidation of ketones using dimethylsulfoxonium methylide 
 
2.1.2 Cyclopropanation 
As seen previously, dimethylsulfoxonium methylide is an excellent methylene 
donor. Shortly after Corey and Chaykovsky’s pioneering work, Izzo et al. were able 
to carry out the cyclopropanation of three unsaturated maleimides 11a-c with yields 
ranging from low to excellent (Figure 3).14  
 
Figure 3: Cyclopropanation of maleimides using dimethylsulfoxonium methylide 
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The cyclopropanation of α,β-unsaturated ketones was further investigated by 
Corey and Chaykovsky.12 The authors demonstrated that the cyclopropanation of α,β-
unsaturated ketones was preferred over the epoxidation, thus, eucarvone 13 gave the 
bicylic compound 14 selectively and in excellent yield (Figure 4). Recently, 
Ledingham and co-workers confirmed that stabilised ylides, such as sulfoxonium 
ylides, gave cyclopropanated products whilst less stable sulfonium ylides led to the 
corresponding epoxide.15 
 
Figure 4: Cyclopropanation of eucarvone using dimethylsulfoxonium methylide 
 
Cyclopropanation with sulfoxonium methylide has been of great interest to the 
scientific community. Similar to the epoxidation, control of the chemoselectivity and 
stereoselectivity was improved. A representative example of stereocontrolled 
cyclopropanation was reported by Ellison and Marshall. The authors obtained the 
diastereoisomer 16 as the major product when subjecting the 4-substituted α,β-
unsaturated cyclohexanone 15 to dimethylsulfoxonium methylide (Figure 5).16  
 
Figure 5: Diastereospecific cyclopropanation using dimethylsulfoxonium methylide 
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Furthermore, chiral α,β-unsaturated esters have proven to be suitable for the 
stereoselective cyclopropanation (Figure 6). The chiral cyclopropane 19 was obtained 
in excellent yield when the sulfoxide 18 was subjected to the cyclopropanation with 
dimethylsulfoxonium methylide.17 Even the unprotected terpenoid 21 underwent 
cyclopropanation of the activated alkene to give 22 in excellent yield.18 
 
Figure 6: Stereoselective cyclopropanation of α,β-unsaturated esters using dimethylsulfoxonium methylide 
 
2.1.3 Ring expansion 
Another important application of dimethylsulfoxonium methylide is the ring 
expansion of small rings. Nadir and co-workers reported the stereospecific 
transformation of the aziridines 23 and 25 to the azetidines 24 and 26 in good yields 
(Figure 7).19 An inversion of configuration was observed on the attacked carbon centre 
during the reaction. 
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Figure 7: Stereospecific ring expansion from aziridines to azetidines using dimethylsulfoxonium methylide 
 
Following their work on the enantioselective epoxidation of ketones, Shibasaki 
et al. reported the conversion of the epoxide 27 into the oxetane 28 in excellent yield 
and enantioselectivity (Figure 8).20 The chiral ligand 9 acted as a chiral amplificator 
and allowed the access to highly enantiorich products. It is noteworthy that the authors 
reported the one-pot sequence from ketones to oxetanes in good to excellent yields. 
Interestingly, the access to oxetanes was limited to terminal epoxides. 
 Moreover, Fokin and his group showed that the chiral oxetane 29 could be 
converted to the functionalised tetrahydrofuran 30 in a stereospecific fashion in good 
yield.21 
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Figure 8: Enantioselective ring expansion of epoxide to oxetane using dimethyl sulfoxonium methylide / 
ring expansion from oxetane to tetrahydrofuran using dimethyl sulfoxonium methylide 
 
Recently, Xu and Dong reported that the thiirane 31 could give the 
corresponding thietane 32 in excellent yield (Figure 9).22 However, the same limitation 
as with epoxides seems to apply to thiiranes as only terminal thietanes could be 
generated. 
 
Figure 9: Ring expansion from thiirane to thietane using dimethylsulfoxonium methylide 
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2.1.4 S–S bond cleavage 
In 1977, Field and Chu reported that when the disulphide 33 was reacted with 
dimethylsulfoxonium methylide, a mixture of three products was obtained, amongst 
which, the product of interest was the dithiol 34 (Figure 10).23 However, this reaction 
could not be optimised and only low yield of 34 was obtained under the best 
conditions. 
 
Figure 10: Non-selective S–S bond cleavage using dimethylsulfoxonium methylide  
 
 In 1996, Tazaki and Yamada reported the homologation of the 1,2-dithiolane 
37 into the 1,3-dithiane 38 with dimethylsulfoxonium methylide in excellent yield 
(Figure 11).24 In this case, the S–S bond cleavage was extremely selective and only 
traces of impurities were observed. 
 
Figure 11: S–S bond cleavage of dithiolane using dimethylsulfoxonium methylide 
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2.1.5 Polymerisation 
In 2002, Shea and co-workers developed an access to the long-chain alcohol 
41 by mixing triethyl borane 39 with dimethylsulfoxonium methylide. Upon oxidation 
of the intermediate 40, the corresponding alcohol was obtained in 78% yield (Figure 
12).25 By applying the same methodology to the heptacyclo-thexyl-borane 42, the 
authors were able to synthesise the macrocycle 43 which was then converted to the 
linear diol 44 in excellent yield.26 
 
Figure 12: Polymerisation of triethylborane using dimethylsulfoxonium methylide / polymerisation of 
heptacyclo-thexyl-borane using dimethylsulfoxonium methylide 
 
2.1.6 Formation of complex sulfoxonium ylides 
Dimethylsulfoxonium methylide can also be used to generate more complex 
sulfoxonium ylides when reacted with a suitable electrophile. After the generation of 
the dimethylsulfoxonium methylide A with a base, the attack of the carbene onto the 
electrophile occurs to give B. As an excess of methylide is used, a second equivalent 
can deprotonate the intermediate to form the desired sulfoxonium ylide C along with 
trimethylsulfoxonium salt (Figure 13). 
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Figure 13: Mechanism for the synthesis of substituted sulfoxonium ylides 
 
Acyl chloride 45, ester 47 and isocyanate 49 have been successfully used 
(Figure 14).27, 28, 29 Although methyl esters have proven to be efficient in some cases, 
p-nitrophenyl esters remain more robust.30  
 
Figure 14: Synthesis of α-carbonylsulfoxonium ylides 
 
Aromatic electrophiles that are prone to undergo nucleophilic aromatic 
substitution are also suitable reagents to prepare functionalised sulfoxonium ylides 
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(Figure 15). For example, dimethylchloropyrimidine 51 could be converted to the 
desired sulfoxonium ylide 52 in good yield. The highly functionalised sulfoxonium 
ylide 54 was obtained in good yield when 52 was reacted with acetyl chloride.31 
 
Figure 15: Synthesis of α-pyrimidylsulfoxonium ylide and further substitution 
 
Finally, various other electrophiles have given access to sulfoxonium ylides 
bearing heteroatoms on the methylene centre such as 56 and 58 (Figure 16).32, 33 
 
Figure 16: Synthesis of sulfoxonium ylides bearing heteroatoms 
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2.2 Application of functionalised sulfoxonium ylides 
2.2.1 Non-metal catalysed reactions 
2.2.1.1 Hydrolysis of sulfoxonium ylides 
In 1965, Metzger and König reported the hydrolysis of the α-
carbonylsulfoxonium ylide 50 with hydrochloric acid in quantitative yield (Figure 
17).29 
 
Figure 17: Hydrolysis of α-carbonylsulfoxonium ylide 
 
In 2003, Nugent and co-workers used another type of hydrolysis to access the 
corresponding chloroketone derivatives 61a-c from α-ketosulfoxonium ylides 60a-c.34 
Those species are useful building blocks for the synthesis of N-protected α-amino 
epoxides which can be used as protease inhibitors and HIV treatment.35 The 
sulfoxonium ylides 60a-c were generated from three different Boc- or Cbz-protected 
amino-acids without loss of the enantiomeric purity. Under mild conditions the authors 
obtained the desired α-chloroketones in good yields (Table 1, entry 1-3). Gratifyingly, 
the protecting group was left intact with those conditions. 
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Table 1: Hydrolysis of α-ketosulfoxonium ylide derived from amino-acids 
 
2.2.1.2 Formation of thioethers 
In addition to the hydrolysis of sulfoxonium ylides, Metzger and König showed 
that the β-carbonyl-thioether 63 could be isolated in almost quantitative yield when 
the sulfoxonium ylide 50 was reacted with the thiophenol 62 (Figure 18).29 
 
Figure 18: Synthesis of β-carbonyl-thioether using sulfoxonium ylide 
 
In 2016, Burtoloso and his group revisited this work and reported that, along 
with aromatic thiols, the aliphatic thiol 65 could undergo the reaction smoothly to give 
66 in good yield (Figure 19).36 Treatment of the ketone 67 with a Brønsted acid 
allowed the synthesis of the benzothiophene 68 in 78% yield. 
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Figure 19: Synthesis of β-keto-thioether using sulfoxonium ylide / access to benzothiophene 
 
2.2.1.3 Difunctionalisation of sulfoxonium ylides 
Metzger and König also reported in 1965 the reactivity of sulfoxonium ylides 
when mixed with halogenoalkane (Figure 20).29 When the sulfoxonium ylide 50 was 
treated with methyl iodide, the authors obtained the corresponding gem-methyl-iodide-
amide 69 in low yield. 
 
Figure 20: Difunctionalisation of sulfoxonium ylide with methyl iodide 
 
Recently, Burtoloso et al. expanded the scope of halogenoalkanes suitable for 
this reaction.27 The α-bromoketone 71 was obtained in good yield when the 
sulfoxonium ylide 70 was reacted with benzyl bromide (Figure 21). Moreover, 
electrophilic halogen sources such as Selectfluor were tolerated in this reaction, giving 
the corresponding gem-dihalogenated ketone 73 in 72% yield. 
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Figure 21: Difunctionalisation of sulfoxonium ylide with benzyl bromide or selectfluor 
 
2.2.2 Metal-catalysed reactions 
2.2.2.1 Carbon–heteroatom bond formation 
Surprisingly, metal catalysed reactions with sulfoxonium ylides is far less 
explored. In 1993, Baldwin and co-workers reported the formation of the pyrrolidinone 
and piperidinone, 75 and 77 respectively, from the corresponding linear sulfoxonium 
ylide in the presence of a rhodium (II) catalyst (Figure 22).37  Moderate to good yields 
of the cycloadduct were obtained.  
 
Figure 22: Rhodium-catalysed cyclisation of sulfoxonium ylides 
 
 Later, investigation of the mechanism hinted towards the generation of a metal-
carbene species A (Figure 23).38 Attack of the carbene centre by the amine to give B 
followed by proto-demetalation can regenerate the catalyst alongside the product.  
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Figure 23: Catalytic cycle of the rhodium-catalysed cyclisation of sulfoxonium ylides 
 
Although highly interesting, no improvement on this carbene chemistry was 
reported until 2009. Huffman and co-workers showed that the reaction scope could be 
broadened and both intra- and intermolecular carbon-heteroatom bond formation were 
described.39 The optimisation of the reaction showed that iridium (I) was a better 
catalyst than rhodium (II) for this transformation, with a loading as low as 1 mol% at 
room temperature. Amines, alcohols and thiols reacted smoothly in those conditions. 
When a secondary amine was used, the temperature had to be increased to 70 °C, and 
the solvent was thus changed to 1,2-DCE (Table 2, Entry 2). To access ethers, the 
corresponding alcohol was used as the solvent (Table 2, Entry 3).  
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Table 2: Iridium-catalysed C–heteroatom bond formation using sulfoxonium ylides 
 
Five-, six- and seven-membered rings, 81, 83 and 85 respectively, were 
synthesised after cyclisation of the corresponding sulfoxonium ylides (Figure 24). All 
reactions were performed at 70 °C in 1,2-DCE and gave the desired cycloadduct in 
good yields. 
 
Figure 24: Iridium-catalysed cyclisation of sulfoxonium ylides 
 
145 
 
The same authors demonstrated that gold catalysts were also potent for the 
carbon-heteroatom bond formation with sulfoxonium ylides (Table 3).38 A slight 
increase in yield was observed as compared to iridium complexes. Platinum, as well 
as silver catalysts, proved to be less efficient.  
 
Table 3: Optimisation of the metal-catalysed cyclisation of sulfoxonium ylides 
 
Interestingly, when this new catalyst was used for the cyclisation of 82, the 
desired piperidinone 83 was obtained in extremely low yield when compared to the 
results obtained with the iridium (I) catalyst (Figure 25). 
 
Figure 25: Iridium- and gold-catalysed cyclisation of sulfoxonium ylides 
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Gratifyingly, this methodology was used by Merck in their synthesis of two 
potent drugs: MK-7655 and MK-7246 (Figure 26).40, 41 
 
Figure 26: Structure of MK-7655 and MK-7246 
 
The opening of the Boc-protected pyroglutamic acid 86 to the sulfoxonium 
ylide 87, followed by an iridium catalysed cyclisation, gave the desired piperidinone 
88 in good yield (Figure 27). More importantly, the protocol was used on multi-
kilogram scale. 
 
Figure 27: Ring opening of pyroglutamic acid and iridium-catalysed cyclisation with sulfoxonium ylides to 
access MK-7655 
 
The same metal-catalysed C–N bond formation was employed to access MK-
7246. The opening of the five-membered lactam 89 followed by an iridium-catalysed 
cyclisation gave the 3-piperidinone 91 (Figure 28). Changing the solvent to a mixture 
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of toluene and DMF did not decrease the reactivity and gave the desired piperdinone 
in 83% yield. Similarly to their previous synthesis, this pathway was used in pilot-
plant on production scale to produce more than a hundred kilograms of 91. 
 
Figure 28: Ring opening of five-membered β-lactam and iridium-catalysed cyclisation with sulfoxonium 
ylides to access MK-7246 
 
Interestingly, a decreased yield was observed when O’Shea and his team tried 
the same iridium catalysed cyclisation with the corresponding diazo intermediate 92, 
even with 10 mol% of rhodium (Figure 29). This last result shows that, in some cases, 
sulfoxonium ylides can be more reactive than other carbene precursors. 
 
Figure 29: Rhodium-catalysed cyclisation using diazo-compound 
 
In 2016, Shekhar et al. showed that sulfoxonium ylides could be used in the 
synthesis of either 7- or 8-substituted-imidazopyrrolopyrazines, depending on the 
tandem Catalyst/Ligand used (Figure 30).42 When the iridium catalyst was used 
without external ligands, the C–N bond formation was observed without further 
cyclisation, to give 95 as the major isomer in low yield. However, if phenanthroline 
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was added to the reaction pot, along with sodium triflate, the reaction gave selectively 
the cyclised heterocycle 96 in 60% yield.  
 
Figure 30: Iridium-catalysed formation of 7-or 8-substituted imidazopyrrolopyrazines 
 
 Using NMR and mass spectrometry, the authors were able to track the iridium 
catalyst throughout the reaction. With the iridium (I) catalyst alone, they proposed that 
coordination of the pyrazine ring occurs prior to the carbene formation to give 
intermediate A (Figure 31). Formation of the carbene B followed by the nucleophilic 
attack of the amine leads to the intermediate C. Proto-demetalation of the complex 
affords the functionalised azole and regenerates the active species.  
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Figure 31: Mechanism for the iridium-catalysed synthesis of the 7-substituted imidazopyrrolopyrazine 
When NaOTf and phenanthroline are added to the reaction, coordination of the 
phenanthroline occurs rapidly, favouring the formation of the carbene A (Figure 32). 
Intermolecular attack of the starting material to form the pyrazinium B proceeds in a 
second step. Delocalisation of the lone-pair of electrons of the amine into the ring 
affords the intermediate C, which gives D upon proto-demetalation of the iridium 
catalyst. The product is obtained after cyclisation and elimination of water. 
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Figure 32: Mechanism for the iridium-catalysed synthesis of the 8-substituted imidazopyrrolopyrazine 
 
2.2.2.2 Polymerisation 
 De Bruin and co-workers used dimethylsulfoxonium methylide in rhodium-
catalysed polymerisation reactions (Figure 33).43 The authors also used a combination 
of the ethyl diazoacetate 98 with dimethylsulfoxonium methylide to form co-polymers 
such as 99 in low yield. 
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Figure 33: Rhodium-catalysed polymerisation of dimethylsulfoxonium methylide / rhodium catalysed co-
polymerisation of dimethylsulfoxonium methylide and diazo-compound 
 
2.2.2.3 Carbon-carbon bond formation 
 In 2012, an example of intramolecular carbon-carbon bond formation catalysed 
by iridium was reported in a patent.44 Cyclisation of the pyrrole derivative 100 with an 
alkyltether chain carrying the sulfoxonium ylide, gave the bicyclic compound 101 in 
moderate yield (Figure 34). 
 
Figure 34: Iridium-catalysed cyclisation via C–C bond formation with sulfoxonium ylide 
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3 Aims and objectives 
As seen in this introduction, although sulfoxonium ylides have great potential 
as bench stable carbene precursors, transition-metal catalysed reactions with those 
species are scarce. Moreover, all those reactions involve the formation of a metal-
carbene species as the first elementary step, which can react to generate a C–C or C–
X bond. This methodology requires the use of an activated coupling partner and can 
not be applied to the functionalisation of inert C–H bond.  
Recently, the metal-catalysed C–H bond functionalisation with carbenes has 
raised a tremendous interest for the rapid formation of complex frameworks. Selected 
examples are presented hereafter to showcase the great scope of possible 
transformations brought by this methodology.   
3.1 Carbenes generated from diazo-compounds 
3.1.1 Previous work 
The first example of metal-catalysed C–H bond functionalisation using 
carbenes and a rhodium (III) catalyst was reported in 2012 by Yu.45 The authors 
reported the rhodium-catalysed functionalisation of the O-methyloxime 102 with the 
diazomalonate 103 (Figure 35). Aside from methylated oximes, the authors 
demonstrated that the carboxylic acid 105 was suitable as a directing group and 
obtained the functionalised naphthyl 106 in excellent yield. 
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Figure 35: Rhodium-catalysed Csp2–H bond functionalisation with diazomalonate and 
methyloximes/carboxylic acids 
 
Rovis et al. complemented this work by using the hydroxamate 107 to obtain 
the isoindolone 109 in 81% yield through a rhodium-catalysed (4+1) cyclisation 
(Figure 36).46 Later, Cramer and co-workers reported the enantioselective version of 
this reaction and obtained 111 in good yield and excellent enantioselectivity when the 
chiral Cp ligand was used.47 
 
Figure 36: Racemic and enantioselective rhodium-catalysed Csp2–H bond functionalisation with diazo-
compounds and hydroxamate 
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Glorius and his group reported the functionalisation of the unprotected oxime 
112 to yield the quinoline N-oxide 114 in quantitative yield (Figure 37).48 
 
Figure 37: Rhodium-catalysed Csp2–H bond functionalisation and cyclisation with diazo-compounds and 
oximes 
 
Finally, Li and co-workers showed that pyrrazoles, pyrimidines, pyridines and 
benzoxazoles could be used as directing group with the diazomalonate 103, to give the 
corresponding products in yields ranging from good to excellent (Figure 38).49 It is 
noteworthy that the ortho-substitution of the arene was needed to prevent bis-
functionalisation with the pyrimidine 116 and the benzoxazole 118. 
 
Figure 38: Rhodium-catalysed Csp2–H bond functionalisation with diazo-compounds and various N-
containing directing groups 
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An extensive effort has been made following those works, and a large variety 
of directing groups have been utilised in the C–H bond functionalisation, i.e. secondary 
amines, sulfoximines, diazenes, alcohols and quinolines.45, 49, 50, 51, 52  
Moreover, Glorius and co-workers reported the cobalt-catalysed activation of 
olefinic C–H bonds (Figure 39).53 Annulation of the vinyl pyridine 119 gave the fully 
aromatic bicyclic compound 120 in moderate yield.  
 
Figure 39: Cobalt-catalysed Csp2–H bond functionalisation of olefins with diazo-compounds 
 
Only two examples of Csp3–H functionalisation using diazo-compounds have 
been described in the literature. In 2016, Zhou and co-workers reported the rhodium-
catalysed functionalisation of the quinoline 121 with the diazo-compound 122 in 
quantitative yield (Figure 40).54  
 
Figure 40: Rhodium-catalysed Csp3–H bond functionalisation with diazo-compounds 
 
However, no reaction was observed, neither with the monocarbonyl diazo-
compound 108, nor with any Csp3–H other than primary such as 124 and 125 (Figure 
41).   
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Figure 41: Limitations of the rhodium-catalysed Csp3–H bond functionalsiation with diazo-compounds 
 
Recently, a similar approach was investigated with a cobalt catalyst and the 
same limitations were observed.55 
3.1.2 Proposed mechanism 
The C–H activation/functionalisation mechanism can be summarised as 
depicted below (Figure 42).56 Coordination of the catalyst to the directing group 
affords the complex A which is converted to B upon a concerted 
metallation/deprotonation (CMD). Nucleophilic attack of the diazo-compound forms 
the diazonium intermediate C which is converted to the carbene species D upon release 
of nitrogen. After migratory insertion to give E, the proto-demetalation of this 
intermediate releases the product along with the active catalyst. 
157 
 
 
Figure 42: Proposed mechanism for the metal-catalysed C–H bond functionalisation with diazo-
compounds 
 
3.2 Alternatives 
Although incredibly versatile and useful synthons, diazo-compounds are 
notorious for being unstable. Thus, alternatives have been studied in order to 
circumvent this drawback.57 
3.2.1 Triazoles 
In 2015, Glorius et al. investigated the use of pyridotriazoles as a new class of 
stable carbene precursors.58 Triazoles have been mainly used in C–H functionalisation 
as directing groups.59 Pyridotriazoles are in equilibrium with the α-diazopyridine form, 
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as depicted with 126 and 127, thus the same reactivity as described previously can be 
expected (Figure 43).60 
 
Figure 43: Equilibrium between the triazole and the α-diazopyridine 
 
This property was successfully applied to the rhodium catalysed C–H 
activation of phenyl pyridine 128 (Figure 44). The authors reported the synthesis of 
the highly conjugated heterocycle 130 in quantitative yield. 
 
Figure 44: Rhodium-catalysed Csp2–H Bond functionalisation/cyclisation with triazoles 
 
The same reagent was used by Lee and his group for the functionalisation of 
the sulfoximine 131 to the benzothiazine 133 in 83% yield (Figure 45).61 The product 
with the anti-relationship between the methyl and the pyridyl group was the major 
diastereoisomer. 
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Figure 45: Rhodium-catalysed Csp2–H bond functionalisation/cyclisation with triazoles and sulfoximines 
  
3.2.2 Tosyl-hydrazones 
Similar to the previous reagent, tosyl-hydrazones are used as stable diazo 
precursors. When subjected to basic conditions, a loss of tosylate occurs to generate 
the desired diazo-compound 136 (Figure 46).62 
 
Figure 46: Mechanism for the generation of diazo-compounds from tosyl-hydrazones 
 
Although more studied than triazoles as carbene precursors, the C–H activation 
with tosyl-hydrazones generally involves a copper, nickel or cobalt catalyst. Wang and 
co-workers focused on the copper catalysed C–H bond functionalisation.63 The authors 
reported the alkylation of the benzoxazole 137 with the tosyl-hydrazone 138 (Figure 
47). Aside from benzoxazoles, the benzothiazole 140 and the 1,2,4,5-
tetrafluorobenzene 142 gave the corresponding products 141 and 143 respectively, in 
good to moderate yield. Both the temperature and the amount of catalyst had to be 
increased and the solvent changed to 1,4-dioxane for those substrates. 
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Figure 47: Copper-catalysed Csp2–H bond functionalisation with tosyl-hydrazones 
 
 Shortly after, Hirano and Miura reported the same reaction with either a nickel 
or cobalt catalyst (Figure 48).64 Both the benzoxazole 144 and phenyloxazole 147 were 
functionalised in good yields, but only 1,3-azoles were investigated. 
 
Figure 48: Nickel- and cobalt-catalysed Csp2–H bond functionalisation with tosyl-hydrazones 
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Only two examples of rhodium-catalysed C–H bond functionalisation with 
tosyl-hydrazones were reported, both by Wang and his group in 2013 and 2014. In 
their first paper, the authors used Wilkinson’s catalyst to activate the 
quinolinylmethanone 149 and synthesise the α,β-unsaturated ketone 151 in good yield 
(Figure 49).65 
 
Figure 49: Rhodium-catalysed Csp3–H functionalisation with tosyl-hydrazones 
 
A year later, the same group reported the rhodium-catalysed functionalisation 
of the oxyacetimide 152 to the phenol 153 in 83% yield (Figure 50).66  
 
Figure 50: Rhodium-catalysed Csp2–H bond functionalisation with tosyl-hydrazones 
 
3.2.3 Enynones 
Recently, Chang et al. reported the use of enynones as possible carbene 
precursors, and their application in the functionalisation of the N-functionalised 
benzamide 107 (Figure 51).67 With the appropriate Cp ligand, the authors could direct 
the reaction towards the (4+2) or the (4+1) cycloadduct, 155 and 156 respectively. 
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Figure 51: Rhodium-catalysed Csp2–H functionalisation with enynones 
 
The authors proposed that the formation of 155 involves a series of cyclisations 
after the first C–H bond functionalisation, as opposed to 156 which proceeds through 
the generation of a rhodium-carbene species. 
After the generation of the pentarhodacycle A, the coordination of the enynone 
154 affords the complex B (Figure 52). The nucleophilic attack of one of the oxygens 
gives the zwitterionic intermediate C which rearranges into the rhodium-carbene D. 
The furan 156 is released, along with the active catalyst, upon migratory insertion and 
reductive elimination of the metal. 
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Figure 52: Mechanism for the rhodium-catalysed (4+1) cycloaddition with enynones 
 
3.3 Hypothesis 
The chemistry around sulfoxonium ylides has been well studied and those 
species have been used in various reactions. However, all metal catalysed reactions 
with sulfoxonium ylides relied on the generation of a metal-carbene species A, as 
depicted in the example below (Figure 53). Recently, Vaitla and co-workers reported 
the synthesis of the functionalised indole 158 through the iridium-catalysed C–N bond 
formation with sulfoxonium ylides.68 Addition of aniline on the iridium-carbene 
intermediate A, gives the zwitterrionic intermediate B which transforms to C upon 
proto-demetalation. After generation of D with a second equivalent of aniline, the 
desired indole is obtained through a cyclisation/re-aromatisation sequence. 
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Figure 53: Iridium-catalysed synthesis of a functionalised indole 
 
Although efficient and elegant, this methodology was expanded to the 
synthesis of pyrroles, it requires the use of activated coupling partners and is limited 
to C–N bond formation. As the direct functionalisation of Csp2–H was not reported, 
we wanted to show that sulfoxonium ylides could be used for the rhodium (III)-
catalysed cross-coupling reaction with C–H bonds, in a similar mechanism to the one 
described with diazo-compounds, triazoles and tosyl-hydrazones.  
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4 Cross coupling of sulfoxonium ylides with C–H bonds 
4.1 Synthesis of sulfoxonium ylides 
4.1.1 From esters 
4.1.1.1 Sulfoxonium ylides synthesis from methyl esters 
A seen in the introduction (Part 2.1.6), several α-ketosulfoxonium ylides have 
been prepared by reacting dimethylsulfoxonium methylide with a methyl ester. The 
carbene can be generated from either trimethylsulfoxonium chloride or the iodide salt. 
The latter shows decreased reactivity but is significantly cheaper than the chloride salt.  
When the procedure was applied to selected ketosulfoxonium ylides, results 
did not appear as promising in comparison to those reported in the literature (Table 4). 
Traces of the pyridine derivative 167 were obtained, giving the sulfoxonium ylide in 
3% yield (Table 4, entry 1). A Boc-protected piperidine 168 was obtained in a 
significantly better yield of 26% (Table 4, entry 2). The gem-diphenyl sulfoxonium 
ylide 169 was synthesised in average yield (Table 4, entry 3). However, when α-β-
unsaturated esters 162 and 164 were used, a complex mixture was obtained without 
significant traces of the desired product (Table 4, entry 4 and 6). The same results were 
observed with the furyl ester 163 and the 1,4-ketoester 165 (Table 4, entry 5 and 7). 
No reactivity was observed when the sulfonyl ester 166 was used (Table 4, entry 8).  
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Table 4: Synthesis of α-ketosulfoxonium ylides using methyl esters 
  
It is worth mentioning that no reaction was observed when the ethyl ester 175 
was reacted with dimethyl sulfoxonium methylide, even at elevated temperature 
(Figure 54). 
 
Figure 54: Synthesis of α-ketosulfoxonium ylides using an ethyl ester 
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4.1.1.2 Sulfoxonium ylides synthesis from p-nitrophenyl ester 
In order to solve the issues of low reactivity often encountered with methyl 
esters, para-nitrophenyl esters have been used as an alternative.30  
The better leaving group allowed the synthesis of various sulfoxonium ylides 
(Table 5). The esterification of the carboxylic acids gave the corresponding esters in 
good yields in all cases. The purification of those esters proved to be difficult in some 
cases, giving a mixture of the p-nitrophenol and the ester. Aromatic compounds were 
tolerated and gave 64, 185 and 186 in 44%, 27% and 36% yield respectively, over the 
two steps (Table 5, entry 1, 2 and 3). Aliphatic groups could be transformed to the 
corresponding sulfoxonium ylides 187 and 188 in 71% and 66% yield (Table 5, entry 
4 and 5). The cyclopropane derivative 181 gave the desired sulfoxonium ylide 189 in 
32% yield (Table 5, entry 6). A benzylic group such as in 182 was well tolerated and 
afforded 190 in 70% yield (Table 5, entry 7). Finally, the conjugated alkynyl substrate 
183, as well as the heterocycle 184, gave complex mixtures without traces of the 
desired products (Table 5, entry 8 and 9). 
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Table 5: Synthesis of α-ketosulfoxonium ylides using p-nitrophenyl esters 
 
4.1.2 From acyl chlorides 
A possible alternative for the synthesis of sulfoxonium ylides is to start with 
the corresponding acyl chloride. Numerous acyl chlorides are commercially available, 
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often at low cost, allowing the rapid construction of a great library of sulfoxonium 
ylides. Finally, due to the great reactivity of acyl chlorides, the formation of the desired 
sulfoxonium ylide often requires only ten minutes as opposed to the reactions starting 
from p-nitrophenylesters (Table 6). 
Thus, an interesting array of sulfoxonium ylides was obtained with acyl 
chlorides with among them, four other aromatic compounds. Para-substitution of the 
benzene ring with an eletron-donating functional group led to the synthesis of 203 in 
19% yield (Table 6, entry 1). It is worth mentioning that in this case, sodium tert-
butoxide was used instead of the potassium salt. A chloro substituent in ortho-position 
of the benzene ring did not impede the reaction and the desired ylide 204 was isolated 
in 80% yield (Table 6, entry 2). Moreover, bis-meta substituted acyl chlorides bearing 
electron withdrawing groups led to the corresponding sulfoxonium ylides 205 and 206 
in 50% and 89% yield (Table 6, entry 3 and 4). In order to assess the effect of the steric 
hindrance in the subsequent C–H bond activation, the bulky adamantyl derivative 207 
was synthesised in almost quantitative yield (Table 6, entry 5). Heteroaromatic acyl 
chlorides were well tolerated in this reaction and gave the furyl 208 and the thiophenyl 
209 in good yields (Table 6, entry 6 and 7). Surprisingly, the isoxazole 199 gave the 
corresponding ylide 210 in significantly lower results and the reaction of 200 led to 
the decomposition of the starting material without traces of the desired compound in 
the crude mixture (Table 6, entry 8 and 9). The benzyl protected alcohol 201 was 
converted into the corresponding product 70 in good yield (Table 6, entry 10). Finally, 
the chloroamide 202 led to no reaction upon treatment with the optimised conditions 
(Table 6, entry 11). 
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Table 6: Synthesis of α-ketosulfoxonium ylides using acyl chlorides 
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4.1.3 Miscellaneous 
In some cases, the use of other electrophiles was synthetically advantageous. 
Thus, acetic anhydride 213 gave the sulfoxonium ylide 214 in good yield (Figure 55). 
 
Figure 55: Synthesis of an α-ketosulfoxonium ylide using acetic anhydride 
 
By reacting the phosphine oxide 215 in the classical conditions, the 
sulfoxonium ylide 216 bearing a phosphorus atom was synthesised in 25% yield 
(Figure 56). This example shows versatility of those carbene precursors. 
 
Figure 56: Synthesis of an α-phosphinylsulfoxonium ylide using a chloro-phosphine oxide 
 
 As seen in the introduction, pyrimidines have been used as electrophiles to 
generate several sulfoxonium ylides.31 Those results could be reproduced to get 52 in 
average yield (Figure 57).  
172 
 
 
Figure 57: Synthesis of an of α-pyrimidylsulfoxonium ylide from a chloro-pyrimidine 
 
4.1.4 Bis-substituted sulfoxonium ylides 
When the pyrimidine sulfoxonium ylide 52 was reacted with the acyl chloride 
217, the chloroformate 219 or the isocyanate 49, the corresponding highly substituted 
sulfoxonium ylides were recovered in low to good yield (Figure 58). The lack of 
reactivity observed with the isocyanate could be explained by the poor state of the 
starting material used. 
 
Figure 58: Bis-functionalisation of α-pyrimidylsulfoxonium ylides 
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As shown by the group groups of Metzger and Burtoloso, the direct alkylation 
of the methylide centre of a sulfoxonium ylide is not possible and leads instead to the 
formation of the gem-difunctionalised product 69.29 Thus, an alternative route had to 
be developed for the synthesis of alkyl-substituted α-ketosulfoxonium ylides. 
 Shea and Zhao reported the synthesis and application of diethylsulfoxonium 
ethylide 223 in the synthesis of co-polymers (Figure 59).69 
 
Figure 59: Synthesis of diethylsulfoxonium ethylide 
 
We assured that the substituted sulfoxonium ylide 226 could be obtained upon 
reaction of diethylsulfoxonium ethylide 223 and the electrophile 192 (Figure 61). The 
synthesis of the triethylsulfoxonium chloride was completed in three steps starting 
from the diethyl sulfur 224 (Figure 60). Thus, triethylsulfur chloride 225 was obtained 
in quantitative yield after a nucleophilic attack of diethyl sulfur 224 on iodoethane 
followed by a halogen exchange with tri-butylbenzylammonium chloride. Oxidation 
with m-CPBA in basic media afforded the triethyl sulfoxonium ylide 222 in moderate 
yield. 
 
Figure 60: 3-steps synthesis of triethylsulfoxonium chloride 
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Following the general conditions developed with acyl chlorides, the 
diethylsulfoxonium ethylide 223 was generated in-situ with potassium tert-butoxide 
in THF at reflux (Figure 61). Slow addition of the p-methoxybenzoyl chloride 192 at 
low temperature gave the sulfoxonium ylide 226 in excellent yield.  
 
Figure 61: Synthesis of methyl-substituted sulfoxonium ylide  
 
4.2 Transition-metal catalysed C–H bond functionalisation 
4.2.1 Optimisation of the reaction conditions 
4.2.1.1 Catalytic attempt 
The investigation into the rhodium-catalysed C–H bond functionalisation using 
sulfoxonium ylides began by using Bolm’s conditions with slight changes.50 The 
hexarhodacycle 227 was obtained in 15% yield, based on the starting rhodium 
complex, when the sulfoxonium ylide 187 was treated with 128, NaOAc, [Cp*RhCl2]2 
and AgOAc in 1,2-DCE (Figure 62). The complex 227 was characterised by 1H NMR 
and 13C NMR and the diastereomeric ratio was calculated based on the crude 1H NMR. 
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Figure 62: Catalytic attempt at the rhodium catalysed Csp2–H bond functionalisation of phenylpyridine 
with a sulfoxonium ylide 
 
 This result was encouraging as it confirmed that the targeted C–C bond 
formation had occurred. However, the reaction was clearly not catalytic, and changes 
had to be made in order to close the catalytic cycle.  
4.2.1.2 Stoichiometric attempts 
In order to improve the understanding of the reaction, a step-wise approach of 
the mechanism was investigated. The C–H activated metallacycle 228 was prepared 
assuring that the lack of reactivity observed was not imputable to the first C–H 
activation. The desired pentarhodacycle was prepared in good yield upon reaction of 
the [Cp*RhCl2]2 with the model substrate 128 in DCM with sodium acetate (Figure 
63).70 
 
Figure 63: Synthesis of the five-membered rhodacycle with phenylpyridine 
 
When the pentarhodacycle 228 was treated with the cyclohexyl sulfoxonium 
ylide 187 in 1,2-DCE, the hexarhodacycle 227 was isolated in low yield (Figure 64). 
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Figure 64: Stoichiometric attempt at the rhodium-catalyed Csp2–H bond functionalisiation of 
phenylpyridine with a sulfoxonium ylide 
 
By looking at the proposed mechanisms of transition-metal catalysed C–H 
functionalisation using carbenes (See Figure 42, Section 3.1.1.2), one can understand 
that the problem observed in those attempts arises from the final catalytic step 
converting E to the desired product with regeneration of the active catalyst upon proto-
demetalation (Figure 65). 
 
Figure 65: Hypothesis of the key-role of the solvent in the proto-demetalation elementary step 
 
It was hypothesised that a proton source was needed in order to close the 
catalytic cycle. Acidic additives and protic solvents were investigated to induce a 
catalytic turnover. 
177 
 
4.2.1.3 Effect of the solvent 
Unfortunately, nor the addition of trifluoroacetic acid (TFA), nor acetic acid, 
promoted the formation of the desired product (Table 7, entry 1 and 2). It was 
hypothesised that ethanol at higher temperature could help the formation of the desired 
product. Indeed, traces of the functionalised phenyl pyridine were observed in the 
crude mixture, validating that protic solvent could close the catalytic cycle (Table 7, 
entry 3). Thus, fluorinated solvent with better protic properties were investigated. The 
conversion increased to 37% when trifluoroethanol (TFE; pKa = 12.3) was used as the 
solvent (Table 7, entry 4). 71 Changing the base from sodium acetate to potassium 
pivalate induced a decrease of conversion (Table 7, entry 5). Finally, the best 
conversion was observed by using hexafluoroisopropanol (HFIP; pKa = 9.3) (Table 7, 
entry 6). 72  
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Entrya Solvent Co-catalyst Additive 
Conversion 
(%)b 
1 DCE 10 mol% AgTFA TFA (1 equiv.) 0 
2 DCE 10 mol% AgSbF6 AcOH (1 equiv.) 0 
3c EtOH 10 mol% AgSbF6 / 7 
4 TFE 10 mol% AgSbF6 NaOAc (1 equiv.) 37 
5 TFE 10 mol% AgSbF6 PivOK (1 equiv.) 29 
6 HFIP 10 mol%, AgOAc NaOAc (1 equiv.) 63 
a) All reactions were carried out with 128 (0.2 mmol), 187 (0.2 mmol), [Cp*RhCl2]2 (0.004 
mmol) except noted otherwise. b) determined by 1H NMR of the crude mixture. c) using 
2.5 mol% of [Cp*RhCl2]2 at 100 °C.  
Table 7: Solvent screening for the rhodium-catalysed Csp2–H bond functionalisation of phenylpyridine 
with a sulfoxonium ylide 
 
4.2.1.4 Effect of the silver co-catalyst 
With the optimal solvent in hand, our focus was placed on the silver additive 
used to promote the formation of the active rhodium monomer. Following reaction 
conditions reported by Zhou and co-workers, a mixture of two silver sources was used, 
leading to similar results as those obtained with silver acetate (Table 8, entry 1 and 
2).73 A significant increase of conversion was obtained using either silver 
tetrafluoroborate or hexafluoroantimonate (Table 8, entry 3 and 4). Silver 
hexafluoroantimonate was used due to the availability of this additive in the laboratory.  
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Entrya Silver 
Conversion 
(%)b 
1 AgOAc 63 
2c AgOAc/AgNTf2 64 
3 AgBF4 73 
4 AgSbF6 72 
a) All reactions were carried out with 128 (0.2 mmol), 187 (0.2 mmol), 
[Cp*RhCl2]2 (0.004 mmol) and NaOAc (0.2 mmol) in HFIP at 60 °C except 
noted otherwise. b) determined by 1H NMR of the crude mixture. c) using 
10 mol% of AgOAc and 10 mol% of AgNTf2.  
Table 8: Silver co-catalyst screening for the rhodium-catalysed Csp2–H bond functionalisation of 
phenylpyridine with a sulfoxonium ylide 
 
4.2.1.5 Effect of the stoichiometry 
Although relatively high conversions were obtained in HFIP with silver 
hexafluoroantimonate, a significant part of unreacted starting material was recovered 
(Table 9, entry 1). Interestingly, an almost linear increase of conversion was observed 
with the increase of the amount of sulfoxonium ylide, with 1.7 equivalent giving the 
optimum result (Table 9, entry 1-6). Moreover, an inert atmosphere was not required 
to carry out the reaction to full conversion (Table 9, entry 7). Finally, inverting the 
stoichiometry by using 2 equivalents of 128 for 1 equivalent of the sulfoxonium ylide 
187 gave lower yield (Table 9, entry 8). 
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Entrya X (equiv.) 
Conversion 
(%)b 
1 1 72 
2 1.1 75 
3 1.2 84 
4 1.5 88 
5 1.7 >99 
6 2 >99 
7c 1.7 >99 
8d 1 70e 
a) All reactions were carried out with 128 (0.2 mmol), [Cp*RhCl2]2 (0.004 
mmol), AgSbF6 (0.02 mmol) and NaOAc (0.2 mmol) in HFIP at 60 °C except 
noted otherwise. b) determined by 1H NMR of the crude mixture. c) under 
air. d) with 128 (0.4 mmol) and 187 (0.2 mmol). e) isolated yield. 
Table 9: Effect of the stoichiometry on the rhodium-catalysed Csp2–H bond functionalisation of 
phenylpyridine with a sulfoxonium ylide 
 
4.2.1.6 Effect of the base 
As reported previously the use of a base can have a significant impact on the 
outcome of the reaction. When potassium pivalate was used instead of sodium acetate 
the conversion significantly decreased (see Table 7 entry 4 and 5). Thus, the effect of 
the base loading was investigated with three different sulfoxonium ylides 187, 188 and 
64. In the case of the cyclohexyl-substituted sulfoxonium ylide 187, no effect of the 
base on the conversion was observed (Table 10, 1 and 2). However, an increase of 
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conversion was seen with the increase of the amount of sodium acetate used in the case 
of 188 (Table 10, entry 3, 4, and 5). Finally, no significant effect of the base on the 
reaction was observed with the phenyl-substituted sulfoxonium ylide 64 and excellent 
conversions were thus obtained with or without sodium acetate (Table 10, entry 6 and 
7).  
 
Entrya 
Sulfoxonium 
ylide 
X (equiv.) 
Yield 
(%)b 
1c 187 1 99 
2c 187 0 99 
3 188 1 77 
4 188 0.2 61 
5 188 0.5 71 
6c 64 1 99 
7c 64 0 95 
a) All reactions were carried out with 128 (0.2 mmol), sulfoxonium ylide 
(0.4 mmol), [Cp*RhCl2]2 (0.004 mmol), AgSbF6 (0.02 mmol) in HFIP at 60 
°C except noted otherwise. b) isolated yield. c) 1.7 equiv. of sulfoxonium 
ylide.  
Table 10: Base screening for the rhodium-catalysed Csp2–H bond functionalisation of phenylpyridine with 
sulfoxonium ylides 
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4.2.1.7 Control experiments 
Finally, a series of control experiments were run in order to prove that all 
species were required for the direct C–H functionalisation of phenyl pyridine 128 with 
the sulfoxonium ylide 187. Removing the silver co-catalyst from the reaction 
decreased significantly the isolated yield, but good conversion was still obtained 
(Table 11, entry 1). Moreover, decreasing the amount of rhodium and silver catalysts 
almost halved the conversion (Table 11, entry 2). Removing the catalyst completely 
stopped the reaction, which shows that it is indeed catalysed by rhodium (Table 11, 
entry 3). Finally, changing the rhodium catalyst for an iridium, a cobalt or a ruthenium 
catalyst did not give any reactivity (Table 11, entry 4, 5, 6 and 7). 
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Entrya Variations to standard conditions 
Conversion 
(%)b 
1 No AgSbF6 81 
2 1 mol% [Rh], 5 mol% Ag 58 
3 No [Cp*RhCl2]2 0 
4 [Cp*IrCl2]2 instead of [Rh] 0 
5 [Cp*CoI2]2 instead of [Rh] 0 
6 [Cp*Co(CO)2I]2 instead of [Rh] 0 
7 [Ru(p-cymene)Cl2]2 instead of [Rh] 0 
a) All reactions were carried out with 128 (0.2 mmol), 187 (0.4 mmol), 
[Cp*RhCl2]2 (0.004 mmol), AgSbF6 (0.02 mmol) and NaOAc (0.2 mmol) in 
HFIP at 60 °C except noted otherwise. b) determined by 1H NMR of the 
crude mixture. 
Table 11: Control experiments for the rhodium-catalysed Csp2–H bond functionalisation of phenylpyridine 
with a sulfoxonium ylide 
 
 Those optimised conditions were used with all the prepared sulfoxonium ylides 
in order to assess the scope of the cross-coupling of C–H bonds with sulfoxonium 
ylides. 
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4.2.2 Scope of the reaction 
4.2.2.1 Sulfoxonium ylide 
Pleasingly, excellent yields were obtained with many sulfoxonium ylides 
(Figure 66). The cyclopropyl derivative 229a was obtained in quantitative yield while 
the bulkier isopropyl coumpound 229b was isolated in lower yield. Moreover, in this 
case the amount of sulfoxonium ylide had to be increased to 2 equivalents in order to 
reach full conversion of the phenyl pyridine. Para-substituted arenes with both an 
electron-withdrawing or an electron-donating group underwent the reaction smoothly 
to give 229d and 229e, respectively. However, electron-poor arenes gave slightly 
decreased yield and the amount of sulfoxonium ylide had to be increased to 2 
equivalents, as observed with 229f. Heteroarene sulfoxonium ylides could undergo the 
reaction well when an extended reaction time was applied, as shown with 229g and 
229h. Finally, the cyclopropane derivative 229i, the adamantyl 229j and the Boc-
protected piperidine 229k afforded the desired products in 90%, 89% and 86% yield 
respectively. 
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Figure 66: Scope of the rhodium-catalysed Csp2–H bond functionalisation of phenylpyridine with 
sulfoxonium ylides 
 
 Interestingly, when the sulfoxonium ylide 190 was used, no traces of the 
desired functionalised phenyl pyridine were obtained, and 230 was recovered in low 
yield as the sole regioisomer (Figure 67). The same outcome was observed with 169 
which gave traces of the functionalised pyridine 229l and the cycloadduct 231 as the 
major product.  
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Figure 67: Cyclisation of sulfoxonium ylides 
 
Although unexpected, this reaction was interesting and further investigation in 
the optimisation of the reaction conditions was started (Figure 68).  Removing both 
catalysts, as well as the phenyl pyridine, gave the bicyclic compound 231 in 70% yield. 
This project was given to another student from the group for further optimisation. 
 
Figure 68: Optimisation of the rhodium-catalysed cyclisation of sulfoxonium ylides 
 
 Unfortunately, several sulfoxonium ylides were not suitable for the C–H 
functionalisation reaction. Ortho-substitution of the arene ring with a halogen atom 
was detrimental and no reaction was observed with the two sulfoxonium ylides 185 
and 204 (Figure 69). The two heteroaromatic rings bearing a nitrogen atom, 167 and 
210, led to the same outcome, probably due to an inhibiting coordination from the 
nitrogen atom to the metal. Reacting the phosphosulfoxonium ylide 216 also led to no 
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reaction. Finally, both the keto- and ester-substituted sulfoxonium ylides with a 
pyrimidine group 218 and 220 gave no reaction under the optimised conditions. 
 
Figure 69: Limitations regarding the scope of sulfoxonium ylides suitable for the rhodium-catalysed Csp2–
H bond functionalisation 
 
As opposed to the two pyrimidine sulfoxonium ylides 218 and 220, the 
substituted amide sulfoxonium ylide 221 gave the fully aromatic tetracyclic compound 
232 in low yield (Figure 70). After a first C–H bond functionalisation, a cyclisation 
occurs to release 232, along with aniline. This reaction relates to that reported by 
Glorius et al. on their work with triazoles as carbene precursors.58 However, regardless 
of all efforts the yield of this cyclisation remained low. 
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Figure 70: Rhodium-catalysed Csp2–H bond functionalsiation/cyclisation of phenylpyridine with a α-
pyrimidyl-α-amidosulfoxonium ylide 
 
The methyl substituted sulfoxonium ylide 226 generated from the 
diethylsulfoxonium ethylide reacted with the phenylpyridine to give the corresponding 
cycloadduct 229m in average yield (Figure 71). Moreover, the amount of sulfoxonium 
ylide, the temperature and the reaction time had to be increased in order to obtain full 
conversion, leading to the formation of a lot of side-products. A pure fraction of the 
product could not be isolated, thus the reported yield was based on 1H NMR with an 
internal standard. 
 
Figure 71: Rhodium-catalysed Csp2–H bond functionalisaiton of phenylpyridine with a methyl-substituted 
sulfoxonium ylide 
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4.2.2.2 Csp2–H bond scope 
Whilst the conditions proved to be general with respect to the sulfoxonium 
ylide, the functionalisation of other Csp2–H bonds was investigated (Figure 72). The 
first attempts were directed towards substituted arenes bearing electron-donating or -
withdrawing groups. Interestingly, a mixture of unseparable regioisomers 233a and 
233b were obtained with the methoxy-substituted arene in a 2.5:1 ratio. However, a 
completely regioselective functionalisation occurred with the electron-poor arene and 
234 was isolated in good yield with two equivalents of sulfoxonium ylide at 90 °C. 
Increasing both the temperature and the amount of sulfoxonium ylide did not allow the 
improvement of the results obtained with electron-rich arenes.  
Heteroaromatic rings were well tolerated in the reaction and the functionalised 
indole 235 was isolated in good yield. The pyrrole derivative was successfully 
functionalised with the isopropyl-substituted sulfoxonium and 236 was recovered in 
75% yield. However, a mixture of mono- and bis-substituted pyrrole, 237 and 238, 
was obtained with the furyl-substituted sulfoxonium. Surprisingly, the cross-coupled 
furylpyridine 239 was recovered in good yield as the sole regioisomer. Finally, the 
functionalised pyridinone 240 was isolated in 71% yield at higher temperature when 
using the pre-formed rhodium catalyst [Cp*Rh(OAc)2•H2O]. 
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Figure 72: Scope of the rhodium-catalysed Csp2–H bond functionalisation of pyridyl-arenes with 
sulfoxonium ylides 
 
4.2.2.3 Directing groups 
4.2.2.3.1 Quinoline 
Although highly interesting as model substrates in order to optimise reaction 
conditions, pyridine is not the most useful directing group with respect to a possible 
application of the products of C–H functionalisation in synthesis. Thus, the 
investigation of other functionalities capable of directing the C–H activation was 
required. The quinoline 241 proved to be efficient in the reaction and gave the desired 
functionalised product in good to quantitative yields (Figure 73). Interestingly, whilst 
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242b and 242c were obtained quantitatively, a significant decrease of yield was 
observed with the cyclohexyl-substituted sulfoxonium ylide 187, as compared to the 
result obtained with phenylpyridine 128.  
 
Figure 73: Scope of the rhodium-catalysed Csp2–H bond functionalisation of quinolinyl-arenes with 
sulfoxonium ylides 
 
4.2.2.3.2 N-methoxybenzamide 
N-functionalised-benzamides have been extensively used as directing groups 
in metal-catalysed C–H activation.46 After a C–H functionalisation of the ortho-
position, a cyclisation can occur leading to the formation of substituted 
isoquinolinones (Figure 74). Unfortunately, no reaction occurred when the optimised 
conditions were used. However, moderate yields were obtained when the pre-made 
rhodium acetate monomer was used as catalyst. Whilst the sulfoxonium ylide 187 gave 
the corresponding isoquinolinone 244a in 59% yield as the only product, 
192 
 
chemoselectivity issues arised with the phenyl derivative 64. In this case, both the 
isoquinolinone 244b and the isocoumarin 245 were isolated.  
 
Figure 74: Rhodium-catalysed Csp2–H bond functionalisation of N-methoxybenzamide with sulfoxonium 
ylides 
 
Regardless of this selectivity issue, both products are interesting heterocycles 
with possible biological properties (Figure 75). The isoquinolinone 246 has been 
reported to have anti-viral activity, while the isocoumarin 247 showed great MptpB 
inhibition properties which is key in the treatment of tuberculosis.74, 75, 76 
 
Figure 75: Biological properties of isoquinolinone and isocoumarin 
 
4.2.2.3.3  O-methyloximes 
In their pioneering work on metal-catalysed C–H bond functionalisation with 
carbenoids, Yu and co-workers showed that methylated oxymes can efficiently direct 
the reaction.45 As was the case with the N-methoxybenzamide 243, no reaction was 
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observed when subjecting the methyl oxime 102 to the optimised conditions. The same 
outcome was obtained with the [Cp*Rh(OAc)2•H2O]. Changing to the cationic 
rhodium monomer, [Cp*Rh(MeCN)3](SbF6)2, allowed the synthesis of 248 in 
excellent yield (Figure 76).  
 
Figure 76: Rhodium-catalysed Csp2–H bond functionalisation of N-methoxybenzamide with sulfoxonium 
ylide 
 
4.2.2.4 Limitations 
As seen in this section, the extension of the reaction to other directing groups 
was not as trivial as expected and led in many cases to a complete absence of reactivity. 
All the directing groups that failed to promote the reaction are depicted below (Figure 
77).  
 
Figure 77: Limitations regarding the scope of directing groups suitable for the rhodium-catalysed Csp2–H 
bond functionalisation with sulfoxonium ylides 
 
However, another student from the group showed that pyrimidines and 
pyrazoles were suitable for this reaction when both the amount of sulfoxonium ylide 
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and the temperature were increased (Figure 78). Average to quantitative yields were 
obtained and the scope was thus extended. 
 
Figure 78: Rhodium-catalysed Csp2–H bond functionalisation with pyrazyl-/pyrimidyl-arenes and 
sulfoxonium ylides 
 
4.3 Further functionalisation 
4.3.1 Cleavage of the directing group 
As mentioned previously, pyridine groups are not the most interesting 
functional groups for synthetic applications. Thus, cleavage of the directing group was 
required to offer new possibilities of functionalisation. 
Ackermann and co-workers have reported the straightforward cleavage of 
pyridine from indoles.77 By reacting the N-functionalised indole 252 with 
methyltriflate, the authors could generate the pyridinium species 253 which could 
undergo a platinum-catalysed hydrogenolysis with ammonium formate as the 
hydrogen source (Figure 79). No purification was required between the two steps and 
the cleaved product 254 was obtained in excellent yield. 
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Figure 79: Cleavage of the pyridyl directing group via quaternisation/hydrogenolysis 
 
Unfortunately, only traces of the desired cleaved pyridine 255 were isolated 
when those conditions were applied to the pyrrole 236 (Figure 80). As the crude 
mixture showed a significant amount of impurities, an attempt at room temperature 
was carried out, which led to the same outcome. 
 
Figure 80: Attempts at the cleavage of the pyridyl directing group via quaternarisation/hydrogenolysis 
 
A similar approach to the cleavage of pyridine was reported by Maes et al. 
whereby the quaternarised pyridine 257 could be removed by action of sodium 
borohydride (Figure 81).78 The piperidine 258 was obtained in 77% yield in this one-
pot sequence. 
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Figure 81: Cleavage of the pyridyl directing group via quaternisation/hydrogenolysis 
 
When those conditions were applied to the protected indole 259, the cleaved 
product 260 was obtained in low yield (Figure 82).  
 
Figure 82: Attempts at the cleavage of the pyridyl directing group via quaternarisation/hydrogenolysis 
 
 The cleavage of the pyridine failed in our hand, thus, the incorporation of the 
directing group into the final product was investigated. 
 
4.3.2 Hydrogenation 
Logothetis reported the transformation of the pyridine 261 into the tetracycle 
262 in 81% yield after hydrogenation of the aromatic ring to the piperidine (Figure 
83).79 Interestingly, protection of the carbonyl was not required. 
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Figure 83: Platinum-catalysed hydrogenation of a pyridine ring followed by cyclisation 
 
Applying this methodology to the functionalised phenyl pyridines could give 
access to interesting tricyclic compounds. However, no traces of the desired product 
were observed when the cyclohexyl 229a, the isopropyl 229b or the methyl 229n 
derivatives  were sujected to the hydrogenation (Figure 84).  
 
Figure 84: Attempt at the platinum-catalysed hydrogenation of pyridine rings followed by cyclisation 
 
When those conditions were applied to the hydrogenation of the quinoline 
derivative 242b, the 4,5,6,7-tetrahydroquinoline 263 was obtained in 47% yield 
(Figure 85). The ketone was also reduced to the corresponding alcohol during the 
reaction. This process proved not to be synthetically useful due to the lack of control. 
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Figure 85: Attempt at the platinum-catalysed hydrogenation of the quinoline ring 
 
Such a reactivity was reported by McEachern and co-workers where the 
hydrogenation of the substituted quinoline 264 led to the corresponding 1,2,3,4- and 
4,5,6,7-tetrahydroquinolines 265 and 266 respectively (Figure 86).80 In all their 
example the 4,5,6,7-tetrahydroquinoline 266 was the major product. 
 
Figure 86: Selectivity of the platinum-catalysed hydrogenation of quinolines 
 
As none of the hydrogenation conditions proved to be adequate for further 
functionalisation, another methodology was investigated. 
 
4.3.3 Nickel-catalysed hydride transfer 
In 2011, Knochel and his group used a nickel-catalysed transfer of hydrides to 
access the 1,2,3,4-tetrahydroquinoline 268 that bears an alcohol group (Figure 87).81 
By mixing nickel chloride with an excess of sodium borohydride, the authors isolated 
268 in excellent yield. Moreover, Li and co-workers used the same approach to 
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transform the quinoline 269 with a carbonyl group to the tricyclic compound 270 in 
good yield.82 The alcohol 271 was also recovered as a side product in low yield. 
 
Figure 87: Nickel-catalysed hydrogenation of quinoline / Nickel-catalysed hydrogenation followed by 
cyclisation 
 
These conditions were applied to the cyclisation of the two quinoline 
derivatives 242a and 242b (Figure 88). A complex mixture of products was obtained 
with the cyclohexyl starting material 242a. However, when 242b was treated under 
the same conditions, the desired tetracyclic product 272 was obtained in traces amount. 
Unfortunately, the yield could not be improved, and other functionalisation procedures 
were investigated. 
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Figure 88: Attempts at the nickel-catalysed hydrogenation of quinolines 
 
4.3.4 Hydrogen-transfer 
In 2011, Rueping and Hubener described the organo-catalysed hydrogen 
transfer to form the tricyclic compound 277 from the quinoline 273.83 Using the 
Hantzsch dihydropyriridine 274 as the hydride donor and the BINOL-derived 
phosphate 275 as the catalyst, the authors isolated a mixture of both saturated and 
unsaturated cyclised intermediate 276 (Figure 89). Hydrogenation of the mixture over 
iridium supported on carbon nanotubes afforded the desired 1,2,3,4-
tetrahydroquinoline 277 in excellent yield and enantiomeric excess.  
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Figure 89: Hydrogenation of quinolines via an organo-catalysed hydrogen transfer 
 
Application of those conditions to the methyl quinoline derivative 242b gave 
the unexpected C-3 cyclisation, leading to the tetracyclic compound 278 in moderate 
yield (Figure 90). A proposed mechanism to explain this cyclisation invokes a first 
1,4-hydrogen transfer onto the isoquinole ring giving the enamide A which can then 
attack the carbonyl to give the intermediate B. Elimination of water followed by the 
re-aromatisation of the naphthyl group affords the dihydrobenzo[c]acridine 278. 
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Figure 90: Formation of dihydrobenzo[c]acridine via an organocatalysed hydrogen transfer / Proposed 
mechanism 
 
 Yamagushi and co-workers reported the hydrogenation of the quinoline 279 to 
the 1,2,3,4-tetrahydroquinoline 280 via an iridium-catalysed hydrogen transfer (Figure 
91).84 The reaction afforded the desired product in excellent yield using a mixture of 
isopropanol and water with a catalytic amount of hydrogen perchlorate.  
 
Figure 91: Hydrogenation of quinolines via an iridium-catalysed hydrogen transfer 
 
 Thus, those conditions were applied to the transformation of the 
methylquinoline derivative 242b (Figure 92). The reproducibility of the reaction 
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proved to be challenging and the benz[c]acridine 281b was isolated in yields ranging 
from low to quantitative. In this case, the fully aromatic benz[c]acridine was isolated 
after the reaction. 
 
Figure 92: Formation of benz[c]acridine via an iridium-catalysed hydrogen transfer 
 
Upon optimisation of the reaction, it was shown that hydrogen perchlorate was 
not needed to obtain the benz[c]acridine in good yield. Three benz[c]acridines could 
be formed in moderate yields from the cyclohexyl, methyl and phenyl derivatives 
242a, 242b and 242c respectively (Figure 93). Interestingly, in all cases a mixture of 
the benz[c]acridine and the corresponding dihydrobenzo[c]acridine was recovered 
after the reaction. However, exposing the mixture of products to air overnight, led to 
the conversion of the dihydrobenzo[c]cacridine into the desired benz[c]acridine. 
 
Figure 93: Scope of the iridium-catalysed hydrogen transfer 
 
Benz[c]acridine is a well-known motif and has been used as fluorescent 
sensors.85 Gryko and Piechowska have reported on the use of functionalised 
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benz[c]acridine as 10-hydrobenzo[h]quinoline (HBQ) replacement (Figure 94).86 
They reported the synthesis of eight different acridines with six of them exhibiting 
similar fluorophore properties as HBQ. 
 
Figure 94: Structure of two benz[c]acridine with fluorophore properties / structure of HBQ 
 
Despite being potentially interesting, the synthesis of benz[c]acridines oftens 
require extremely harsh conditions (Figure 95). The intermediate 286, precursor of 
282, was obtained by heating 284 and benzoic acid at 200 °C with zinc chloride 
without any solvent. 
 
Figure 95: Synthesis of benz[c]acridine 
 
In this context, the new access to functionalised benz[c]acridine observed in 
our case could improve on the development and applications of such a framework. 
4.4 Mechanistic study 
4.4.1 Reversibility of the C–H bond cleavage 
As seen previously, the rhodacycle formed prior to proto-demetalation was 
recovered when a non-protic solvent was used for the cross-coupling reaction. Based 
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on this result it was hypothesised that the first C–H functionalisation was not likely to 
be the rate determining step. Thus, when the phenyl pyridine 128 was treated with the 
sulfoxonium ylide 187 in the optimised conditions with a mixture of 1,2-
dichlorobenzene and deuterated HFIP, the reaction was significantly slower and 
deuterium incorporation in the starting material and the product was observed (Figure 
96). Interestingly, a significant scrambling of the deuterium label was observed and 
more than two third of hydrogen atoms in ortho-position of the phenyl pyridine were 
exchanged. Hence, the C–H bond functionalisation leading to the rhodium complex 
228 must be reversible. Moreover, no deuterium exchange was observed at this 
position when the rhodium catalyst was not present in the solution. 
 
Figure 96: Reversibility of the C–H bond cleavage 
 
Moreover, incorporation of deuterium in the ortho-position as well as at the 
two methylene positions next to the carbonyl was observed when the product 229a 
was subjected to the standard conditions (Figure 97).  Surprisingly, when the product 
229a was treated with d-HFIP, deuterium was observed in α-positions of the carbonyl. 
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Those experiments show that the solvent has a great impact on the outcome and is 
likely to play a key role in the proto-demetalation. 
 
Figure 97: Deuterium scrambling on the product 
 
4.4.2 Deuterium-labelling experiment 
A series of experiments based around a deuterium-labelled starting material 
were designed to understand the relative rate of the first C–H activation. Firstly, when 
the mono-deuterated phenyl pyridine d-128 was set to react in the optimised conditions 
without any sulfoxonium ylide, no traces of deuterium were seen on the recovered 
starting material (Figure 98). 
 
Figure 98: Rhodium-catalysed deuterium exchange with HFIP 
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Secondly, no incorporation of the deuterium atom was observed in the product 
229 when the standard conditions were used with the model sulfoxonium ylide 187 
and deuterated phenyl pyridine d-128 (Figure 99). Moreover, only traces of deuterium 
were found on the starting material after only 2 hours.  
 
Figure 99: Deuterium exchange with HFIP 
 
This experiment confirms that the C–H bond activation is not only reversible 
but occurs faster than the formation of the product. 
 
4.4.3 Kinetic isotope effect 
Through those experiments we can say that the rate determining step is not the 
C–H bond cleavage. Since the hypothesis was that the proto-demetalation could be the 
key event of the catalytic cycle, thus making the solvent the most important entity in 
the release of the desired product, a series of experiments with d-HFIP were ran. Due 
to the high cost of d-HFIP, a mixture of 1,2-DCE and d-HFIP was used. It is 
noteworthy that the yield obtained after seventeen hours in those conditions was 
significantly decreased as compared to those in only HFIP (Figure 100). Nonetheless, 
almost half of the product was recovered after 12 hours with non-deuterated solvents 
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(Orange plot). However, a significant decrease of rate was observed when deuterated 
HFIP was used (Blue plot).  
 
 
Figure 100: KIE experiment 
 
Based on the isolated yield of products after 2 h, we could estimate the KIE 
(kH/kD) to be around 2.6, thus validating the hypothesis of the proto-demetalation being 
the rate determining step along with the fact that HFIP is key to close the catalytic 
cycle. 
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4.4.4 Determination of the rate-law via NMR monitoring 
In 2016, Burés reported the use of the variable time normalisation in the 
elucidation of the rate law of reactions.87, 88 By changing the concentration of one 
reagent at a time from a reference condition, the effect of this change could be seen by 
overlaying the concentration profile. The two reaction profiles obtained can only 
overlap when the concentration of the investigated species is raised to the correct 
power, enabling the elucidation of the rate order in this species. This method involves 
the time normalisation between two data points by averaging the concentration of the 
observed species between those points according to the following formula. 
∫ [𝐴]𝛼d𝑡 =
𝑡=𝑛
𝑡=0
 ∑ (
[𝐴]𝑖 + [𝐴]𝑖−1
2
)
𝛼
 (𝑡𝑖 − 𝑡𝑖−1)
𝑛
𝑖=1
 
 
This normalisation removes the kinetic effect of the observed species on the 
reaction profile. This method allows a quick access to the reaction order of each species 
present in the reaction. 
The reaction conditions had to be changed in order to be applicable with this 
method of analysis. Due to the presence of silver salts in the mixture, an NMR 
monitoring would not be possible. Thus, the pre-formed rhodium acetate monomer 
was used as the catalyst. A control experiment showed that this catalyst was potent in 
the reaction and a similar yield of product was obtained (Figure 101). Moreover, a 
mixture of deuterated toluene and HFIP was used for the reaction to avoid the use of 
deuterated HFIP. Acceptable conversions were obtained with a one to one mixture of 
toluene and HFIP, thus this mixture was kept for the study. Finally, since the base had 
a relatively low impact on the reaction outcome, it was removed from the mixture. 
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Figure 101: Control experiments 
 
The optimised conditions were used as the reference for the study. Every 
concentration was changed one at a time in order to complete the variable time 
normalisation analysis (Figure 102). 
 
Figure 102: Concentrations used for the time normalisation 
 
Below, are reported all the results obtained after a single attempt at varying the 
concentrations.   
Firstly, the concentration of HFIP was changed and gave the first six graphs. 
In orange are the plots for the attempts with the new concentration of HFIP while the 
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plots in black are for the reference reaction (Figure 103). As expected the reaction was 
slower when less HFIP was added to the mixture. Changing the power of the HFIP 
concentration to one did not fully overlap the reference (in grey) with the new plot (in 
orange). The best overlap was obtained with the power of 0.7 or 0.8. From this result 
it is clear that the HFIP is involved in the rate-determining step, although the proto-
demetalation proceeds via a complex mechanism explaining the non-integer value of 
the rate order. 
 
 
Figure 103: Plots obtained for the determination of the order in HFIP (Orange: modified concentration/ 
Grey: reference) 
 
Secondly, the focus was placed on the concentration of the rhodium catalyst. 
In this case the concentration was increased as compared to the reference and a 
significant increase of rate was observed as depicted by the blue plot (Figure 104). 
When the concentration was raised to the power of two, a good overlap between the 
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two plots was obtained. Thus, a dimer of rhodium must be involved in the rate 
determining step. 
 
Figure 104: Plots obtained for the determination of the order in rhodium catalyst (Blue: modified 
concentration/Grey: reference) 
 
Surprisingly, the decrease of the concentration in sulfoxonium ylide did not 
affect the reaction rate (Figure 105). The reaction presents a zero-order dependence in 
sulfoxonium ylide, and it is believed that the excess needed for the reaction to reach 
full conversion is due to the decomposition of a part of this reagent during the course 
of the reaction. 
 
Figure 105: Plots obtained for the determination of the order in sulfoxonium ylide (Green: modified 
concentration/Grey: reference) 
  
Increasing the concentration of phenyl pyridine, in purple, as compared to the 
reference experiment led to an increase in rate (Figure 106). The best overlap was 
obtained with the concentration raised to the power of 1.5. Similarly to the 
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concentration of HFIP, a non-integer value for the kinetic order was obtained, pointing 
to a complex mechanism for the rate determining step involving most probably two 
molecules of phenyl pyridine. 
 
Figure 106: Plots obtained for the determination of the order in phenylpyridine (Purple: modified 
concentration/Grey: reference) 
 
Finally, by merging all those results into one plot with all the best rate orders 
found earlier, a linear plot with the five curves overlayed was obtained, validating all 
the reaction orders (Figure 107). To summarise, the reaction presents a zero-order 
dependence in sulfoxonium ylide, and a second order in the rhodium catalyst. The 
order-dependence in starting material 128 and HFIP would be 1.5 and 0.7-0.8, 
respectively. 
0
10
20
30
40
50
0 50 100 150
C
o
n
ve
rs
io
n
 (
%
)
Σ[128]1Δt
0
0.1
0.2
0.3
0.4
0.5
0 20 40 60
Σ[128]1.5Δt
0
0.1
0.2
0.3
0.4
0.5
0 10 20 30
Σ[128]2Δt
214 
 
 
Figure 107: Time normalised analysis 
 
It is worth mentioning that in this case the conversion was kept below 40% in 
order to obtain reliable results. Beyond this conversion, an inflection point can be 
observed with the five plots diverging from each other. This same observation has been 
reported by Gade et al., showing that the global order of the mechanism is likely to 
change in the late stage of their manganese-catalysed hydroboration due to the low 
concentration of starting material, or a potential deactivation of some of the active 
species.89 In our case, a possible product inhibition could be hypothesised along with 
the deactivation of the catalyst by the release of DMSO.39  
A monitoring of the catalyst concentration would show any decomposition of 
the catalyst over the reaction time. Moreover, a product inhibition could be assessed 
by adding a known concentration of product from the beginning. Any difference from 
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the original plot would indicate that the product has an influence on the reaction, thus 
explaining the deviation observed beyond a certain conversion. 
4.4.5 Proposed mechanism 
Nonetheless, a refined mechanism for this reaction can be proposed with all 
the results gained with the mechanistic study (Figure 108).  
The generation of the active cationic rhodium species A can occur via the 
release of an acetate ligand.90 Coordination of the catalyst to the pyridine followed by 
abstraction of the ortho C–H bond via a CMD mechanism gives the pentarhodacycle 
B and releases acetic acid.91 Through the deuterium labelling experiments we have 
shown that this species is in rapid equilibrium with the starting phenyl pyridine 128.  
This rhodacycle is converted to the intermediate C upon nucleophilic attack of the 
sulfoxonium ylide onto the eletronically deficient rhodium atom. Further elimination 
of dimethylsulfoxide gives the rhodium carbene species D which is converted to E 
after a migratory insertion step. It is noteworthy that Cramer and Qu have shown 
through DFT calculation that the leaving-group elimination/ C–C bond formation can 
be written as a concerted mechanism if the leaving group is in anti- position to the 
formed C–C bond.92 The proto-demetalation, assisted by HFIP, can release the desired 
functionalised pyridine along with the active catalyst. Thanks to the kinetic isotope 
effect experiments using catalytic conditions or stoichiometric conditions we have 
shown that this last step is likely to be the rate-determining step of the catalytic cycle. 
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Figure 108: Proposed mechanism for the rhodium-catalysed Csp2–H functionalisation with sulfoxonium 
ylides 
 
 Although this catalytic cycle is in-line with the commonly accepted pathway, 
we have shown through the NMR study and rate-law determination that the proto-
demetalation step is likely to involve a more complex mechanism due to the non-
integer rate-orders found for the HFIP, the phenyl-pyridine and the rhodium catalyst. 
 Recently, Cramer and Qu reported that a second equivalent of phenylpyridine 
could promote the proto-demetalation of the rhodium catalyst, by acting as a proton-
carrier (Figure 109).92 Moreover, Ellman and co-workers showed that the active 
rhodacycle was in equilibrium with the 18-electon complex 289.93 Because of the 
positive effect of the second molecule of phenyl pyridine in the proto-demetalation 
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step, a second order in phenyl pyridine could be expected. However, due to the 
inhibitory effect of the phenyl pyridine through deactivation of the active catalyst 228 
into 289, the rate order in 128 must be between 1 and 2 on a macromolecular scale, 
depending on the equilibriums between 287/228 and 289/228. 
 
Figure 109: Proto-demetalation assisted with phenylpyridine / Equilibrium between the resting state and 
the active catalyst 
  
Similarly, a second molecule of 128 is likely to be involved in the proto-
demetalation step to regenerate of the active species and release the product (Figure 
110). However, if the rhodium catalyst is taken out of the catalytic cycle through the 
coordination of a second molecule of 128, then, an order of 1.5 can be expected, as 
both positive and negative effects are in competition.  
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Figure 110: Possible explanation for the 1.5 rate-order in 128 
 
 Moreover, the solvent has a key-role in the mechanism and presents a rate-
order between 0.7 and 0.8.72 We have shown that the first C–H bond cleavage is 
reversible and that the equilibrium is faster than the reaction. As the HFIP is involved 
in both the proto-demetalation and the non-productive equilibrium, a positive and 
negative effect on the overall reaction is expected, giving a non-integer value in rate 
order between 0 and 1 (Figure 111).94 Moreover, several studies have reported the 
hydrogen bonding ability of HFIP which could explain why other hydrogen-donor 
solvents failed to push the reaction to full conversion.  
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Figure 111: Possible explanation for the 0.7-0.8 rate order in HFIP 
 
 Finally, it was determined that a second-order in rhodium catalyst applied to 
the reaction, pointing to the need of a dimer during the rate-determining step. However, 
this result is still unexplained and further studies with other rhodium catalysts such as 
[Cp*Rh(MeCN)2](SbF6)2,
 are required in order to fully understand the transition state 
of the rate-determining step.  
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5 Conclusion  
5.1 Summary 
As a conclusion, we have reported the first rhodium-catalysed C–H bond cross-
coupling reaction using α-ketosulfoxonium ylides. Firstly, we showed that a wide 
variety of sulfoxonium ylides could be accessed in good yields via the para-
nitrophenyl ester or the acyl chloride. Moreover, bis-substituted sulfoxonium ylides 
could be obtained from the pyrimidine or the triethylsulfoxonium ethylide, although 
the latter proved to be demanding in terms of synthesis. 
 Secondly, through the optimisation of the reaction, we observed a strong effect 
of the solvent used on the outcome of the reaction. Fluorinated solvents significantl 
improved the reactivity and hexafluoroisopropanol was kept for the development of 
the scope. 
 We reported 25 examples of C–H bond functionalisation with yields ranging 
from 30% to quantitative. Csp2–H on electron-withdrawing and -donating arenes 
underwent the coupling smoothly along with heterocyclic arenes. 4 different directing 
groups have been used, although the reaction conditions had to forced in order to 
obtain decent yields. Finally, we showed that several sulfoxonium ylides could 
undergo a cyclisation in good yields, without a metal catalyst. 
 
Figure 112: Rhodium-catalysed cross-coupling of C–H bonds with α-ketosulfoxonium ylides 
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 The functionalised phenyl-quinolines were successfully converted to 
benz[c]acridines in moderate yields via an unprecedented iridium-catalysed 
dehydrative cyclisation (Figure 113). This moiety could be of interest as fluorescent 
sensors with a milder synthesis as compared to the harsh conditions used to access this 
framework in reported conditions. 
 
Figure 113: Synthesis of functionalised benz[c]acridine 
 
 Finally, through the mechanistic study we have shown that, as expected from 
the observations of the optimisation, the proto-demetalation step is the rate-
determining step with the solvent playing a key-role. Moreover, we saw that the first 
C–H bond functionalisiation was reversible and significantly faster than the rest of the 
mechanism. The time-normalisation helped us understand the role of every species in 
the reaction and showed that the sulfoxonium ylide is not involved in the rate-
determining step. Both the HFIP and the phenyl-pyridine exhibited a non-integer rate-
order because of a positive/negative effect on the reaction. A rate-order of 2 in catalyst 
was obtained from the NMR study and remains unclear at the moment.  
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5.2 Citations 
 Pleasingly, this work has been cited in several reports since its publication, 
showing that it has brought a momentum in the development of sulfoxonium ylides as 
coupling partners in the C–H bond functionalisation. Shortly after our report, Li and 
co-workers used a different set of conditions to functionalise Csp2–H bonds (Figure 
114).95 Interestingly, the conditions reported in this chapter and their conditions were 
almost complementary as some of our troublesome substrates underwent the reaction 
smoothly in their hands, whereas some issues reported in their work could be solved 
by using our conditions. The same authors managed to develop two chemoselective 
sets of conditions to selectively synthesise either the isocoumarin 245 or the 
isoquinolinone 244b from the methoxybenzamide 243.96 Finally, they could access 
fully aromatic bicycles such as the naphthopyran 293 in excellent yield in a one-pot 
sequence.97,98 
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Figure 114: Li’s work on C–H bond functionalisation with sulfoxonium ylides 
  
Ellman and co-worker reported that olefinic Csp2–H could undergo the rhodium-
catalysed cross-coupling with sulfoxonium ylide in excellent yield with an imidazole 
or pyrazole directing group (Figure 115).99,100 
 
Figure 115: Ellman’s functionalisation of olefinic Csp2–H withsulfoxonium ylides 
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 Cheng et al. showed that azobenzenes were suitable for the rhodium-catalysed 
C–H bond functionalisation with sulfoxonium ylides. The authors could isolate the 
indazole 298 form the azobenzene 297 in good yield (Figure 116).101 
 
Figure 116: Rhodium-catalysed functionalisation of azobenzene with suslfoxonium ylides 
 
 Recently, Wang and his group expanded the chemistry of sulfoxonium ylides 
to ruthenium catalysts. The authors synthesised the isoquinoline 300 in 74% yield with 
a ruthenium catalyst (Figure 117).102 
 
Figure 117: Ruthenium-catalysed C–H bond functionalisation with sulfoxonium ylides 
 
5.3 Outlook 
We have shown that aromatic Csp2–H could undergo the rhodium-catalysed 
cross-coupling reaction with sulfoxonium ylide and Ellman and co-workers have 
expanded the work to olefinic Csp2–H. However, nobody has described the 
functionalisation of Csp3–H so far, thus making it highly interesting as a continuation 
of this project. 
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Moreover, although a lot of information on the reaction was obtained through 
the mechanistic study, several questions remain unanswered, such as the rate order of 
2 in catalyst. A duplicate of the NMR study is required in order to minimise the 
experimental error. The use of the cationic rhodium catalyst, i.e. 
[Cp*Rh(MeCN)2](SbF6)2, could also give new hints on the transition state in the rate 
determining step. Finally, performing the NMR study on a second directing group 
could give us insight on the generality of the proposed mechanism. 
Finally, the removal of the directing group proved to be more challenging than 
anticipated. In 2016, Yu and co-workers reported the use of amino-acids as transient 
directing group in the palladium-catalysed cross-coupling of the iodo-aryl 302 and the 
aldehyde 301 (Figure 118).103 Applying a similar methodology to our project would 
bypass the removal step of the directing group and enabling easier further 
functionalisation. 
 
Figure 118: Palladium-catalysed cross-coupling with amino-acids as transient directing group 
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6 Experimental section 
6.1 Synthesis of catalysts 
Synthesis of [Cp*RhCl2]2. To a flame dried round bottom flask under nitrogen and 
equipped with a reflux apparatus was added RhCl3•3H2O (1 g, 4.8 mmol 1 equiv.), 
MeOH (20 mL) followed by 1,2,3,4,5-pentamethylcyclopentadiene (0.75 mL, 8.2 
mmol, 1.7 equiv.). The mixture was stirred at reflux for 48 h. Then, the reaction was 
cooled down to room temperature and filtered to afford [Cp*RhCl2]2 as a red powder 
(1.02 g, 83%). HRMS (ESI) calcd for (C20H30ClRh2 +): 511.0146; found: 511.0151; 
Anal. Calcd for C20H30Cl4Rh2: C 38.97, H 4.87; found C 38.97, H 4.88, the NMR data 
is in accordance with that reported in the literature.104 
 
Synthesis of 228. To a flame dried Schlenk flask, under N2, was added [Cp*RhCl2]2 
(92 mg, 0.15 mmol, 1 equiv.), NaOAc (25 mg, 0.3 mmol, 2 equiv.), dry 
dichloromethane (6 mL) and phenylpyridine (32 µL, 0.23 mmol, 1.5 
equiv.). The mixture was stirred at room temperature overnight. Then, the mixture was 
filtered, the filtrate was evaporated and recrystallised from DCM/pentane to afford 228 
as a red powder (93 mg, 97%). 1H NMR (500 MHz, CDCl3): δ 8.75 (d, J = 5.4 Hz, 
1H), 7.82 (dd, J = 7.6, 1.0 Hz, 1H), 7.79-7.76 (m, 1H), 7.74-7.69 (m, 1H), 7.61 (dd, J 
= 7.8, 1.3 Hz, 1H), 7.24 (dd, J = 7.4, 1.2 Hz, 1H), 7.13 (ddd, J = 7.4, 5.6, 1.3 Hz, 1H), 
7.06 (ddd, J = 7.8, 7.4, 1.1 Hz, 1H), 1.63 (s, 15H), the NMR data is in accordance with 
that reported in the literature.70 
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Synthesis of Cp*Rh(OAc)2•H2O. To a flame dried round-bottom flask, under 
nitrogen, was added [Cp*RhCl2]2 (0.3 g, 0.5 mmol, 1 equiv.), AgOAc (0.4 g, 2.4 
mmol, 4.9 equiv.) and dry toluene (21 mL). The mixture was stirred at 75 °C for 30 
min. After cooling to room temperature, the mixture was filtered, washed with 
dichloromethane and the filtrate was evaporated to give the title compound as a red 
solid (0.331 g, 90%). 1H NMR (500 MHz, CDCl3): δ 1.98 (s, 6H), 1.69 (s, 15H); Anal. 
Calcd for C14H23O5Rh: C 44.93, H 6.19; found C 46.54, H 6.10, the NMR data is in 
accordance with that reported in the literature. 105 
 
Synthesis of [Cp*Rh(MeCN)3(SbF6)2]. A flame dried Schlenk tube sealable by a J-
young key was charged in a glovebag with AgSbF6 (0.44 g, 1.3 mmol, 4 equiv.) and 
[Cp*RhCl2]2 (0.2 g, 0.3 mmol, 1 equiv.). The tube was taken out of the glovebag and 
refilled with nitrogen before acetonitrile was added (1.6 mL). The mixture was stirred 
4 h, transferred in a centrifuge tube and spun for 2 min at 1200 rpm. The yellow 
supernatant was collected, new acetonitrile (1 mL) was added and the tube was spun 
for another 2 min. The process was repeated until the supernatant became colourless. 
The combined solution was concentrated to give the title compound as a yellow solid 
(0.46 g, 86%). 1H NMR (500 MHz, d6-DMSO): δ 2.08 (s, 9H), 1.55 (s, 15H); Anal. 
Calcd for C16H24F12N3RhSb2: C 23.08, H 2.90, N 5.05; found C 22.94, H 2.92, N 4.94, 
the NMR data is in accordance with that reported in the literature.106 
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6.2 Synthesis of substrates 
2-(1H-Pyrrol-1-yl)pyridine (CH1). To a flame dried round bottom flask, under N2, 
was added pyrrole (510 µL, 7.4 mmol, 1 equiv.) followed by dry DMF (20 
mL). The mixture was cooled to 0 °C before NaH (736 mg, 18.4 mmol, 2.5 
equiv.) was added and the mixture was stirred 15 min. The mixture was warmed up to 
room temperature and 2-bromopyridine (760 µL, 8.1 mmol, 1.1 equiv.) was added. 
The mixture was stirred 15 h at 120 °C. Then, the reaction was cooled down to room 
temperature and extracted 3 times with EtOAc. The combined organic layer was 
washed thoroughly with water and brine, dried over MgSO4 and concentrated. 
Purification by flash chromatography (PE:EtOAc/95:5) afforded the titled compound 
as a pale pink oil (0.83 g, 78%).107 1H NMR (500 MHz, CDCl3): δ 8.45-8.40 (m, 1H), 
7.77-7.71, (m, 1H), 7.51 (t, J = 2.3 Hz, 2H), 7.32 (d, J = 8.5 Hz, 1H), 7.10 (ddd, J = 
7.4, 4.9, 0.7 Hz, 1H), 6.36 (t, J = 2.3 Hz, 2H), the NMR data is in accordance with that 
reported in the literature.108 
 
1-(Pyridin-2-yl)-1H-indole (CH2). To a flame dried round bottom flask, under N2, 
was added indole (0.86 mg, 7.4 mmol, 1 equiv.) followed by dry DMF (20 
mL). The mixture was cooled to 0 °C before NaH (736 mg, 18.4 mmol, 
2.5 equiv.) was added and the mixture was stirred 15 min. The reaction 
was warmed up to room temperature and 2-bromopyridine (845 µL, 8.8 mmol, 1.2 
equiv.) was added. The mixture was stirred 15 h at 130 °C. Then, the reaction was 
cooled down to room temperature and extracted 3 times with EtOAc. The gathered 
organic layer was washed thoroughly with water and brine, dried over MgSO4 and 
concentrated. Purification by flash chromatography (PE:EtOAc/95:5) afforded the 
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titled compound as a pale yellowish oil (0.4 g, 26%).107 1H NMR (500 MHz, CDCl3): 
δ 8.58 (ddd, J = 4.9,1.8, 0.7 Hz, 1H), 8.21 (dd, J = 8.4, 0.8 Hz, 1H), 7.83 (ddd, J = 8.2, 
7.4, 1.9 Hz, 1H), 7.73 (d, J = 3.5 Hz, 1H), 7.67 (dt, J = 7.9, 0.9 Hz, 1H), 7.51 (dt, J = 
8.3, 0.9 Hz, 1H), 7.32-7.28 (m, 1H), 7.23-7.19 (m, 1H), 7.17 (ddd, J = 7.3, 4.9, 0.9 Hz, 
1H), 6.72 (dd, J = 3.5, 0.7 Hz, 1H), the NMR data is in accordance with that reported 
in the literature.109 
 
2-(3-Methoxyphenyl)pyridine (CH3). To a flame dried round bottom flask, under 
N2, was added a mixture of degassed EtOH/H2O/toluene (39 mL, 
10:45:45) followed by 2-bromopyridine (477 µL, 5 mmol, 1 equiv.), 
Na2CO3 (3.9 g, 37 mmol, 7.4 equiv.), Pd(PPh3)4 (173 mg, 0.15 mmol, 
0.03 equiv.) and (3-methoxyphenyl)boronic acid (1 g, 6.5 mmol, 1.3 equiv.). The 
mixture was stirred at reflux overnight. After cooling down to room temperature, the 
reaction was quenched with a saturated solution of NH4Cl. The mixture was extracted 
with 3 times with EtOAc.The gathered organic layer was washed with water, brine, 
dried over MgSO4 and concentrated under vacuum. Purification by flash column 
chromatography (PE:EtOAc/9:1) afforded the titled compound as a colourless oil (0.6 
g, 65%).58  1H NMR (500 MHz, CDCl3): δ 8.73-8.67 (m, 1H), 7.79-7.69 (m, 2H), 7.62-
7.51 (m, 2H), 7.38 (t, J = 8.0 Hz, 1H), 7.23 (td, J = 4.9, 1.1 Hz, 1H), 7.01-6.93 (m, 
1H), 3.90 (s, 3H), the NMR data is in accordance with that reported in the literature.110 
 
Ethyl 3-(pyridin-2-yl)benzoate (CH4). To a flame dried round bottom flask, under 
N2, was added a mixture of degassed EtOH/H2O/toluene (39 mL, 
10:45:45) followed by 2-bromopyridine (477 µL, 5 mmol, 1 equiv.), 
Na2CO3 (3.9 g, 37 mmol, 7.4 equiv.), Pd(PPh3)4 (173 mg, 0.15 mmol, 
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0.03 equiv.) and (3-(ethoxycarbonyl)phenyl)boronic acid (1.71 g, 6.5 mmol, 1.3 
equiv.). The mixture was stirred at reflux overnight. After cooling down to room 
temperature, the reaction was quenched with a saturated solution of NH4Cl. The 
mixture was extracted with 3 times with EtOAc.The gathered organic layer was 
washed with water, brine, dried over MgSO4 and concentrated under vacuum. 
Purification by flash column chromatography (PE:EtOAc/9:1) afforded the titled 
compound as a colourless oil (0.9 g, 81%).58 1H NMR (500 MHz, CDCl3): δ 8.74-8.69 
(m, 1H), 8.63 (t, J = 1.6 Hz, 1H), 8.23 (dt, J = 7.7, 1.6 Hz, 1H), 8.10 (dt, J = 7.7, 1.3 
Hz, 1H), 7.82-7.76 (m, 2H), 7.56 (t, J = 7.9 Hz, 1H), 7.30-7.23 (m, 1H), 4.42 (q, J = 
7.1 Hz 2H), 1.42 (t, J = 7.1 Hz, 3H), the NMR data is in accordance with that reported 
in the literature.111 
 
2-(Furan-3-yl)pyridine (CH5). To a flame dried round bottom flask, under N2, was 
added a mixture of degassed EtOH/H2O/Toluene (17 mL, 10:45:45) followed 
by 2-bromopyridine (320 µL, 3.4 mmol, 1 equiv.), Na2CO3 (2.7 g, 25 mmol, 
7.4 equiv.), Pd(PPh3)4 (116 mg, 0.10 mmol, 0.03 equiv.) and furan-3-ylboronic 
acid (0.5 g, 4.5 mmol, 1.3 equiv.). The mixture was stirred at reflux overnight. After 
cooling down to room temperature, the reaction was quenched with a saturated 
solution of NH4Cl. The mixture was extracted with 3 times with DCM. The gathered 
organic layer was washed with water, brine, dried over Na2SO4 and concentrated under 
vacuum. Purification by flash column chromatography (PE:EtOAc/9:1) afforded the 
titled compound as a colourless oil (0.2 g, 45%).58 1H NMR (500 MHz, CDCl3): δ 
8.64-8.61 (m, 1H), 7.90 (dd, J = 3.0, 1.1 Hz, 1H), 7.70 (td, J = 8.0, 2.0 Hz, 1H), 7.67 
(dd, J = 5.1, 1.2 Hz, 1H), 7.62 (d, J = 7.8 Hz, 1H), 7.40 (dd, J = 5.0, 3.1 Hz, 1H), 7.17 
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(ddd, J = 7.4, 4.8, 1.0 Hz, 1H), the NMR data is in accordance with that reported in 
the literature.112 
 
2H-[1,2'-Bipyridin]-2-one (CH6). To a flame dried round bottom flask, under N2, 
was added pyridin-2(1H)-one (0.95 g, 10 mmol, 1 equiv.), CuI (95 mg, 0.5 
mmol, 0.05 equiv.), N,N’-dimethylethylenediamine (0.1 mL, 1 mmol, 0.1 
equiv.), K3PO4 (4.2 g, 20 mmol, 2 equiv.), dry toluene (20 mL) and 2-
bromopyridine (1.9 mL, 20 mmol, 2 equiv.). The mixture was stirred at reflux 
overnight. Then, the mixture was cooled down to room temperature, the reaction was 
quenched with a saturated solution of NH4Cl and extracted 3 times with EtOAc. The 
gathered organic layer was washed with water, brine, dried over MgSO4 and 
concentrated under vacuum. Purification by flash column chromatography 
(DCM:MeOH/98:2) afforded the titled compound as a white solid (0.9 g, 50%).113 1H 
NMR (500 MHz, CDCl3): δ 8.60-8.55 (m, 1H), 7.95 (dt, J = 8.2, 0.8 Hz, 1H), 7.90-
7.86 (m, 1H), 7.86-7.82 (m, 1H), 7.39 (ddd, J = 9.2, 6.5, 2.3 Hz, 1H), 7.32 (ddd, J = 
7.4, 4.9, 1.0 Hz, 1H), 6.66-6.62 (m, 1H), 6.30 (td, J = 6.9, 1.1 Hz, 1H), the NMR data 
is in accordance with that reported in the literature.114 
 
2-Phenylquinoline (CH7). To a flame dried round bottom flask, under N2, was added 
PdCl2(PPh3)2 (34 mg, 0.05 mmol, 0.02 equiv.) followed by 1,4-dioxane (8 
mL), water (8 mL), 2-bromoquinoline (0.5 g, 2.4 mmol, 1 equiv.) 
phenylboronic acid (0.35 g, 2.9 mmol, 1.2 equiv.) and Na2CO3 (1.7 g, 16 
mmol, 6.7 equiv.). The mixture was stirred at reflux overnight. After cooling down to 
room temperature, the reaction was quenched with a saturated solution of NH4Cl. The 
mixture was extracted with 3 times with DCM.The gathered organic layer was washed 
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with water, brine, dried over Na2SO4 and concentrated under vacuum. Purification by 
flash column chromatography (PE:EtOAc/9:1) afforded the titled compound as a white 
solid (0.28 g, 57%).115 1H NMR (500 MHz, CDCl3): δ 8.24 (d, J = 8.6 Hz, 1H), 8.21-
8.14 (m, 3H), 7.89 (d, J = 8.8 Hz, 1H), 7.84 (d, J = 7.9 Hz, 1H), 7.74 (t, J = 7.6 Hz, 
1H), 7.57-7.42 (m, 4H), the NMR data is in accordance with that reported in the 
literature.116 
 
N-Methoxybenzamide (CH8). To a flame dried round bottom flask, under N2, at 0 
°C, was added benzoic acid (0.4 g, 3.3 mmol, 1 equiv.), DCM (10 
mL), (COCl)2 (0.3 mL, 4 mmol, 1.2 equiv.) and DMF (2 drops). The 
mixture was stirred at room temperature for 5 h before all solvents were removed in 
vacuo. A second flame dried round bottom flask, under N2, was charged with K2CO3 
(0.9 g, 6.6 mmol, 2 equiv.), EtOAc (24 mL), water (12 mL) and methoxyamine 
hydrochloride (0.33 g, 4 mmol, 2 equiv.). The mixture was cooled to 0 °C before 
addition of the freshly prepared acyl chloride in EtOAc. The mixture was stirred at 
room temperature overnight, and then, was extracted 3 times with EtOAc. The 
gathered organic layer was washed with water, brine, dried over MgSO4 and 
concentrated under vacuum.  Purification by flash column chromatography afforded 
the titled compound as a white solid (0.4 g, 82%). 1H NMR (500 MHz, CDCl3): δ 8.62 
(br s, 1H), 7.76-7.71 (m, 2H), 7.53 (tt, J = 6.8, 1.3 Hz, 1H), 7.47-7.41 (m, 2H), 3.90 
(s, 3H), the NMR data is in accordance with that reported in the literature.117  
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6.3 Synthesis of sulfoxonium ylides 
6.3.1 Synthesis of sulfoxonium ylides using methyl esters 
Method I: Representative example for the synthesis of 167. 
To a flame dried 100 mL round bottom flask, under nitrogen and covered from light, 
was transferred trimethylsulfoxonium iodide (5.8 g, 26 mmol, 3.6 equiv.). The solid 
was suspended in dry THF (25 mL) before potassium tert-butoxide was added (2.9 g, 
26 mmol, 3.6 equiv.). The mixture was stirred at reflux for 2 h. After cooling to room 
temperature, methyl nicotinate (1 g, 7 mmol, 1 equiv.) was added to the mixture. The 
mixture was stirred at reflux for another 4 h. The mixture was filtered through a plug 
of celite and all volatiles were removed under vacuum. Purification by flash 
chromatography (DCM:MeOH/98:2) afforded 167 as a white powder (41 mg, 3%). 
 
Compound 167. This compound was obtained as a white powder (41 mg, 3%) from 
methyl nicotinate (1 g, 7 mmol) following Method I. 1H NMR (500 
MHz, CDCl3): δ 8.96 (dd, J = 2.1, 0.7 Hz, 1H), 8.62 (dd, J = 4.8, 1.6 
Hz, 1H), 8.06 (dt, J = 8.0, 2.0 Hz, 1H), 7.31 (ddd, J = 8.0, 4.8, 0.7, 1H), 5.01 (s, 1H), 
3.52 (s, 6H); 13C NMR (125 MHz, CDCl3): δ 179.9 (e), 151.3 (o), 148.2 (o), 134.2 (e), 
134.0 (o), 123.2 (o), 69.4 (o), 42.3 (o, 2C), the NMR data is in accordance with that 
reported in the literature.118 
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Compound 168. This compound was obtained as a white solid (960 mg, 26%) from 
1-(tert-butyl) 4-methyl piperidine-1,4-dicarboxylate (3 g, 12 
mmol) following Method I. m.p.: 134-136 °C. 1H NMR (500 
MHz, CDCl3): δ 4.36 (s, 1H), 4.12 (br s, 2H), 3.39 (s, 6H), 2.80-2.63 (m, 2H), 2.25-
2.14 (tt, J = 12.0,3.6 Hz, 1H), 1.84-1.72 (m, 2H), 1.58-1.40 (m, 11H); 13C NMR (125 
MHz, CDCl3): δ 192.3 (e), 154.7 (e), 79.2 (e), 68.0 (o), 46.6 (o), 42.2 (o, 2C), 28.9 (e, 
4C), 28.3 (o, 3C); IR (neat): ν = 3015 (w), 2985 (w), 2929 (w), 2857 (w), 1685 (vs), 
1556 (vs), 1454 (w), 1394 (vs), 1364 (m), 1353 (m), 1291 (m), 1258 (w), 1231 (m), 
1161 (vs), 1134 (vs), 1111 (s), 1095 (m), 1083 (m), 1022 (s), 960 (w), 858 (s), 764 
(m), 681 (w); Anal. Calcd for C14H25NO4S: C 55.42, H 8.25, N 4.62, S 10.56; found 
C 55.42, H 8.33, N 4.52, S 10.49. 
 
Compound 169. This compound was obtained as a white powder (0.5 g, 40%) from 
methyl 2,2-diphenylacetate (1 g, 4.4 mmol) following Method I. 
1H NMR (500 MHz, CDCl3): δ 7.35-7.29 (m, 8H), 7.27-7.21 (m, 
2H), 4.87 (s, 1H), 4.40 (s, 1H), 3.42 (s, 6H),  this product was not 
characterised further due to poor results in the rhodium-catalysed C–H bond 
functionalisation. 
 
6.3.2 Synthesis of sulfoxonium ylides using p-nitrophenyl esters 
Method II: Representative example for the synthesis of 64. 
To a flame dried 100 mL round bottom flask, under nitrogen and at 0 °C, was added 
benzoic acid (1.2 g, 10 mmol, 1 equiv.) in dry THF (57), followed by para-nitrophenol 
(1.8 g, 13 mmol, 1.3 equiv.) and DCC (2.7 g, 13 mmol, 1.3 equiv.). The mixture was 
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stirred overnight at room temperature, filtered over celite and evaporated. Purification 
by flash column chromatography (PE: 100% to PE:EA/98:2) afforded the para-
nitrophenyl ester as a pale-yellow solid (1.2 g, 51%).  
To a flame dried 100 mL round bottom flask, under nitrogen and covered from 
light, was transferred trimethylsulfoxonium iodide (3.3 g, 15 mmol, 3 equiv.). The 
solid was suspended in dry THF (28 mL) before potassium tert-butoxide was added 
(1.7 g, 15 mmol, 3 equiv.). The mixture was stirred at reflux for 2 h. After cooling to 
room temperature, the residue (1.2 g, 5 mmol, 1 equiv.) in THF (10 mL) was added 
and the mixture was stirred at reflux for 1 h. The mixture was filtered through a plug 
of celite and all volatiles were removed under vacuum. Purification by flash 
chromatography (DCM:MeOH/98:2) afforded 64 as a pale-yellow powder (0.83 g, 
86%). 
 
Compound 64. This compound was obtained as a yellowish powder (0.8 g, 44%) (1st 
step: 51%; 2nd: step 86%) from benzoic acid (1.2 g, 10 mmol) 
following Method II. 1H NMR (500 MHz, CDCl3): δ 7.82-7.78 (m, 
2H), 7.46-7.37 (m, 3H), 4.97 (s, 1H), 3.52 (s, 6H), the NMR data is in accordance with 
that reported in the literature.42  
 
Compound 185. This compound was obtained as a white powder (0.3 g, 27%) (1st 
step: 34%; 2nd: step 78%) from 2-bromo-3-methylbenzoic acid (1 
g, 4.7 mmol) following Method II. 1H NMR (500 MHz, CDCl3): 
δ 7.22-7.14 (m, 3H), 4.58 (s, 1H), 3.54 (s, 6H), 2.42 (s, 3H), this product was not 
characterised further due to poor results in the rhodium-catalysed C–H bond 
functionalisation. 
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Compound 186. This compound was obtained as a white powder (0.5 g, 36%) (1st 
step: 45%; 2nd: step 79%) from 4-bromobenzoic acid (1 g, 5 
mmol) following Method II. 1H NMR (500 MHz, CDCl3): δ 7.68 
(dt, J = 9.0, 2.4 Hz, 2H), 7.54 (dt, J = 9.0, 2.5 Hz, 2H), 4.96 (s, 1H), 3.54 (s, 6H), the 
NMR data is in accordance with that reported in the literature.42 
 
Compound 187. This compound was obtained as a white powder (0.37 g, 71%) (1st 
step: 80%; 2nd: step 89%) from 2-cyclohexylacetic acid (1.1 g, 5.5 
mmol) following Method II. m.p.: 113-114 °C. 1H NMR (500 
MHz, CDCl3): δ 4.34 (s, 1H), 3.39 (s, 6H), 2.04 (d, J = 6.8 Hz, 2H), 1.79-1.60 (m, 6H), 
1.32-1.20 (m, 2H), 1.18-1.08 (m, 1H), 0.99-0.87 (m, 2H); 13C NMR (125 MHz, 
CDCl3): δ 190.5 (e), 69.6 (o), 48.9 (e), 42.2 (o, 2C), 35.5 (o), 33.2 (e, 2C), 26.3 (e), 
26.1 (e, 2C); IR (neat): ν = 3073 (w), 3010 (m), 2921 (s), 1547 (vs), 1449 (m), 1420 
(m), 1385 (vs), 1320 (m), 1263 (w), 1170 (vs), 1146 (s), 1100 (m), 1031 (vs), 994 (m), 
855 (s), 839 (s), 758 (m), 723 (m),683 (m); HRMS (CI (CH4)) calcd for (C11H20O2S + 
H): 217.1257; found: 217.1256. 
 
Compound 188. This compound was obtained as a white powder (1.4 g, 66%) (1st 
step: 76%; 2nd: step 87%) from iso-butyric acid (2.4 g, 28 mmol) 
following Method II. 1H NMR (500 MHz, CDCl3): δ 4.36 (s, 1H), 3.38 
(s, 6H), 2.35 (sept., J = 7.0 Hz, 1H), 1.09 (d, J = 6.9 Hz, 6H), the NMR data is in 
accordance with that reported in the literature.42 
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Compound 189. This compound was obtained as a white powder (0.58 g, 32%) (1st 
step: 41%; 2nd: step 78%) from (1S,2S)-2-phenylcyclopropane-1-
carboxylic acid (0.8 g, 5 mmol) following Method II. m.p.: 163-166 
°C. 1H NMR (500 MHz, CDCl3): δ 7.29-7.23 (m, 2H), 7.16 (tt, J = 6.9, 1.3 Hz, 1H), 
7.13-7.07 (m, 2H), 4.54 (s, 1H), 3.41 (d, J = 4.2 Hz, 6H),  2.42 (ddd, J = 9.1, 6.2, 4.2 
Hz, 1H), 1.85 (ddd, J = 8.3, 5.5, 4.2 Hz, 1H), 1.60-1.54 (m, 1H), 1.16 (ddd, J = 8.2,6.3, 
4.2 Hz, 1H); 13C NMR (125 MHz, CDCl3): δ 187.7 (e), 141.7 (e), 128.2 (o, 2C), 125.9 
(o, 2C), 125.8 (o), 69.1 (o), 42.3 (o), 42.3 (o), 31.0 (o), 25.2 (o), 16.5 (e); IR (neat): ν 
= 3092 (w), 3028 (m), 3004 (m), 2918 (m), 1605 (m), 1552 (vs), 1494 (m), 1412 (vs), 
1362 (s), 1308 (m), 1158 (vs), 1125 (s), 1103 (s), 1076 (m), 1025 (s), 999 (s), 968 (m), 
959 (m), 929 (s), 900 (w), 860 (m), 831 (s), 747 (vs), 693 (vs); HRMS (ESI) calcd for 
(C13H16O2S + Na): 259.0769; found: 259.0767. 
 
Compound 190. This compound was obtained as a white powder (0.39 g, 70%) (1st 
step: 76%; 2nd: step 93%) from 2-(naphthalen-2-yl)acetic acid 
(1 g, 5.4 mmol) following Method II. 1H NMR (500 MHz, 
CDCl3): δ 7.83 (m, 3H), 7.70 (s, 1H), 7.48-7.39 (m , 3H), 4.27 (s, 1H), 3.64 (s, 2H), 
3.35 (s, 6H), this product was not characterised further due to poor results in the 
rhodium-catalysed C–H bond functionalisation. 
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6.3.3 Synthesis of sulfoxonium ylides using acyl chlorides 
 
Method III: Representative example for the synthesis of 206. 
To a flame dried 250 mL round bottom flask, under nitrogen and covered from light, 
was transferred trimethylsulfoxonium iodide (1.8 g, 8.4 mmol, 3 equiv.). The solid was 
suspended in dry THF (17 mL) before potassium tert-butoxide was added (0.9 g, 8.4 
mmol, 3 equiv.). The mixture was stirred at reflux for 2 h. After cooling to 0 °C, 3,5-
difluorobenzoyl chloride (330 µL, 2.8 mmol, 1 equiv.) in THF (6 mL) was added 
dropwise to the mixture. The mixture was stirred at 0 °C for 1 h. The mixture was 
filtered through a plug of celite and all volatiles were removed under vacuum. 
Purification by flash chromatography (DCM:MeOH/98:2) afforded 206 as a white 
powder (577 mg, 89%). 
 
Compound 203. This compound was obtained as a white solid (0.123 g, 19%) from 
4-methoxybenzoyl chloride (0.4 mL, 2.9 mmol) following 
Method III (sodium tert-butoxide was used as the base). 1H 
NMR (500 MHz, CDCl3): δ 7.79-7.74 (m, 2H), 6.92-6.87 (m, 2H), 4.90 (s, 1H), 3.84 
(s, 3H), 3.51 (s, 6H), the NMR data is in accordance with that reported in the 
literature.42 
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Compound 204. This compound was obtained as a white solid (1 g, 80%) from 2-
chlorobenzoyl chloride (638 µL, 5.4 mmol) following Method III. 1H 
NMR (500 MHz, CDCl3): δ 7.54-7.48 (m, 1H), 7.38-7.33 (m, 1H), 
7.29-7.22 (m, 2H), 4.75 (s, 1H), 3.54 (s, 6H), the NMR data is in accordance with that 
reported in the literature.27  
 
Compound 205. This compound was obtained as a white solid (1.2 g, 50%) from 3,5-
bis(trifluoromethyl)benzoyl chloride (1.3 mL, 7.2 mmol) 
following Method III. 1H NMR (500 MHz, CDCl3): δ 8.26 (s, 
2H), 7.95 (s, 1H), 5.09 (s, 1H), 3.28 (s, 6H), this product was not 
characterised further due to poor results in the rhodium-catalysed C–H bond 
functionalisation. 
 
Compound 206. This compound was obtained as a white solid (0.577 g, 89%) from 
3,5-difluorobenzoyl chloride (0.33 mL, 2.8 mmol) following 
Method III. m.p.: 148-151 °C. 1H NMR (500 MHz, CDCl3): δ 
7.30-7.24 (m, 2H), 6.84 (tt, J = 8.5, 2.3 Hz, 1H), 4.93 (s, 1H), 3.50 
(s, 6H); 13C NMR (125 MHz, CDCl3): δ 179.0 (e), 163.8 (e, d, J = 11.8 Hz), 161.8 (e, 
d, J = 12.0 Hz), 142.5 (e, t, J = 7.4 Hz), 109.5 (o, d, J = 6.6 Hz), 109.4 (o, d, J = 6.4 
Hz), 105.7 (o, t, J = 25.7 Hz), 69.4 (o), 42.2 (o, 2C); IR (neat): ν = 3086 (w), 3019 (w), 
2918 (w),1619 (w), 1541 (vs), 1434 (m), 1388 (s), 1325 (m), 1299 (m), 1219 (w), 1164 
(vs), 1112 (vs), 1076 (w), 1041 (m), 1028 (m), 981 (s), 971 (s), 934 (m), 857 (vs), 774 
(w), 752 (s), 686 (m), 664 (s); Anal. Calcd for C10H10F2O2S: C 51.72, H 4.31; found 
C 51.62, H 4.27. 
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Compound 207. This compound was obtained as a white solid (0.591 g, 93%) from 
1-adamantanecarbonyl chloride (0.5 g, 2.5 mmol) following 
Method III. m.p.: 163-166 °C. 1H NMR (500 MHz, CDCl3): δ 4.38 
(s, 1H), 3.35 (s, 6H), 2.01-1.95 (m, 3H), 1.78-1.74 (m, 6H), 1.72-1.62 (m, 6H); 13C 
NMR (125 MHz, CDCl3): δ 197.3 (e), 66.2 (o), 42.8 (e), 42.3 (o, 2C), 39.6 (e, 3C), 
36.8 (e, 3C), 28.4 (o, 3C); IR (neat): ν = 3001 (w), 2904 (m), 2849 (m), 1524 (vs), 
1452 (w), 1383 (s), 1314 (m), 1190 (s), 1172 (vs), 1101 (w), 1073 (m), 1028 (s), 988 
(m), 946 (m), 854 (s), 817 (w), 746 (w), 659 (w); HRMS (CI (CH4)) calcd for 
(C14H22O2S + H): 255.1413; found: 255.1409. 
 
Compound 208. This compound was obtained as a white solid (0.7 g, 71%) from 
furan-2-carbonyl chloride (0.5 mL, 5.4 mmol) following Method III. 
1H NMR (500 MHz, CDCl3): δ 7.41 (dd, J = 1.7, 0.8 Hz, 1H), 6.92 
(dd, J = 3.4, 0.8 Hz, 1H), 6.44 (dd, J = 3.5, 1.8 Hz, 1H), 5.00 (s, 1H), 3.51 (s, 6H), the 
NMR data is in accordance with that reported in the literature.119 
 
Compound 209. This compound was obtained as a beige solid (0.6 g, 80%) from 
thiophene-2-carbonyl chloride (0.4 mL, 3.8 mmol) following Method 
III. 1H NMR (500 MHz, CDCl3): δ 7.44 (dd, J = 3.7, 1.2 Hz, 1H), 
7.40 (dd, J = 5.0, 1.1 Hz, 1H), 7.04 (dd, J = 5.0, 3.7 Hz, 1H), 4.87 (s, 1H), 3.51 (s, 6H), 
the NMR data is in accordance with that reported in the literature.42  
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Compound 210. This compound was obtained as a white solid (0.6, 80%) from 5-
methylisoxazole-3-carbonyl chloride (0.5 g, 3.4 mmol) following 
Method III. 1H NMR (500 MHz, CDCl3): δ 6.33 (s, 1H), 5.36 (s, 
1H), 3.53 (s, 6H), 2.46 (d, J = 0.9 Hz, 3H), this product was not characterised further 
due to poor results in the rhodium-catalysed C–H bond functionalisation. 
 
Compound 70. This compound was obtained as a white solid (363 g, 54%) from 2-
(benzyloxy)acetyl chloride (427 µL, 2.7 mmol) following Method 
III. 1H NMR (500 MHz, CDCl3): δ 7.38-7.27 (m, 5H), 4.90 (s, 1H), 
4.59 (s, 2H), 3.92 (s, 2H), 3.42 (s, 6H), the NMR data is in accordance with that 
reported in the literature.27 
 
6.3.4 Miscellaneous 
Compound 214. This compound was obtained as a white solid (2.2 g, 80%) from 
acetic anhydride (1.9 mL, 20 mmol) following Method III. m.p.: 68-70 
°C. 1H NMR (500 MHz, CDCl3): δ 4.36 (s, 1H), 3.34 (s, 6H), 1.88 (s, 3H); 
13C NMR (125 MHz, CDCl3): δ 187.8 (e), 69.6 (e), 41.9 (o, 2C), 27.6 (o); IR (neat): ν 
= 3070 (w), 3009 (w), 2987 (m), 1538 (vs), 1435 (m), 1377 (vs), 1331 (m), 1303 (m), 
1162 (vs), 1027 (vs), 992 (s), 949 (m), 920 (m), 847 (s), 753 (m), 697 (m), 633 (m); 
HRMS (CI (CH4)) calcd for (C5H10O2S + H): 135.0474; found: 135.0476. 
 
Compound 216. This compound was obtained as a white solid (180 mg, 25%) from 
diphenylphosphinic chloride (475 µL, 2.5 mmol) following Method III. 
1H NMR (500 MHz, CDCl3): δ 7.89-7.83 (m 4H), 7.51-7.41 (m , 6H), 
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4.15 (s, 1H), 3.40 (s, 6H), this product was not characterised further due to poor 
results in the rhodium-catalysed C–H bond functionalisation. 
 
Compound 52. This compound was obtained as a white solid (1.6 g, 58%) from 2-
chloro-4,6-dimethylpyrimidine (2 g, 14 mmol) following Method I. 
1H NMR (500 MHz, CDCl3): δ 6.28 (1H), 4.34 (s, 1H), 3.50 (s, 6H), 
2.27 (s, 6H), the NMR data is in accordance with that reported in the literature.31 
 
6.3.5 Bis-substituted sulfoxonium ylides 
Method IV: Representative example for the synthesis of 218. 
To a flame dried Schlenk tube, under nitrogen, was added 52 (165 mg, 0.8 mmol, 2 
equiv.) and 1,4-dioxane (3 mL). The mixture was cooled to 0 °C and a solution of 
propionyl chloride (38 µL, 0.4 mmol, 1 equiv.) in 1,4-dioxane (0.9 mL) was added 
dropwise. The mixture was stirred at room temperature for 1 h, then was filtered over 
celite and concentrated. Recrystallisation from ethyl acetate gave 218 as a white solid 
(70 mg, 64%). 
 
Compound 218. This compound was obtained as a white solid (70 mg, 64%) from 
propionyl chloride (38 µL, 0.4 mmol) following Method IV. 1H 
NMR (500 MHz, CDCl3): δ 6.72 (s, 1H), 3.66 (s, 6H), 2.65 (q, J = 
7.5 Hz, 2H), 2.44 (s, 6H), 1.04 (t, J = 7.5 Hz, 3H), this product was 
not characterised further due to poor results in the rhodium-catalysed C–H bond 
functionalisation. 
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Compound 220. This compound was obtained as a white solid (237 mg, 63%) from 
ethyl chloroformate (130 µL, 1.4 mmol) following Method IV. 1H 
NMR (500 MHz, CDCl3): δ 6.69 (s, 1H), 4.18 (q, J = 7.2 Hz, 2H), 
3.67 (s, 6H), 2.43 (s, 6H), 1.26 (t, J = 7.2 Hz, 3H), the NMR data is 
in accordance with that reported in the literature.31 
 
Compound 221. This compound was obtained as a white solid (154 mg, 20%) from 
phenyl isocyanate (297 µL, 2.7 mmol) following Method IV. 1H 
NMR (500 MHz, CDCl3): δ 12.11 (s, 1H), 7.57 (dd, J = 8.5, 1.0 Hz, 
2H), 7.32-7.26 (m 2H), 7.00 (t, J = 7.2 Hz, 1H), 6.53 (s, 1H), 3.91 (s, 
6H), 2.42 (s, 6H), the NMR data is in accordance with that reported in the literature.31 
 
Compound 469.  
 
 
Compound 225. To a flame dried schlenk tube under N2 was added diethyl sulfide 
(2.0 g, 22.7 mmol, 1.0 equiv.) followed by iodoethane (3.9 g, 25.0 mmol, 1.1 equiv.) 
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and iodine (2.9 g, 11.4 mmol, 0.5 equiv.). The tube was sealed and the mixture was 
stirred at 70 °C overnight. Then, after cooling down, the mixture was transferred into 
a conical flask with water (70 mL), DCM (46 mL) and tributylbenzylammonium 
chloride (7.1 g, 22.7 mmol, 1.0 equiv.). The mixture was protected from light and 
stirred overnight at room temperature. The two layers were separated and the aqueous 
layer was washed 5 times with DCM (30 mL). The aqueous layer was evaporated to 
give 225 as a hygroscopic white solid (3.5 g, 99%). 1H NMR (500 MHz, D2O): δ 3.31 
(q, J = 7.5 Hz, 6H), 1.45 (t, J = 7.5 Hz, 9H), the NMR data is in accordance with that 
reported in the literature.69   
 
Compound 222. 225 (3.5 g, 22.4 mmol, 1.0 equiv.)  was dissolved with water (112 
mL) in a round bottom flask, the resulting solution was cooled to 0 °C and NaOH (5.4 
g, 0.13 mol, 6.0 equiv.) was added. The mixture was stirred at 0 °C until homogeneity. 
m-CPBA (22.2 g, 77% in mineral oil, 90.0 mmol, 4.0 equiv.) was added portionwise 
and the mixture was stirred at 50 °C for 30 min. Then the pH was adjusted to pH = 1 
with 6 M HCl (20 mL) at 0 °C. The precipitate was filtered off and washed with water. 
The corresponding filtrate was concentrated to ≈ 60 mL and washed with DCM (20 
mL). The pH of the aqueous layer was adjusted to pH = 5-6 with saturated Na2CO3 
and evaporated to dryness. The resulting solid was dispersed in warm i-PrOH (40 mL) 
and the mixture was filtered. All volatiles were removed in vacuo and the crude 
product was recrystallised from i-PrOH to give 222 as a white solid (1.16 g, 38%). 1H 
NMR (500 MHz, D2O): δ 3.96 (q, J = 7.4 Hz, 6H), 1.57 (t, J = 7.4 Hz, 9H), the NMR 
data is in accordance with that reported in the literature.69 
 
245 
 
Compound 226. To a flame dried 250 mL round bottom flask, under nitrogen and 
covered from light, was transferred 222 (1.2 g, 6.9 mmol, 3 equiv.). The solid was 
suspended in dry THF (14 mL) before potassium tert-butoxide was added (0.8 g, 6.9 
mmol, 3 equiv.). The mixture was stirred at reflux for 2 h. After cooling to 0 °C, 
methoxybenzoyl chloride (0.3 mL, 2.3 mmol, 1 equiv.) in THF (5 mL) was added 
dropwise to the mixture. The mixture was stirred at 0 °C for 1 h. The mixture was 
filtered through a plug of celite and all volatiles were removed under vacuum. 
Purification by flash chromatography (DCM/MeOH: 98/2) afforded 226 as a white 
powder (0.5 g, 88%). m.p.: 93-95 °C. 1H NMR (500 MHz, CDCl3): δ 7.52-7.47 (m, 
2H), 6.87-6.80 (m, 2H), 4.25 (dq, J = 13.2, 7.5 Hz, 2H), 3.77 (s, 3H), 3.26 (dq, J = 
13.3, 7.3, Hz, 2H), 1.97 (s, 3H), 1.31 (t, J = 7.5 Hz, 6H); 13C NMR (125 MHz, CDCl3): 
δ 181.9 (e), 160.2 (e), 133.8 (e), 129.1 (o, 2C), 113.0 (o, 2C), 67.1 (e), 55.2 (o), 46.4 
(o, 2C), 11.5 (o), 5.0 (o, 2C); IR (neat): ν = 2977 (w), 2937 (w), 2907 (w), 2842 (w), 
1605 (m), 1580 (m), 1506 (vs), 1467 (m), 1448 (m), 1409 (m), 1384 (m), 1370 (s), 
1297 (m), 1281 (w), 1241 (s), 1196 (w), 1173 (vs), 1132 (w), 1105 (m), 1072 (w), 
1055 (w), 1029 (s), 1013 (m), 990 (s), 965 (m), 837 (s), 822 (s), 797 (s), 758 (m), 748 
(m), 693 (s), 633 (m); HRMS (ESI) calcd for (C14H20O3S + Na): 291.1031; found: 
291.1029. 
 
6.4 Rhodium-catalysed cross-coupling of α-ketosulfoxonium ylides 
with C–H bonds 
6.4.1 Scope of sulfoxonium ylides 
Method V: Representative example for the synthesis of 229a. 
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A flame dried Schlenk tube, sealable with a J-Young key, was charged with AgSbF6 
(6.9 mg, 0.02 mmol, 0.1 equiv.) in an argon-filled glovebox. The tube was taken out 
and [Cp*RhCl2]2 (2.5 mg, 0.004 mmol, 0.02 equiv.) was added, followed by HFIP (1 
mL) under air. Then, phenyl pyridine (29 μL, 0.2 mmol, 1.0 equiv.), NaOAc (16 mg, 
0.2 mmol, 1.0 equiv.), 187 (73.5 mg, 0.34 mmol, 1.7 equiv.) and HFIP (0.5 mL) were 
sequentially added in that order. The tube was sealed and the mixture was stirred at 60 
°C for 17 h. After cooling to room temperature, the mixture was filtered through a 
short plug of silica and all volatiles were removed in vacuo. Purification by flash 
chromatography (PE:EtOAc/9:1 to 8:2) afforded 229a as a colourless oil (58 mg, 
quant.). 
 
Method VI: Representative example for the synthesis of 229b. 
The procedure was identical to Method III except that 2.0 equiv. of sulfoxonium ylide 
were used. 
 
Method VII: Representative for the synthesis of 234. 
The procedure was identical to Method III except that 2.0 equiv. of sulfoxonium ylide 
and the mixture was stirred at 90 °C overnight. 
 
Compound 229a. This compound was obtained as a colourless oil (58 mg, quant.) 
from 187 following Method V. 1H NMR (500 MHz, CDCl3): δ 
8.64-8.60 (m, 1H), 7.74 (dt, J = 7.7, 1.9 Hz, 1H), 7.45-7.41 (m, 
2H), 7.40-7.34 (m, 2H), 7.26-7.21 (m, 2H), 3.89 (s, 2H), 2.21 (d, J 
= 6.8 Hz, 2H), 1.76-1.66 (m, 1H), 1.65-1.51 (m, 5H), 1.28-1.03 (m, 3H), 0.81 (dq, J = 
12.8, 3.0 Hz, 2 H); 13C NMR (125 MHz, CDCl3): δ 208.0 (e), 159.7 (e), 148.7 (o), 
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140.3 (e), 136.6 (o), 133.0 (e), 131.7 (o), 129.8 (o), 128.5 (o), 127.2 (o), 123.9 (o), 
121.8 (o), 49.8 (e), 48.3 (e), 33.7 (o), 33.1 (e, 2C), 26.2 (e), 26.1 (e, 2C); IR (neat): ν 
= 3061 (w), 2920 (vs), 2849 (s), 1711 (vs), 1586 (s), 1561 (m), 1495 (w), 1471 (m), 
1445 (m), 1425 (s), 1372( w), 1335 (m), 1286 (m), 1213 (w), 1181 (w), 1150 (w), 1091 
(m), 1023 (m), 910 (br), 795 (m), 750 (vs), 731 (s); HRMS (ESI) calcd for (C20H23NO 
+ Na): 316.1677; found: 316.1675; Anal. Calcd for C20H23NO: C 81.86, H 7.85, N 
4.78; found C 81.77, H 7.93, N 4.67. 
 
Compound 229b. This compound was obtained as a colourless oil from 188 following 
Method VI. 1H NMR (500 MHz, CDCl3): δ 8.63-8.59 (m, 1H), 7.74 (dt, 
J = 7.7, 1.8 Hz, 1H), 7.45-7.41 (m, 2H), 7.39-7.34 (m, 2H), 7.26-7.21 
(m, 2H), 3.97 (s, 2H), 2.63 (sept, J = 7.1 Hz, 1H), 0.98 (d, J = 7.0 Hz, 
6H); 13C NMR (125 MHz, CDCl3): δ 211.9 (e), 159.7 (e), 148.6 (o), 140.3 (e), 136.6 
(o), 133.2 (e), 131.7 (o), 129.8 (o), 128.5 (o), 127.1 (o), 123.9 (o), 121.8 (o), 45.7 (e), 
40.1 (o), 18.3 (o, 2C); IR (neat): ν = 3061 (w), 2968 (m), 2932 (w), 2872 (w), 1709 
(s), 1586 (m), 1561 (m), 1495 (w), 1469 (m), 1442 (m), 1425 (m), 1381 (w), 1364 (w), 
1335 (w), 1312 (w), 1295 (w), 1199 (w), 1040 (m), 1023 (m), 990 (m), 795 (m), 750 
(vs), 634 (w), 620 (w); HRMS (CI (CH4)) calcd for (C16H17NO + H): 240.1383; found: 
240.1385. 
 
Compound 229c. This compound was obtained as an amorphous yellowish solid (55 
mg, 95%) from 64 following Method V (without NaOAc). 1H NMR 
(500 MHz, CDCl3): δ 8.41-8.37 (m, 1H), 7.92-7.87 (m, 2H), 7.69 (dt, 
J = 7.8, 2.1 Hz, 1H), 7.55-7.48 (m, 2H), 7.47-7.44 (m, 1H), 7.44-7.37 
(m, 4H), 7.36-7.30 (m, 1H), 7.13 (ddd, J = 7.5, 4.8, 1.2, 1H), 4.52 (s, 
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2H); 13C NMR (125 MHz, CDCl3): δ 197.8 (e), 159.4 (e), 148.5 (o), 139.9 (e), 137.0 
(e), 136.5 (o), 133.2 (e), 132.6 (o), 131.8 (o), 129.7 (o), 128.5 (o), 128.3 (o, 2C), 128.1 
(o, 2C), 127.2 (o), 123.7 (o), 121.6 (o), 43.5 (e); IR (neat): ν = 3076 (w), 2915 (w), 
1688 (vs), 1587 (s), 1560 (m), 1497 (w), 1470 (s), 1449 (s), 1424 (m), 1401 (m), 1336 
(s), 1296 (m), 1263 (w), 1211 (s), 1197 (m), 1148 (w), 1089 (w), 1025 (m), 990 (s), 
939 (m), 845 (w), 796 (m), 745 (vs), 726 (s), 691 (s), 662 (m); HRMS (CI (NH3)) calcd 
for (C19H15NO + H): 274.1226; found: 274.1220. 
 
Compound 229d. This compound was obtained as a white solid (60 mg, 85%) from 
186 following Method V. m.p.: 93-94 °C. 1H NMR (500 MHz, 
CDCl3): δ 8.36-8.33 (m, 1H), 7.76 (d, J = 8.6 Hz, 2H), 7.70 (dt, J 
= 7.7, 1.7 Hz, 1H), 7.55 (d, J = 8.6 Hz, 2H), 7.51-7.48 (m, 1H), 
7.48-7.45 (m, 1H), 7.42-7.37 (m, 2H), 7.34-7.29 (m, 1H), 7.15 
(ddd, J = 7.5, 4.8, 1.3 Hz, 1H), 4.47 (s, 2H); 13C NMR (125 MHz, CDCl3): δ 196.9 (e), 
159.3 (e), 148.5 (o), 139.6 (e), 136.7 (o), 135.8 (e), 133.0 (e), 131.9 (o, 2C), 131.7 (o), 
129.8 (o), 129.8 (o, 2C), 128.6 (o), 127.7 (e),127.4 (o), 123.7 (o), 121.8 (o), 43.5 (e); 
IR (neat): ν = 3020 (w), 2908 (w), 1676 (vs), 1610 (w), 1586 (s), 1569 (m), 1560 (m), 
1470 (s), 1423 (m), 1417 (m), 1394 (m), 1342 (m), 1292 (m), 1215 (s), 1147 (m), 1115 
(w), 1070 (m), 995 (vs), 944 (w), 889 (w), 848 (w), 804 (vs), 793 (m), 747 (vs), 689 
(m), 618 (m); Anal. Calcd for C19H14BrNO: C 64.95, H 3.99, N 3.99; found C 64.91, 
H 3.98, N 3.77. 
 
249 
 
Compound 229e. This compound was obtained as a yellowish solid (57 mg, 94%) 
from 203 following Method V. m.p.: 94-97 °C. 1H NMR (500 
MHz, CDCl3): δ 8.47 (ddd, J = 4.9, 1.8, 0.9 Hz, 1H), 7.89-7.85 
(m, 2H), 7.69 (dt, J = 7.7, 1.8 Hz, 1H), 7.49-7.43 (m, 2H), 7.40-
7.34 (m, 2H), 7.34-7.30 (m, 1), 7.16 (ddd, J = 7.6, 4.9, 1.2 Hz, 
1H), 6.89-6.86 (m, 2H), 4.46 (s, 2H), 3.84 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 
196.5 (e), 163.2 (e), 159.5 (e), 148.7 (o), 140.0 (e), 136.6 (o), 133.5 (e), 131.5 (o), 
130.5 (o, 2C), 129.9 (e), 129.8 (o), 128.5 (o), 127.1 (o), 123.9 (o), 121.7 (o), 113.5 (o, 
2C), 55.4 (o), 43.0 (e); IR (neat): ν = 3054 (w), 2974 (w), 2898 (w), 1678 (vs), 1590 
(vs), 1560 (m), 1511 (m), 1462 (m), 1441 (m), 1431 (m), 1344 (s), 1316 (m), 1265 (s), 
1221 (s), 1198 (w), 1163 (vs), 1113 (w), 1090 (w), 1011 (s), 992 (s), 956 (w), 827 (vs), 
811 (m), 794 (m), 748 (vs), 720 (m), 621 (m); Anal. Calcd for C20H17NO: C 79.17, H 
5.61, N 4.62; found C 78.77, H 5.68, N 4.47. 
 
Compound 229f. This compound was obtained as a white solid (41 mg, 66%) from 
206 following Method VI. m.p.: 117-120 °C. 1H NMR (500 MHz, 
CDCl3): δ 8.35-8.29 (m, 1H), 7.72 (dt, J = 7.8, 1.9 Hz, 1H), 7.55-
7.47 (m, 2H), 7.45-7.38 (m, 4H), 7.35-7.30 (m, 1H), 7.15 (ddd, J 
= 7.4, 4.9, 1.1 Hz, 1H), 6.98 (tt, J = 8.5, 2.3 Hz, 1H), 4.46 (s, 2H); 
13C NMR (125 MHz, CDCl3): δ 195.3 (e), 163.9 (e, d, J = 11.8 Hz), 161.9 (e, d, J = 
11.9 Hz), 159.1 (e), 148.4 (o), 140.2 (e, t, J = 7.2 Hz), 139.3 (e), 136.9 (o), 132.6 (e), 
132.0 (o), 129.8 (o), 128.7 (o), 127.6 (o), 123.6 (o), 121.9 (o), 111.1 (o, dd, J = 20.3, 
6.4, 2C), 107.8 (o, t, J = 25.2 Hz), 43.8 (e); IR (neat): ν = 3054 (w), 2901 (w), 1684 
(s), 1619 (m), 1592 (s), 1561 (w), 1474 (m), 1455 (w), 1436 (s), 1425 (m), 1416 (m), 
1345 (s), 1299 (s), 1231 (w), 1167 (m), 1151 (m), 1120 (s), 1091 (w), 1048 (w), 980 
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(s), 874 (m), 854 (m), 795 (m), 746 (vs), 709 (s), 669 (m), 622 (w), 609 (w); Anal. 
Calcd for C19H13F2NO: C 73.76, H 4.21, N 4.53; found C 73.41, H 4.25, N 4.39. 
 
Compound 229g. This compound was obtained as a orange amorphous solid (51 mg, 
97%) from 208 following Method V and stirring for 48 h. 1H NMR 
(500 MHz, CDCl3): δ 8.47 (ddd, J = 4.8, 1.8, 0.9 Hz, 1H), 7.71 (dt, J 
= 7.7, 1.8 Hz, 1H), 7.51 (dd, J = 1.8, 0.8 Hz, 1H), 7.49-7.44 (m, 2H), 
7.41-7.34 (m, 3H), 7.18 (ddd, J = 7.6, 4.9, 1.1 Hz, 1H), 7.08 (dd, J = 
3.6, 0.7 Hz, 1H), 6.47 (dd, J = 3.5, 1.8 Hz, 1H), 4.35 (s, 2H); 13C NMR (125 MHz, 
CDCl3): δ 186.8 (e) 159.4 (e), 152.5 (e), 148.6 (o), 146.0 (o), 140.2 (e), 136.5 (o), 
132.5 (e), 131.7 (o), 129.8 (o), 128.5 (o), 127.3 (o), 123.9 (o), 121.7 (o), 117.1 (o), 
112.0 (o), 43.0 (e); IR (neat): ν = 3114 (w), 2981 (w), 1668 (vs), 1591 (m), 1561 (m), 
1469 (s), 1439 (m), 1397 (s), 1300 (w), 1258 (s), 1165 (m), 1083 (w), 1038 (m), 1004 
(s), 990 (m), 952 (w), 884 (m), 772 (s), 745 (vs), 718 (m), 622 (w); HRMS (ESI) calcd 
for (C17H13NO2 + Na): 264.1025; found: 264.1017. 
 
Compound 229h. This compound was obtained as a yellowish solid (52 mg, 93%) 
from 209 following Method VI and stirring for 24 h. m.p.: 76-79 °C. 
1H NMR (500 MHz, CDCl3): δ 8.50-8.47 (m, 1H), 7.71 (dt, J = 7.7, 
2.0 Hz, 1H), 7.60 (dd, J = 3.8, 1.1 Hz, 1H), 7.57 (dd, J = 5.0, 1.1 Hz, 
1H), 7.50-7.44 (m, 2H), 7.41-7.35 (m, 3H), 7.18 (ddd, J = 7.6, 4.9, 1.1 
Hz, 1H), 7.06 (dd, J = 5.0, 3.9 Hz, 1H), 4.44 (s, 2H); 13C NMR (125 MHz, CDCl3): δ 
190.7 (e), 159.4 (e), 148.7 (o), 144.1 (e), 140.1 (e), 136.6 (o), 133.2 (o), 132.8 (e), 
132.0 (o), 131.6 (o), 129.8 (o), 128.5 (o), 127.9 (o), 127.3 (o), 123.9 (o), 121.8 (o), 
44.0 (e); IR (neat): ν = 3105 (w), 1657 (s), 1586 (s), 1560 (m), 1519 (m), 1472 (m), 
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1443 (m), 1414 (s), 1354 (w), 1328 (m), 1234 (m), 1226 (s), 1176 (w), 1082 (m), 1060 
(m), 1023 (m), 993 (m), 944 (m), 863 (m), 799 (m), 742 (vs), 732 (vs), 714 (vs); Anal. 
Calcd for C17H13NOS: C 73.10, H 4.66, N 5.02, S 11.47; found C 73.07, H 4.76, N 
4.83, S 11.42. 
 
Compound 229i. This compound was obtained as an amorphous beige solid (28 mg, 
90%) from phenyl pyridine (14 μL, 0.1 mmol, 1.0 equiv.) and 189 
(40 mg, 0.17 mmol) following Method V. 1H NMR (500 MHz, 
CDCl3): δ 8.55 (d, J = 4.7 Hz, 1H), 7.69 (dt, J = 7.7, 1.8 Hz, 1H), 
7.48-7.42 (m, 1H), 7.41-7.34 (m, 3H), 7.33-7.28 (m, 1H), 7.28-7.22 (m, 2H), 7.21-7.15 
(m, 2H), 7.02-6.94 (m, 2H), 4.09 (dd, J = 16.4, 3.4 Hz, 2H), 2.42-2.36 (m, 1H), 2.22-
2.15 (m, 1H), 1.60-1.55 (m, 1H), 1.28-1.23 (m, 1H); 13C NMR (125 MHz, CDCl3): δ 
206.4 (e), 159.5 (e), 148.7 (o), 140.5 (e), 140.2 (e), 136.5 (o), 132.9 (e), 131.7 (o), 
129.8 (o), 128.6 (o), 128.3 (o, 2C), 127.3 (o), 126.3 (o), 126.1 (o, 2C), 123.8 (o), 121.8 
(o), 48.7 (e), 31.7 (o), 29.1 (o), 19.1 (e); IR (neat): ν = 3060 (w), 3028 (w), 2920 (w), 
1693 (vs), 1601 (w), 1585 (m), 1562 (m), 1495 (m), 1471 (m), 1440 (m), 1426 (s), 
1341 (s), 1313 (m), 1287 (m), 1151 (m), 1095 (s), 1071 (s), 1030 (w), 942 (m), 905 
(w), 765 (s), 751 (vs), 703 (vs), 658 (s); HRMS (CI (CH4)) calcd for (C22H19NO + H): 
314.1539; found: 314.1544. 
 
Compound 229j. This compound was obtained as a white solid (59 mg, 89%) from 
207 following Method VI. m.p.: 69-73 °C. 1H NMR (500 MHz, 
CDCl3): δ 8.62 (ddd, J = 4.9, 1.7, 0.9 Hz, 1H), 7.72 (dt, J = 7.7, 1.8 
Hz, 1H), 7.42-7.37 (m, 2H), 7.37-7.31 (m, 2H), 7.21 (ddd, J = 7.5, 
4.8, 1.1 Hz, 1H), 7.19-7.14 (m, 1H), 4.06 (s, 2H), 1.98 (br s, 3H), 
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1.75-1.68 (m, 9H), 1.66-1.59 (m, 3H); 13C NMR (125 MHz, CDCl3): δ 212.6 (e), 160.1 
(e), 148.6 (o), 140.6 (e), 136.5 (o), 133.3 (e), 131.6 (o), 129.7 (o), 128.2 (o), 126.9 (o), 
124.2 (o), 121.6 (o), 46.4 (e), 41.1 (e), 38.4 (e, 3C), 36.5 (e, 3C), 28.0 (o, 3C); IR 
(neat): ν = 3056 (w), 2914 (s), 2901 (s), 2850 (m), 1691 (s), 1587 (m), 1560 (w), 1495 
(w), 1470 (m), 1448 (m), 1426 (m), 1366 (w), 1345 (w), 1326 (w), 1304 (w), 1292 
(w), 1194 (m), 1159 (m), 1089 (w), 1025 (m), 910 (s), 790 (m), 756 (s), 735 (vs), 669 
(m), 646 (m); Anal. Calcd for C23H25NO: C 83.34, H 7.55, N 4.23; found C 83.03, H 
7.66, N 4.03. 
 
Compound 229k. This compound was obtained as an amorphous beige solid (68 mg, 
86%) from 168 following Method VI. 1H NMR (500 MHz, 
CDCl3): δ 8.61-8.56 (m, 1H), 7.75 (dt, J = 7.8, 1.8 Hz, 1H), 7.48-
7.42 (m, 2H), 7.40-7.34 (m, 2H), 7.26-7.21 (m, 2H), 4.02 (br s, 
2H), 3.97 (s, 2H), 2.78-2.61 (m, 2H), 2.52 (tt, J = 11.3, 3.6 Hz, 
1H), 1.71-1.60 (m, 2H), 1.50-1.38 (m, 12H); 13C NMR (125 MHz, CDCl3): δ 209.4 
(e), 159.6 (e), 154.6 (e), 148.5 (o), 140.0 (e), 136.7 (o), 132.8 (e), 131.8 (o), 129.8 (o), 
128.6 (o), 127.3 (o), 123.9 (o), 121.9 (o), 79.5 (e), 47.6 (o), 46.0 (e), 28.4 (o, 3C), 27.5 
(e, 4C); IR (neat): ν = 2975 (w), 2941 (w), 2854 (w), 2246 (w), 1717 (m), 1671 (vs), 
1588 (m), 1561 (w), 1472 (m), 1444 (m), 1425 (vs), 1391 (m), 1365 (m), 1336 (w), 
1276 (m), 1237 (s), 1160 (vs), 1132 (vs), 1028 (m), 1010 (s), 989 (w), 911 (m), 798 
(w), 753 (vs), 730 (vs); HRMS (ESI) calcd for (C23H29N2O3 + Na): 381.2178; found: 
381.2177. 
. 
253 
 
Compound 230. This compound was obtained as a yellow solid (10 mg, 27%) from 
190 following Method V. 1H NMR (500 MHz, CDCl3): δ 7.89 (d, J = 
8.2 Hz, 1H), 7.80 (d, J = 8.4 Hz, 1H), 7.70 (d, J = 8.1 Hz, 1H), 7.56 (td, 
J = 7.0, 1.3 Hz, 1H), 7.50 (td, J = 8.2, 1.3 Hz, 1H), 7.44 (d, J = 8.3 Hz, 
1H), 3.84 (s, 2H), 3.74 (s, 2H); 13C NMR (125 MHz, CDCl3): δ 214.8 (e), 135.0 (e), 
133.9 (e), 132.7 (e), 130.0 (e), 128.9 (o), 128.0 (o), 126.8 (o), 125.7 (o), 124.2 (o), 
122.8 (o), 45.1 (e), 42.6 (e), the NMR data is in accordance with that reported in the 
literature.120 
 
Compound 231. This compound was obtained as a yellow solid (40 mg, 57%) from 
169 following Method V. 1H NMR (500 MHz, CDCl3): δ 7.44 (d, J = 7.5 
Hz, 1H), 7.41-7.29 (m , 5H), 7.24 (d, J = 7.5 Hz, 1H), 7.17-7.14 (m, 2H), 
4.72 (s, 1H), 3.71 (s, 2H); 13C NMR (125 MHz, CDCl3): δ 213.9 (e), 141.3 
(e), 138.1 (e), 137.3 (e), 128.8 (o, 2C), 128.5 (o, 2C), 128.0 (o), 127.9 (o), 127.4 (o), 
126.1 (o), 124.9 (o), 59.8 (o), 43.0 (e), the NMR data is in accordance with that 
reported in the literature.121 
 
Compound 232. This compound was obtained as an orange solid (18 mg, 38%) from 
221 following Method V. 1H NMR (500 MHz, CDCl3): δ 10.00 (m, 
1H), 8.74 (d, J = 9.0 Hz, 1H), 8.35 (d, J = 8.6 Hz, 1H), 8.00 (ddd, J = 
8.9, 6.9, 1.5 Hz, 1H), 7.61 (dt, J = 7.0, 1.3 Hz, 1H), 7.45 (ddd, J = 8.8, 
6.6, 1.1 Hz, 1H), 7.32 (d, J = 8.5 Hz, 1H), 7.20 (ddd, J = 8.6, 6.6, 1.1 
Hz, 1H), 7.06 (s, 1H), 2.60 (s, 6H); 13C NMR (125 MHz, CDCl3): δ 167.4 (e, 2C), 
165.0 (e), 153.1 (e), 142.7 (e), 137.4 (e), 134.1 (o), 131.8 (o), 131.1 (o), 123.7 (o), 
122.8 (o), 121.5 (o), 120.8 (o), 118.9 (o), 118.1 (o), 114.0 (e), 107.7 (e), 24.2 (o, 2C); 
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IR (neat): ν =  3113 (w), 3054 (w), 2919 (w), 1651 (vs), 1622 (s), 1609 (s), 1583 (vs), 
1520 (m), 1505 (m), 1475 (vs), 1451 (s), 1369 (m), 1325 (w), 1275 (s), 1219 (s), 1164 
(m), 1147 (s), 1099 (m), 1063 (w), 1047 (m), 991 (m), 954 (m), 936 (w), 895 (w), 872 
(m), 841 (w), 813 (w), 780 (m), 743 (vs), 711 (s), 676 (m);  HRMS (CI (CH4)) calcd 
for (C19H15N3O + H): 302.1288; found: 302.1298. 
 
Compound 229m. This compound was obtained from phenylpyridine (29 μL, 0.2 
mmol, 1.0 equiv) and 226 (107 mg, 0.4 mmol, 2.0 equiv) 
according to Method V but stirring at 90 °C for 48 h. After 
purification by flash chromatography (PE:EA/9:1 to 8:2), 
229m could not be obtained entirely free from unidentified impurities. A yield of 50% 
was determined by 1H NMR after adding 1,3,5-trimethoxybenzene (34 mg, 0.2 mmol, 
1.0 equiv.) as internal standard. A fraction suitable for characterisation was obtained 
following Method V. 1H NMR (500 MHz, CDCl3): δ 8.74-8.68 (m, 1H), 7.93-7.87 
(m, 2H), 7.81 (td, J = 7.7, 1.9 Hz, 1H), 7.45 (dt, J = 7.8, 1.0 Hz, 1H), 7.40-7.36 (m, 
1H), 7.33-7.24 (m, 4H), 6.82-6.76 (m, 2H), 5.11 (q, J = 7.0 Hz, 1H), 3.79 (s, 3H), 1.43 
(d, J = 6.9 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 199.8 (e), 163.0(e), 159.9 (e), 
149.2 (o), 140.1 (e), 139.2 (e), 136.6 (o), 131.2 (o, 2C), 130.2 (o), 129.4 (e), 129.0 (o), 
127.7 (o), 126.7 (o), 124.3 (o), 122.0 (o), 113.4 (o, 2C), 55.3 (o), 43.3 (o), 19.0 (o); IR 
(neat): ν = 3041 (w), 2969 (w), 2844 (w), 1667 (vs), 1595 (vs), 1508 (m), 1494 (w), 
1464 (m), 1442 (m), 1372 (w), 1325 (m), 1305 (w), 1283 (w), 1262 (s), 1242 (s), 1225 
(s), 1189 (w), 1163(vs), 1149 (m), 1112 (w), 1092 (w), 1023 (s), 998 (m), 988 (m), 
949 (m), 907 (w), 843 (s), 815 (w), 790 (m), 783 (m), 759 (vs), 6974 (m), 618 (m); 
HRMS (CI (CH4)) calcd for (C21H19NO2 + H): 318.1489; found: 318.1494. 
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6.4.2 Scope of Csp2–H 
Compound 233a/233b This mixture of compounds was obtained as a colourless oil 
(32 mg, 50%, 2.5:1 mixture of 
regioisomer) from 2-(3-
methoxyphenyl)pyridine (37 mg, 0.2 
mmol, 1.0 equiv.) and 187 following 
Method V. 1H NMR (500 MHz, CDCl3): δ 8.67-8.59 (m, 1.4H, maj+min), 7.79-7.67 
(m, 1.4H, maj+min), 7.46-7.38 (m, 1.4H, maj+min), 7.33 (t, J = 7.8 Hz, 0.6H, min), 
7.26-7.20 (m, 1.4H, maj+min), 7.15 (d, J = 8.4 Hz, 1H, maj), 7.05 (d, J = 7.9 Hz, 0.5 
H, min), 6.98 (d, J = 2.5 Hz, 1H, maj), 6.96-6.89 (m, 1.5 H, maj+min), 3.85-3.82 (m, 
3.9H, maj+min), 3.79 (s, 2.8H, maj+min), 2.27 (d, J = 7.0 Hz, 0.9H, min), 2.18 (d, J 
= 6.8 Hz, 2H, maj), 1.86-1.48 (m, 13.6H, maj+min), 1.29-1.01 (m, 4.9H, maj+min), 
0.93-0.72 (m, 3.3H, maj+min); 13C NMR (125 MHz, CDCl3): δ 208.7 (e, min), 208.5 
(e, maj), 159.5 (e, maj), 159.4 (e, min), 158.5 (e, maj), 157.8 (e, min), 148.9 (o, min), 
148.7 (o, maj), 142.0 (e, min), 141.3 (e, maj), 136.6 (o, maj), 136.3 (o, min), 132.6 (o, 
maj), 127.7 (o, min), 125.1 (e, maj), 124.1 (o, min), 123.9 (o, maj), 122.6 (e, min), 
122.0 (o, min), 121.9 (o, maj), 121.8 (o, min), 115.3 (o, maj), 114.1 (o, maj), 110.3 (o, 
min), 55.7 (o, min), 55.4 (o, maj), 49.7 (e, min), 49.6 (e, maj), 47.5 (e, maj), 41.9 (e, 
min), 33.7 (o, min), 33.7 (o, maj), 33.1 (e, 2C, min), 33.1 (e, 2C, maj), 26.2 (e, min), 
26.2 (e, maj), 26.1 (e, 2C, min), 26.1 (e, 2C, maj); IR (neat): ν = 2921 (s), 2849 (m), 
1710 (s), 1609 (m), 1589 (m), 1562 (m), 1504 (m), 1472 (m), 1462 (m), 1448 (m), 
1426 (m), 1372 (w), 1352 (w), 1322 (m), 1300 (m), 1258 (m), 1218 (m), 1177 (m), 
1150 (w), 1092 (w), 1054 (m), 1033 (s), 991 (w), 965 (w), 946 (w), 909 (m), 858 (w), 
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789 (w), 774 (m), 729 (vs), 646 (w), 611 (w); HRMS (CI (CH4)) calcd for (C21H25NO2 
+ H): 324.1958; found: 324.1967. 
 
Compound 234. This compound was obtained as an amorphous pale-yellow solid (29 
mg, 40%; 53 mg, 73%) from ethyl 3-(pyridin-2-
yl)benzoate (45 mg, 0.2 mmol, 1.0 equiv.) and 187 
following Method V and Method VII respectively. 1H 
NMR (500 MHz, CDCl3): δ 8.62 (d, J = 4.6, 1H), 8.12 (d, J = 1.7 Hz, 1H), 8.04 (dd, J 
= 8.0, 1.9 Hz, 1H), 7.77 (td, J = 7.7, 1.7 Hz, 1H), 7.49 (dt, J = 7.8, 0.9 Hz, 1H), 7.32 
(d, J = 7.9 Hz, 1H), 7.29-7.23 (m, 1H), 4.38 (q, J = 7.2 Hz, 2H), 3.96 (s, 2H), 2.22 (d, 
J = 7.0 Hz, 2H), 1.77-1.65 (m, 1H), 1.64-1.57 (m, 3H), 1.56-1.48 (m, 2H), 1.38 (t, J = 
7.2 Hz, 3H), 1.26-1.15 (m, 2H), 1.13-1.05 (m, 1H), 0.86-0.74 (m, 2H); 13C NMR (125 
MHz, CDCl3): δ 207.1 (e), 166.2 (e), 158.7 (e), 148.7 (o), 140.3 (e), 138.2 (e), 136.8 
(o), 131.9 (o), 130.9 (o), 129.4 (e), 129.4 (o), 124.0 (o), 122.1 (o), 70.0 (e), 50.0 (e), 
48.3 (e), 33.6 (o), 33.0 (e, 2C), 26.1 (e), 26.0 (e, 2C), 14.3 (o); IR (neat): ν = 2921 (s), 
2850 (m), 1714 (vs), 1610 (m), 1587 (m), 1563 (w), 1472 (w), 1447 (w), 1427 (w), 
1410 (w), 1366 (w), 1296 (m), 1274 (m), 1242 (vs), 1171 (w), 1108 (s), 1043 (m), 
1020 (w), 992 (w), 916 (m), 793 (w), 752 (s), 731 (m), 645 (w); HRMS (CI (CH4)) 
calcd for (C23H27NO3 + H): 366.2064; found: 366.2068. 
 
Compound 235. This compound was obtained as an amorphous yellowish solid (52 
mg, 78%) from 1-(pyridin-2-yl)-1H-indole (39 mg, 0.2 mmol, 
1.0 equiv.) and 187 following Method V. 1H NMR (500 MHz, 
CDCl3): δ 8.58-8.53 (m, 1H), 7.89 (td, J = 7.7, 2.0 Hz, 1H), 
7.65-7.60 (m, 1H), 7.56-7.52 (m, 1H), 7.46-7.41 (m, 1H), 7.27 (ddd, J = 7.4, 4.9, 1.0 
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Hz, 1H), 7.21-7.15 (m, 2H), 6.56 (s, 1H), 4.01 (s, 2H), 2.29 (d, J = 6.8 Hz, 2H), 1.80-
1.69 (m, 1H), 1.68-1.59 (m, 3H), 1.59-1.51 (m, 2H), 1.30-1.17 (m, 2H), 1.15-1.04 (m, 
1H), 0.87-0.77 (m, 2H); 13C NMR (125 MHz, CDCl3): δ 206.4 (e), 151.1 (e), 149.1 
(o), 138.3 (o), 136.8 (e), 133.9 (e), 128.5 (e), 122.2 (o), 121.7 (o), 120.9 (o), 120.4 (o), 
120.2 (o), 110.2 (o), 105.7 (o), 49.4 (e), 42.9 (e), 33.5 (o), 33.0 (e, 2C), 26.1 (e), 26.0 
(e, 2C); IR (neat): ν = 2933 (m), 2915 (s), 1842 (m), 1724 (s), 1580 (m), 1561 (m), 
1470 (vs), 1459 (s), 1436 (vs), 1406 (m), 1392 (w), 1371 (m), 1349 (m), 1330 (m), 
1313 (m), 1279 (w), 1220 (m), 1192 (w), 1152 (w), 1099 (w), 1048 (m), 1021 (w), 989 
(w), 969 (w), 929 (w), 887 (w), 855 (w), 805 (m), 780 (s), 743 (vs), 727 (s), 658 (w); 
HRMS (CI (CH4)) calcd for (C22H24N2O + H): 333.1961; found: 333.1963. 
 
Compound 236. This compound was obtained as a yellowish oil (34 mg, 75%) from 
2-(1H-pyrrol-1-yl)pyridine (29 mg, 0.2 mmol, 1.0 equiv.) and 188 
following Method V. 1H NMR (500 MHz, CDCl3): δ 8.36-8.32 (m, 1H), 
7.77-7.72 (m, 1H), 7.33-7.29 (m, 1H), 7.12 (ddd, J = 7.4, 4.9, 0.9 Hz, 
1H), 7.08 (dd, J = 3.1, 1.8 Hz, 1H), 6.29 (t, J = 3.2 Hz, 1H), 6.19-6.15 (m, 1H), 4.05 
(s, 2H), 2.74 (sept, J = 6.9 Hz, 1H), 1.05 (d, J = 6.9 Hz, 6H); 13C NMR (125 MHz, 
CDCl3): δ 211.5 (e), 152.6 (e), 147.8 (o), 138.6 (o), 127.1 (e), 120.6 (o), 120.3 (o), 
115.4 (o), 112.7 (o), 109.8 (o), 40.9 (e), 39.5 (o), 18.3 (o, 2C); IR (neat): ν = 2970 (m), 
2932 (w), 1709 (s), 1590 (s), 1477 (vs), 1441 (vs), 1381 (m), 1334 (s), 1285 (w), 1255 
(w), 1234 (w), 1205 (w), 1179 (w), 1154 (m), 1115 (w), 1095 (w), 1043 (m), 998 (w), 
912 (w), 877 (w), 784 (s), 707 (vs), 654 (w); HRMS (CI (CH4)) calcd for (C14H16N2O 
+ H): 229.1335; found: 229.1341. 
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Compound 237. This compound was obtained as a yellowish oil (28 mg, 56%) from 
2-(1H-pyrrol-1-yl)pyridine (29 mg, 0.2 mmol, 1.0 equiv.) and 208 
following Method V. 1H NMR (500 MHz, CDCl3): δ 8.14-8.11 (m, 
1H), 7.75-7.69 (m, 1H), 7.57-7.53 (m, 1H), 7.32 (d, J = 8.4 Hz, 1H), 
7.13-7.08 (m, 2H), 7.07-7.04 (m, 1H), 6.52-6.48 (m, 1H), 6.30 (t, J = 
3.3 Hz, 1H), 6.26-6.22 (m, 1H), 4.48 (s, 2H); 13C NMR (125 MHz, CDCl3): δ 186.0 
(e), 152.6 (e), 152.5 (e), 147.9 (o), 145.9 (o), 138.5 (o), 126.0 (e), 120.6 (o), 120.4 (o), 
116.8 (o), 115.3 (o), 113.1 (o), 112.0 (o), 109.9 (o), 38.5 (e); IR (neat): ν = 3127 (w), 
2904 (w), 1677 (s), 1589 (s), 1570 (m), 1474 (vs), 1441 (vs), 1390 (m), 1333 (s), 1287 
(w), 1258 (m), 1237 (m), 1202 (w), 1158 (m), 1112 (w), 1095 (w), 1083 (w), 1025 
(m), 994 (m), 984 (m), 913 (m), 900 (m), 882 (m), 822 (w), 782 (s), 738 (m), 710 (m), 
682 (m), 663 (w), 609 (w); HRMS (CI (CH4)) calcd for (C15H12N2O2 + H): 253.0972; 
found: 253.0977. 
 
Compound 238. This compound was obtained as an orange amorphous solid (23 mg, 
32%) from 2-(1H-pyrrol-1-yl)pyridine (29 mg, 0.2 mmol, 1.0 
equiv.) and 208 following Method V. 1H NMR (500 MHz, 
CDCl3): δ 8.47-8.42 (m, 1H), 7.75 (td, J = 7.7, 1.9 Hz, 1H), 7.52-
7.49 (m, 2H), 7.31 (d, J = 7.9 Hz, 1H), 7.23 (ddd, J = 7.5, 4.9, 
1.0 Hz, 1H), 7.03 (d, J = 3.6 Hz, 2H), 6.46 (dd, J = 3.5, 1.7 Hz, 
2H), 6.17 (s, 2H), 4.07 (s, 4H); 13C NMR (125 MHz, CDCl3): δ 185.2 (e, 2C), 151.9 
(e), 151.1 (e, 2C), 149.2 (o), 146.3 (o, 2C), 138.2 (o), 126.1 (e, 2C), 122.8 (o), 122.5 
(o), 117.7 (o, 2C), 112.2 (o, 2C), 110.2 (o, 2C), 37.3 (e, 2C); IR (neat): ν = 3122 (w), 
2922 (w), 1672 (vs), 1661 (vs), 1588 (m), 1567 (m), 1503 (w), 1465 (vs), 1442 (s), 
1419 (m), 1388 (s), 1326 (m), 1300 (m), 1290 (m), 1255 (m), 1234 (w), 1220 (w), 
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1156 (w), 1082 (w), 1052 (w), 1039 (w), 1015 (w), 990 (s), 909 (m), 881 (m), 844 (w), 
818 (w), 780 (s), 770 (s), 750 (vs), 728 (s), 707 (m), 684 (w), 664 (m), 655 (m), 642 
(m), 616 (m); HRMS (CI (CH4)) calcd for (C21H16N2O4 + H): 361.1183; found: 
361.1182. 
  
Compound 239. This compound was obtained as an amorphous brown solid (38 mg, 
63%) from 2-(furan-3-yl)pyridine (29 mg, 0.2 mmol, 1.0 equiv.) and 
189 following Method V. 1H NMR (500 MHz, CDCl3): δ 8.50 (ddd, 
J = 4.8, 1.8, 0.9 Hz, 1H), 7.64 (td, J = 7.8, 1.9 Hz, 1H), 7.43-7.38 
(m, 2H), 7.27-7.21 (m, 2H), 7.18 (tt, J = 6.4, 1.4 Hz, 1H), 7.09 (ddd, J = 7.5, 4.8, 1.1 
Hz, 1H), 7.04-6.99 (m, 2H), 6.75 (d, J = 2.0 Hz, 1H), 4.46 (s, 2H), 2.53 (ddd, J = 9.0, 
6.5, 4.1 Hz, 1H), 2.36 (ddd, J = 8.1, 5.3, 4.1 Hz, 1H), 1.71 (ddd, J = 9.3, 5.3, 4.2 Hz, 
1H), 1.32 (ddd, J = 8.1, 6.6, 4.2 Hz, 1H); 13C NMR (125 MHz, CDCl3): δ 204.6 (e), 
152.4 (e), 149.2 (o), 147.9 (e), 141.9 (o), 140.3 (e), 136.4 (o), 128.3 (o, 2C), 126.3 (o), 
126.2 (o, 2C), 122.3 (e), 121.1 (o), 120.6 (o), 109.8 (o), 43.4 (e), 31.4 (o), 29.4 (o), 
18.9 (e); IR (neat): ν = 3027 (w), 2981 (w), 1698 (vs), 1612 (s), 1584 (s), 1558 (m), 
1515 (m), 1496 (w), 1482 (m), 1428 (s), 1396 (s), 3141 (s), 1235 (m), 1180 (m), 1144 
(m), 1085 (m), 1071 (m), 997 (m), 979 (m), 934 (w), 910 (m), 893 (m), 788 (s), 740 
(vs), 696 (vs), 674 (m); HRMS (CI (CH4)) calcd for (C20H17NO + H): 304.1332; found: 
304.1335. 
 
Compound 240. This compound was obtained as an amorphous yellowish solid (28 
mg, 45%) from 2H-(1,2'-bipyridin)-2-one (34 mg, 0.2 mmol, 1.0 
equiv.) and 187 following Method V with stirring at 90 °C. 1H 
NMR (500 MHz, CDCl3): δ 8.62-8.55 (m, 1H), 7.82 (td, J = 7.6, 
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2.0 Hz, 1H), 7.93-7.33 (m, 3H), 6.58 (dd, J = 9.2, 0.8 Hz, 1H), 6.08 (d, J = 7.0 Hz, 
1H), 3.49 (s, 2H), 1.96 (d, J = 6.7 Hz, 2H), 1.64-1.49 (m, 4H), 1.44-1.37 (m, 2H), 1.22-
1.11 (m, 2H), 1.10-1.00 (m, 1H), 0.80-0.68 (m, 2H); 13C NMR (125 MHz, CDCl3): δ 
204.2 (e), 163.5 (e), 151.5 (e), 149.3 (o), 142.3 (e), 139.8 (o), 138.3 (o), 125.1 (o), 
124.0 (o), 120.1 (o), 108.4 (o), 49.8 (e), 47.9 (e), 33.5 (o), 32.9 (e, 2C), 26.0 (e), 25.9 
(e, 2C); IR (neat): ν = 3048 (w), 2918 (m), 2850 (m), 1714 (m), 1657 (vs), 1582 (vs), 
1514 (vs), 1468 (m), 1434 (m), 1420 (m), 1393 (m), 1357 (w), 1273 (w), 1245 (w), 
1146 (m), 1094 (w), 1083 (w), 1057 (w), 990 (m), 966 (w), 935 (w), 917 (m), 784 (s), 
746 (s), 732 (s), 685 (w), 623 (w); HRMS (CI (CH4)) calcd for (C19H22N2O2 + H): 
311.1754; found: 317.1754. 
 
6.4.3 Scope of directing groups 
6.4.3.1 Quinolines 
Compound 242a. This compound was obtained as an colourless paste (53 mg, 77%) 
from 2-phenylquinoline (41 mg, 0.2 mmol, 1.0 equiv.) and 187 
following Method VII. 1H NMR (500 MHz, CDCl3): δ 8.22 (d, J = 
8.3 Hz, 1H), 8.09 (d, J = 8.5 Hz, 1H), 7.85 (dd, J = 8.2, 1.2 Hz, 1H), 
7.74 (ddd, J = 8.6, 6.9, 1.4 Hz, 1H), 7.60-7.52 (m, 3H), 7.44-7.39 (m, 
2H), 7.32-7.27 (m, 1H), 4.01 (s, 2H), 2.20 (d, J = 6.8 Hz, 2H), 1.68-1.58 (m, 1H), 1.56-
1.46 (m, 3H), 1.45-1.38 (m, 2H), 1.13-0.95 (m, 3H), 0.75-0.65 (m, 2H); 13C NMR (125 
MHz, CDCl3): δ 208.1 (o), 159.7 (o), 147.5 (o), 140.7 (o), 136.7 (e), 133.4 (o), 131.8 
(o), 130.0 (o), 129.7 (o), 129.2 (o), 128.7 (o), 127.5 (o), 127.3 (o), 126.7 (e), 126.5 (o), 
122.2 (o), 49.9 (e), 48.4 (e), 33.6 (o), 33.0 (e, 2C), 26.1 (e), 25.9 (e, 2C); IR (neat): ν 
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= 3059 (w), 2921 (s), 2849 (w), 1710 (s), 1618 (w), 1596 (m), 1556 (w), 1504 (w), 
1488 (w), 1446 (m), 1423 (m), 1405 (w), 1373 (w), 1353 (m), 1312 (m), 1282 (m), 
1266 (w), 1243 (w), 1212 (w), 1181 (w), 1141 (w), 1123 (w), 1101 (w), 1045 (m), 
1035 (m), 908 (s), 833 (s), 763 (vs), 729 (vs), 687 (m), 646 (m), 622 (m); HRMS (CI 
(CH4)) calcd for (C24H25NO + H): 344.2009; found: 344.2006. 
 
Compound 242b. This compound was obtained as an colourless paste (52 mg, 95%) 
from 2-phenylquinoline (41 mg, 0.2 mmol, 1.0 equiv.) and 214 
following Method VII. 1H NMR (500 MHz, CDCl3): δ 8.24 (d, J = 8.3 
Hz, 1H), 8.09 (d, J = 7.0 Hz, 1H), 7.85 (d, J = 8.1 Hz, 1H), 7.74 (ddd, J 
= 8.3, 6.7, 1.5 Hz, 1H), 7.64-7.59 (m, 2H), 7.56 (ddd, J = 8.4, 6.9, 1.0 
Hz, 1H), 7.46-7.41 (m, 2H), 7.36-7.31 (m, 1H), 3.97 (s, 2H), 2.12 (s, 3H); 13C NMR 
(125 MHz, CDCl3): δ 206.6 (e), 159.3 (e), 147.4 (e), 140.3 (e), 136.7 (o), 133.6 (e), 
131.9 (o), 130.1 (o), 129.7 (o), 129.2 (o), 128.8 (o), 127.5 (o), 127.4 (o), 126.6 (e), 
126.5 (o), 121.8 (o), 49.0 (e), 29.7 (o); IR (neat): ν = 3058 (w), 2891 (w), 1705 (vs), 
1617 (m), 1596 (s), 1556 (m), 1504 (m), 1487 (m), 1471 (w), 1442 (m), 1423 (m), 
1352 (m), 1313 (m), 1266 (w), 1242 (w), 1216 (m), 1159 (m),1127 (w), 1037 (m), 
1012 (w), 978 (w), 942 (w), 834 (s), 792 (w), 765 (vs), 732 (s), 680 (m), 636 (w), 621 
(w); HRMS (CI (CH4)) calcd for (C18H15NO + H): 262.1226; found: 262.1226. 
 
Compound 242c. This compound was obtained as an colourless paste (69 mg, quant.) 
from 2-phenylquinoline (41 mg, 0.2 mmol, 1.0 equiv.) and 64 
following Method V. 1H NMR (500 MHz, CDCl3): δ 8.18 (d, J = 
8.9 Hz, 1H), 7.92-7.87 (m, 2H), 7.78 (d, J = 8.2 Hz, 1H), 7.68 (br 
s, 1H), 7.64-7.59 (m, 2H), 7.56 (t, J = 7.4 Hz, 1H), 7.51-7.42 (m, 
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4H), 7.41-7.33 (m, 3H), 4.62 (s, 2H); 13C NMR (125 MHz, CDCl3): δ 197.8 (e), 159.4 
(e), 147.3 (e), 140.1 (e), 137.0 (e), 136.6 (o), 133.6 (e), 132.7 (o), 132.1 (o), 130.1 (o), 
129.4 (o), 129.3 (o), 128.7 (o), 128.4 (o, 2C), 128.3 (o, 2C), 127.3 (o), 127.3 (o), 126.6 
(e), 126.3 (o), 122.0 (o), 43.5 (e); IR (neat): ν = 3057 (w), 2889 (w), 1685 (vs), 1616 
(w), 1593 (m), 1579 (m), 1553 (m), 1504 (m), 1488 (m), 1445 (m), 1419 (m), 1335 
(m), 1312 (m), 1216 (m), 1199 (w), 1180 (w), 1152 (w), 1112 (w), 1077 (w), 1035 
(m), 997 (m), 955 (w), 944 (w), 909 (w), 889 (w), 845 (s), 793 (w), 774 (vs), 761 (s), 
750 (vs), 730 (s), 688 (vs), 661 (s), 621 (m); HRMS (CI (CH4)) calcd for (C23H17NO 
+ H): 324.1383; found: 324.1381. 
 
6.4.3.2 N-methoxybenzamide 
Method VIII: Representative example for the synthesis of 244a. 
[Cp*Rh(OAc)2•H2O] (6 mg, 0.016 mmol, 0.08 equiv) and HFIP (1 mL) were added 
under nitrogen to a flame-dried Schlenk tube sealable by a J-young key. Then, N-
methoxybenzamide (30 mg, 0.2 mmol, 1 equiv), 187 (86 mg, 0.4 mmol, 2 equiv) and 
HFIP (0.5 mL) were sequentially added in that order. The tube was sealed and the 
mixture was stirred at 90 °C for 17 hours. After cooling to room temperature, all 
volatiles were removed under reduced pressure. Purification by flash chromatography 
(PE:EtOAc/8:2) afforded 244a as a beige amorphous solid (32 mg, 59%).  
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Compound 244a. This compound was obtained as a beige amorphous solid (32 mg, 
59%) from N-methoxybenzamide (30 mg, 0.2 mmol) and 187 
following Method VIII. 1H NMR (500 MHz, CDCl3): δ  8.39 (d, 
J = 8.3 Hz, 1H), 7.64-7.57 (m, 1H), 7.47-7.37 (m, 2H), 6.22 (s, 1H), 4.07 (s, 3H), 2.57 
(d, J = 6.6 Hz, 2H), 1.84-1.61 (m, 6H), 1.30-1.12 (m, 3H), 1.06-0.94 (m, 2H); 13C 
NMR (125 MHz, CDCl3): δ 159.0 (e), 141.6 (e), 135.9 (e), 132.2 (o), 127.5 (o), 125.8 
(e), 125.8 (o), 125.4 (o), 104.8 (o), 63.7 (o), 39.0 (e), 36.7 (o), 33.2 (e, 2C), 26.3 (e), 
26.1 (e, 2C); IR (neat): ν = 2919 (s), 2849 (m), 1654 (vs), 1621 (vs), 1598 (vs), 1556 
(m), 1483 (m), 1469 (w), 1446 (m), 1422 (w), 1398 (m), 1336 (m), 1301 (w), 1258 
(m), 1237 (w), 1206 (w), 1171 (m), 1148 (w), 1061 (w), 974 (s), 942 (w), 913 (w), 901 
(m), 875 (m), 820 (s), 788 (w), 751 (s), 700 (w), 684 (s), 634 (m), 614 (m); HRMS (CI 
(NH3)) calcd for (C17H21NO2 + H): 272.1645; found: 272.1640. 
 
Compound 244b. This compound was obtained as a beige amorphous solid (30 mg, 
57%) from N-methoxybenzamide (30 mg, 0.2 mmol) and 64 following 
Method VIII. 1H NMR (500 MHz, CDCl3): δ 8.47 (d, J = 8.0 Hz, 1H), 
7.68-7.61 (m, 3H), 7.54 (d, J = 7.9 Hz, 1H), 7.52-7.44 (m, 4H), 6.48 (s, 1H), 3.70 (s, 
3H); 13C NMR (125 MHz, CDCl3): δ 158.7 (e), 142.1 (e), 135.8 (e), 132.6 (e), 132.4 
(o), 129.3 (o, 2C), 129.2 (o), 128.2 (o, 2C), 127.8 (o), 126.6 (o), 126.3 (e), 126.2 (o), 
106.7 (o), 63.4 (o), the NMR data is in accordance with that reported in the 
literature.122  
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Compound 245. This compound was obtained along with 244b as a beige amorphous 
solid (11 mg, 25%) from N-,ethoxybenzamide (30 mg, 0.2 mmol) and 
64 following Method VIII. 1H NMR (500 MHz, CDCl3): δ 8.32 (d, J 
= 8.2 Hz, 1H), 7.91-7.87 (m, 2H), 7.72 (td, J = 7.7, 1.6 Hz, 1H), 7.53-7.41 (m , 5H), 
6.96 (s, 1H); 13C NMR (125 MHz, CDCl3): δ 162.4 (e), 153.7 (e), 137.6 (e), 134.9 (o), 
132.0 (e), 130.0 (o), 129.7 (o), 128.9 (o, 3C), 128.2 (o), 126.0 (o), 125.3 (o), 120.6 (e), 
101.8 (o), the NMR data is in accordance with that reported in the literature.123  
 
6.4.3.3 O-methyl oxime 
Compound 248. [Cp*Rh(MeCN)3(SbF6)2] (13 mg, 0.016 mmol, 0.08 equiv) and HFIP 
(1 mL) were added under nitrogen to a flame-dried Schlenk tube 
sealable by a J-young key. Then, (E)-acetophenone O-methyloxyme 
(30 mg, 0.2 mmol, 1 equiv), NaOAc (16 mg, 1 mmol, 1 equiv), 64 (78 
mg, 0.4 mmol, 2 equiv) and HFIP (0.5 mL) were sequentially added in that order. The 
tube was sealed and the mixture was stirred at 90 °C for 17 hours. After cooling to 
room temperature, all volatiles were removed under reduced pressure. Purification by 
flash chromatography (PE:EtOAc/95:5 to 9:1) afforded 248 as a white amorphous 
solide (37 mg, 69%).  1H NMR (500 MHz, CDCl3): δ 8.08 (m, 2H), 7.57 (tt, J = 6.7, 
1.3 Hz, 1H), 7.51-7.45 (m, 2H), 7.38-7.30 (m, 3H), 7.27-7.22 (m, 1H), 4.53 (s, 2H), 
3.60 (s, 3H), 2.16 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 197.5 (e), 155.9 (e), 137.0 
(e), 137.0 (e), 132.9 (o), 132.8 (e), 131.9 (o), 128.5 (o, 2C), 128.4 (o), 128.4 (o), 128.2 
(o, 2C), 127.1 (o), 61.4 (o), 44.1 (e), 15.5 (o); IR (neat): ν = 3056 (w), 2956 (w), 2897 
(w), 2816 (w), 1681 (vs), 1616 (w), 1597 (w), 1578 (w), 1494 (w), 1449 (m), 1425 
(w), 1408 (m), 1364 (w), 1339 (m), 1310 (w), 1301 (w), 1220 (s), 1199 (m), 1183 (m), 
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1158 (w), 1077 (w), 1040 (vs), 999 (s), 954 (m), 889 (s), 876 (s), 848 (w), 762 (vs), 
727 (m), 695 (s), 666 (s), 637 (m); HRMS (CI (CH4)) calcd for (C17H17NO2 + H): 
268.1332; found: 268.1339. 
 
Compound 248’. This compound was obtained along with 248 as a white amorphous 
solid (11 mg, 21%). 1H NMR (500 MHz, CDCl3): δ 8.03-7.97 (m, 2H), 
7.57 (tt, J = 6.9, 1.3 Hz, 1H), 7.47 (t, J = 8.0 Hz, 2H), 7.36-7.30 (m, 2H), 
7.28-7.23 (m, 1H), 7.16-7.11 (m, 1H), 4.23 (s, 2H), 3.70 (s, 3H), 2.14 (s, 
3H); 13C NMR (125 MHz, CDCl3): δ 197.3 (e), 155.4 (e), 136.9 (e), 136.4 (e), 133.1 
(o), 131.8 (e), 130.6 (o), 128.6 (o, 2C), 128.5 (o), 128.3 (o, 2C), 127.1 (o), 126.3 (o), 
61.5 (o), 43.2 (e), 22.2 (o); IR (neat): ν = 2934 (m), 1687 (vs), 1587 (w), 1580 (w), 
1493 (w), 1447 (m), 1372 (w), 1333 (m), 1274 (w), 1216 (m), 1127 (w), 1082 (m), 
1051 (vs), 1040 (vs), 1009 (m), 894 (s), 757 (s), 732 (m), 719 (w), 69 (s), 663 (m); 
HRMS (CI (CH4)) calcd for (C17H17NO2 + H): 240.1332; found: 268.1339. 
 
6.5 Further functionalisation 
Method IX: Representative example for the synthesis of 281a. 
Compound 242a (34 mg, 0.1 mmol, 1.0 equiv) was added to a Schlenck tube followed 
by i-PrOH (0.5 mL), [Cp*IrCl2]2 (3.2 mg, 0.004 mmol, 0.04 equiv) and water (24 μL) 
in that order. The tube was sealed and the mixture was stirred at 90 °C overnight. Then, 
the mixture was allowed to cool to room temperature, diluted with DCM and saturated 
NaHCO3 was added. The aqueous layer was extracted with DCM. The combined 
organic layers were washed with water, brine, then dried over Na2SO4, filtered and 
concentrated under reduced pressure. After solubilising the residue in a minimum of 
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DCM, some SiO2 was added and all volatiles removed under reduced pressure, the 
residue was loaded on a short silica gel column and purified by flash chromatography 
(PE:EtOAc/98:2 to 95:5). A mixture of 281a and the corresponding 7,12-
dihydrobenzo[c]acridine was recovered which was converted to 281a upon storing 
under air overnight (20 mg, 63%). 
 
Compound 281a. This compound was obtained as yellow solid (20 mg, 63%) from 
242a following Method IX. m.p.: 136-140 °C. 1H NMR (500 
MHz, CDCl3): δ 9.49 (br s, 1H), 8.82 (s, 1H), 8.39 (br s, 1H), 
8.09 (d, J = 8.3 Hz, 1H), 7.88-7.77 (m, 2H), 7.75-7.67 (m, 2H), 
7.62 (t, J = 7.6 Hz, 1H), 7.49 (s, 1H), 3.05 (d, J = 6.7 Hz, 2H), 1.90-1.62 (m, 6H), 1.30-
1.07 (m, 5H); 13C NMR (125 MHz, CDCl3): δ 148.2 (e), 147.0 (e), 134.3 (e), 133.7 
(e), 131.7 (o), 130.9 (e), 129.5 (o), 129.5 (o), 129.0 (o), 128.1 (o), 127.2 (o), 127.2 (o), 
126.6 (e), 126.4 (o), 125.7 (o), 125.3 (o), 125.1 (e), 41.0 (e), 38.2 (o), 33.7 (e, 2C), 
26.5 (e), 26.2 (e, 2C); IR (neat): ν = 3051 (w), 2918 (m), 2844 (m), 1628 (w), 1614 
(w), 1583 (w), 1567 (w), 1536 (w), 1488 (m), 1449 (m), 1407 (w), 1378 (w), 1362 (w), 
1348 (w), 1335 (w), 1307 (w), 1259 (w), 1223 (w), 1186 (w), 1131 (w), 1057 (w), 
1031 (w), 1006 (w), 951 (m), 901 (s), 864 (m), 851 (m), 810 (w), 790 (w), 769 (w), 
749 (vs), 691 (m), 653 (m), 625 (s); HRMS (CI (CH4)) calcd for (C24H23N + H): 
326.1903; found: 326.1895. 
 
Compound 281b. This compound was obtained as yellow solid (19 mg, 49%) from 
242b (44 mg, 0.17 mmol, 1.0 equiv.) following Method IX. m.p.: 
107-109 °C. 1H NMR (500 MHz, CDCl3): δ 9.50-9.44 (m, 1H), 8.72 
(s, 1H), 8.38 (d, J = 8.7 Hz, 1H), 8.03 (d, J = 8.3 Hz, 1H), 7.86-7.80 
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(m, 1H), 7.78-7.73 (m, 1H), 7.73-7.66 (m, 2H), 7.62-7.57 (m, 1H), 7.49 (s, 1H), 2.75 
(d, J = 1.2 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 147.9 (e), 147.2 (e), 133.9 (e), 
131.6 (o), 131.5 (e), 130.9 (e), 129.6 (o, 2C), 129.0 (o), 128.0 (o), 127.1 (o), 126.8 (o), 
126.7 (e), 126.5 (o), 125.8 (o), 125.7 (e), 125.2 (o), 19.4 (o); IR (neat): ν = 2970 (m), 
2922 (m), 1929 (w), 1829 (w), 1630 (w), 1613 (w), 1582 (w), 1565 (w), 1536 (w), 
1487 (m), 1437 (w), 1407 (w), 1369 (m), 1306 (m), 1276 (w), 1221 (w), 1188 (w), 
1152 (w), 1135 (w), 1076 (m), 1028 (m), 973 (w), 960 (w), 949 (w), 901 (m), 880 (m), 
854 (m), 806 (w), 790 (w), 768 (m), 748 (vs), 709 (m), 667 (w), 643 (w), 610 (w); 
HRMS (CI (CH4)) calcd for (C18H13N + H): 244.1121; found: 244.1127. 
 
Compound 281c. This compound was obtained as yellow solid (26 mg, 55%) from 
242c (50 mg, 0.16 mmol, 1.0 equiv.) following Method IX, the 
mixture was stored under air 48 h. m.p.: 166-170 °C. 1H NMR (500 
MHz, CDCl3): δ 9.56 (d, J = 7.9 Hz, 1H), 8.69 (s, 1H), 8.40 (d, J = 
8.7 Hz, 1H), 7.92 (d, J = 8.2 Hz, 1H), 7.90-7.86 (m, 1H), 7.85-7.73 
(m, 3H), 7.67 (s, 1H), 7.65-7.51 (m, 6H); 13C NMR (125 MHz, CDCl3): δ 147.8 (e), 
147.3 (e), 139.8 (e), 137.8 (e), 134.0 (o), 133.4 (e), 131.2 (e), 130.0 (o, 2C), 129.9 (o), 
129.5 (o), 129.2 (o), 128.6 (o, 2C), 128.2 (o), 128.0 (o), 127.8 (o), 127.7 (o), 127.2 (o), 
126.7 (e), 125.8 (o), 125.3 (o), 124.7 (e); IR (neat): ν = 3055 (w), 3027 (w), 2955 (w), 
2921 (w), 1953 (w), 1607 (w), 1598 (w), 1564 (w), 1534 (m), 1486 (w), 1440 (m), 
1407 (m), 1374 (m), 1308 (m), 1241 (w), 1221 (w), 1208 (w), 1174 (w), 1159 (w), 
1125 (w), 1107 (w), 1070 (m), 1029 (w), 1016 (w), 981 (w), 966 (w), 952 (w), 932 
(w), 908 (w), 889 (s), 867 (w), 840 (m), 811 (w), 778 (m), 766 (s), 751 (vs), 715 (s), 
698 (vs), 674 (s), 641 (s), 611 (m); HRMS (CI (CH4)) calcd for (C23H15N + H): 
306.1277; found: 306.1273. 
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6.6 Mechanistic sutdy 
6.6.1 Synthesis of monodeuterated phenyl pyridine 
 
 
Compound 304. A flame dried schlenk was charged with Pd(OAc)2 (72 mg, 0.3 mmol, 
0.2 equiv.), dry acetonitrile (10 mL), 128 (0.3 mL, 1.8 mmol, 1.0 equiv.) and N-
bromosuccinimide (0.3 g, 1.9 mmol, 1.1 equiv.). The tube was sealed and the mixture 
was stirred at 100 °C for 48 h. All volatiles were removed in vacuo and the crude 
mixture was purified by flash chromatography (PE:EtOAc/9:1 to 85:15) to give 304 
as a colourless oil (0.15 g, 36%). 1H NMR (500 MHz, CDCl3): δ 8.74-8.69 (m, 1H), 
7.77 (td, J = 7.7, 1.8 Hz, 1H), 7.68 (dd, J = 8.1, 1.1 Hz, 1H), 7.60 (dt, J = 7.9, 1.1 Hz, 
1H), 7.54 (dd, J = 7.7, 1.8 Hz, 1H), 7.41 (td, J = 7.5-1.2 Hz, 1H), 7.30 (ddd, J = 7.5, 
4.9, 1.1 Hz, 1H), 7.28-7.23 (m, 1H), the NMR data is in accordance with that reported 
in the literature.124  
 
Compound d-128. A flame dried schlenk was charged with 304 (147 mg, 0.6 mmol, 
1.0 equiv.) in diethyl ether (6 mL). The mixture was cooled down to  ̶ 40 °C and nBuLi 
(0.8 mL, 1.6 M in hexanes, 1.3 mmol, 2.0 equiv.) was added dropwise. The mixture 
was further stirred 1 h at   ̶ 40 °C. Then D2O (0.21 mL, 10.5 mmol, 17.5 equiv.) was 
added at    ̶ 40 °C and the mixture was stirred another 30 min. Ethyl acetate and brine 
were added, the aqueous layer was extracted with more EtOAc. The gathered organic 
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layer was washed with water/brine, dried over MgSO4 and evaporated. Flash 
chromatography (PE:EtOAc/8:2) afforded d-128 as a colourless oil (54 mg, 55%). 1H 
NMR (500 MHz, CDCl3): δ 8.72-8.69 (m, 1H), 8.01-7.97 (m, 1H), 7.78-7.71 (m, 2H), 
7.51-7.46 (m, 2H), 7.45-7.40 (m, 1H), 7.25-7.21 (m, 1H), the NMR data is in 
accordance with that reported in the literature. 124 
 
6.6.2 Reversibility of Csp2–H cleavage 
 
 
A flame dried Schlenk tube, sealable with a J-Young key, was charged with AgSbF6 
(6.9 mg, 0.01 mmol, 0.1 equiv.) in an argon-filled glovebox. The tube was taken out 
and [Cp*RhCl2]2 (2.5 mg, 0.002 mmol, 0.02 equiv.) was added, followed by 1,2-DCB 
(0.38 mL). Then, 128 (14 μL, 0.1 mmol, 1.0 equiv.), NaOAc (8 mg, 0.1 mmol, 1.0 
equiv.), 187 (37 mg, 0.17 mmol, 1.7 equiv.) and d-HFIP (0.38 mL) were sequentially 
added in that order. The vial was sealed and the mixture was stirred at 60 °C for 17 h. 
After cooling to room temperature, all volatiles were removed in vacuo. Purification 
by flash chromatography (PE/EtOAc:9/1 to 8/2) afforded d-128 as a colourless oil (9 
mg, 58%) and d-229 as a colourless oil (8 mg, 27%). 
 
d-128: 1H NMR (500 MHz, CDCl3): δ 8.73-8.68 (m, 1H), 8.01-7.97 (m, 0.7H), 7.78-
7.71 (m, 2H), 7.51-7.46 (m, 2H), 7.45-7.40 (m, 1H), 7.25-7.21 (m, 1H). 
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d-229a: 
1H NMR (500 MHz, CDCl3): δ 8.69-8.55 (m, 1H), 7.80-7.69 (m, 1H), 7.48-
7.41 (m, 1.27H), 7.40-7.31 (m, 2H), 7.27-7.19 (m, 2H), 3.94-3.80 (m, 0.95 H), 2.24-
2.14 (m, 1.18H), 1.77-1.48 (m, 8H), 1.34-1.02 (m, 5H), 0.87-0.73 (m, 2H).  
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6.6.3 Deuterium-labelling experiment 
 
 
A flame dried Schlenk tube, sealable with a J-Young key, was charged with AgSbF6 
(6.9 mg, 0.02 mmol, 0.1 equiv.) in an argon-filled glovebox. The tube was taken out 
and [Cp*RhCl2]2 (2.5 mg, 0.004 mmol, 0.02 equiv.) was added, followed by HFIP (1 
mL). Then, d-128 (29 μL, 0.2 mmol, 1.0 equiv.), NaOAc (16 mg, 0.2 mmol, 1.0 
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equiv.), 187 (73 mg, 0.34 mmol, 1.7 equiv.) and HFIP (0.5 mL) were sequentially 
added in that order. The vial was sealed and the mixture was stirred at 60 °C for 1 or 
2 h. After cooling to room temperature, all volatiles were removed in vacuo. 
Purification by flash chromatography (PE/EtOAc:9/1 to 8/2) afforded d-128 as a 
colourless oil (10 mg, 67% (on a 0.1 mmol scale); 9 mg, 35%) and 229a as a 
colourless oil (5 mg, 17% (on a 0.1 mmol scale); 9 mg, 49%). 
 
d-128: δ 8.73-8.68 (m, 1H), 8.01-7.97 (m, 1.55H), 7.78-7.71 (m, 2H), 7.51-7.46 (m, 
2H), 7.45-7.40 (m, 1H), 7.25-7.21 (m, 1H). 
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6.6.4 Kinetic isotope effect 
 
 
To a vial equipped with magnetic stirrer, under air atmosphere, was added AgSbF6 
(6.9 mg, 0.02 mmol, 0.1 equiv.), [Cp*RhCl2]2 (2.5 mg, 0.004 mmol, 0.02 equiv.) 
followed by 1,2-DCE (0.75 mL). Then, 128 (29 μL, 0.2 mmol, 1.0 equiv.), NaOAc (16 
mg, 0.2 mmol, 1.0 equiv.), 187 (73 mg, 0.34 mmol, 1.7 equiv.) and HFIP (0.75 mL) 
were sequentially added in that order. The vial was sealed and the mixture was stirred 
at 60 °C for 2 h. After cooling to room temperature, all volatiles were removed in 
vacuo, 1,3,5-trimethoxybenzene (35 mg, 0.2 mmol, 1.0 equiv.) was added and the 
conversion was determined by 1H NMR. 
 
 
 
To a vial equipped with magnetic stirrer, under air atmosphere, was added AgSbF6 
(3.4 mg, 0.01 mmol, 0.1 equiv.), [Cp*RhCl2]2 (1.3 mg, 0.002 mmol, 0.02 equiv.) 
followed by 1,2-DCE (0.38 mL). Then, 373 (14 μL, 0.1 mmol, 1.0 equiv.), NaOAc (8 
mg, 0.1 mmol, 1.0 equiv.), 429 (37 mg, 0.17 mmol, 1.7 equiv.) and d-HFIP (0.38 mL) 
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were sequentially added in that order. The vial was sealed and the mixture was stirred 
at 60 °C for 2 h. After cooling to room temperature, all volatiles were removed in 
vacuo. Purification by flash chromatography (PE/EtOAc: 9/1 to 8/2) afforded d-373 
as a colourless oil (13 mg, 87%) and d-472a as a colourless oil (2 mg, 7%). 
 
6.6.5 Normalised time scaled method 
 
 
 
Representative example for the reference reaction: To a V-shaped flask was added 
[Cp*Rh(OAc)2•H2O] (1 mg, 0.0027 mmol, 0.04 equiv.), 128 (9 µL, 0.067 mmol, 1 
equiv.), 187 (24 mg, 0.11 mmol, 1.7 equiv), mesitylene (9 µL, 0.067 mmol, 1 equiv.), 
d8-toluene (0.25 mL) and HFIP (0.25 mL). The solution was transferred into a NMR 
tube sealable with a J-Young key. The tube was sealed and put to react at 60 °C in the 
NMR machine.   
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